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ABSTRACT 
 
 
Despite substantial advances in orthopaedics, different types of bone lesions still remain 
clinically difficult to manage. The delivery of adequate cell types, such as mesenchymal stem 
cells (MSCs), and osteoinductive factors via biomaterial carriers represents a promising strategy 
to promote local tissue repair. Hydrogels show great potential as cell delivery vehicles, as they 
provide three-dimensional (3D) microenvironments that partially recapitulate the native 
extracellular-matrix (ECM). An optimal carrier should increase cell retention, survival and 
engraftment, provide a template for new tissue formation and, ideally, induce guided-
differentiation of transplanted cells.  
The main aim of this thesis was to develop injectable vehicles able to direct MSCs 
differentiation down the osteoblastic lineage, which represent a relevant strategy in the context 
of bone regeneration. A specific target was to better understand how MSCs behave in 3D and 
translate that knowledge into the design of improved MSCs carriers. 
The modulation of cell behaviour in 3D microenvironments is a challenging task, as it 
must take into account the influence of multiple parameters, as well as their interplay. These 
include not only matrix extrinsic factors, such as soluble and direct cell-cell contact signaling, 
but also several matrix-related factors, which must be carefully controlled as they differentially 
affect distinct cellular activities. This thesis specifically focused on the behavior of human bone 
marrow MSCs (hMSCs), which are currently recognized as a powerful cell source for bone 
tissue regeneration, when cultured under 3D conditions within alginate hydrogels, which are 
among the most common materials used for cell entrapment and delivery. 
The first study addressed the effect of the cell entrapping density on hMSCs response, 
which represents a critical and frequently overlooked parameter. Different cell densities were 
tested and in all conditions hMSCs presented steady-state levels of metabolic activity and 
remained in a nearly non-proliferating state. Yet, cells recovered “normal” activity levels after 
being retrieved from 3D matrices and re-cultured as 2D monolayers. A high cell density showed 
to be crucial for promoting the establishment of cell-cell contacts and consequent formation of 
multicellular clusters rich in endogenous ECM, and stimulated hMSCs osteogenic 
differentiation. The study clearly highlighted the importance of optimizing the initial cell density 
when establishing 3D cultures for specific applications. 
Envisaging the potential clinical interest of such aggregates, it was then investigated how 
their formation could be driven by specific matrix cues. The process of cell self-assembly 
involves mechanosensing mechanisms and depends on a balance between cell-matrix and cell-
cell signaling. Because the combined effect of these cues is still not fully clarified, particularly in 
3D, the behaviour of hMSCs cultured within hydrogels with tailored stiffness and composition 
was evaluated. As demonstrated, hMSCs aggregation only occurred in more compliant matrices 
(G’  120 Pa), both in the presence and absence of matrix-bound adhesion ligands ([RGD]: 0, 
100 and 200 µM). Fibronectin assembly stabilized cell-cell contacts within aggregates, even in 
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non-adhesive matrices. However, hMSCs were only able to substantially contract the artificial 
matrix when RGD was present. Moreover, compliant matrices facilitated cell proliferation and 
provided a permissive environment for hMSCs osteogenic differentiation, even without RGD. 
Cell interactions with the original artificial matrix became less important as time progressed, 
while the de novo produced ECM turned into a more critical determinant of cell fate. This study 
provided further insights into the mechanisms by which hMSCs sense their microenvironment to 
organize into tissues, and established a biomaterial-based strategy to promote the formation of 
ECM-MSCs microtissues in 3D. 
After demonstrating that both matrix-intrinsic and extrinsic factors affected hMSCs 
behaviour in 3D, the use of osteoinductive cues as a strategy to specifically guide their 
differentiation along the osteoblastic lineage was pursued. The idea was to design a 
multifunctional carrier system to be used for the co-delivery of hMSCs and osteoinductive 
peptides. The osteogenic growth peptide (OGP) inspired the design of two peptide sequences, 
where the bioactive fragment of OGP was either flanked by a protease-sensitive linker or by its 
scrambled sequence, to provide faster and slower release rates, respectively. These peptides 
were fully characterized and chemically grafted to alginate. The two OGP analogues released 
bioactive fragments in vitro, at different kinetics, which stimulated hMSCs proliferation and 
osteogenesis. hMSCs-laden OGP-alginate hydrogels were further tested at an ectopic site in a 
xenograft mouse model. After 4 weeks, OGP-alginate hydrogels were more degraded and 
colonized by new vascularized tissue than the control (without OGP). hMSCs produced 
endogenous ECM, migrated outward the hydrogels and proliferated to some extent. OGP 
groups stimulated hMSCs osteogenic differentiation, as compared with the control, and none of 
the groups expressed adipogenic genes. Interestingly, the OGP analogue with slower release 
kinetics also stimulated hMSCs chondrogenic differentiation. Overall, this study demonstrated 
the ability of the proposed platform to direct the fate of transplanted hMSCs in loco, and OGP-
releasing hydrogels emerged as a potentially useful system to promote bone regeneration. 
In summary, the results presented in this thesis provide new insights to the design of cell-
instructive ECM-like artificial 3D matrices, and represent a step forward towards the 
development of improved carriers for MSCs-based bone regenerative therapies. 
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RESUMO 
 
 
Apesar dos avanços substanciais em ortopedia, diferentes tipos de lesões ósseas ainda 
permanecem clinicamente difíceis de gerir. A distribuição de tipos adequados de células, tais 
como células estaminais mesenquimais (MSCs), e fatores osteoindutores, através do uso de 
biomateriais, representa uma estratégia promissora para promover a reparação local de tecido. 
Os hidrogéis apresentam um grande potencial como veículos de entrega de células, uma vez 
que proporcionam microambientes tridimensionais (3D) que recapitulam parcialmente a matriz 
extracelular nativa (ECM). Um veículo ideal deve aumentar a retenção das células no local, a 
sua sobrevivência e enxerto, e fornecer um modelo para a formação de novo tecido. 
Idealmente, deverá também induzir a diferenciação guiada das células transplantadas.  
O principal objetivo desta tese foi desenvolver veículos injetáveis capazes de direcionar 
a diferenciação de MSCs ao longo da linhagem osteoblástica, o que representam uma 
estratégia relevante no contexto da regeneração óssea.  Um objectivo específico era entender 
melhor como se comportam as MSCs em 3D e traduzir esse conhecimento no desenvolvimento 
de melhores veículos de MSCs. 
O controlo do comportamento celular em microambientes 3D é uma tarefa desafiadora 
pois deve levar em conta a influência de vários parâmetros, bem como a sua interação. Estes 
incluem não apenas os fatores extrínsecos à matriz, tais como sinalização solúvel e contato 
direto célula-célula, mas também vários fatores relacionados com a matriz, que devem ser 
cuidadosamente controlados já que eles afetam, de diferentes formas, atividades celulares 
distintas. Esta tese centrou-se especificamente no comportamento de MSCs de medula óssea 
humana (hMSCs), que são atualmente reconhecidas como uma fonte de células promissora 
para a regeneração de tecido ósseo, quando cultivadas em condições 3D dentro de hidrogéis 
de alginato, que estão entre os materiais mais frequentemente utilizados para a cultura e 
entrega de células. 
O primeiro estudo abordou o efeito da densidade celular na resposta de hMSCs em 3D, 
o qual representa um parâmetro crítico e muitas vezes desconsiderado. Diferentes densidades 
celulares foram testadas e em todas as condições as hMSCs apresentaram níveis 
estacionários de atividade metabólica e reduzidos de proliferação. No entanto, as células 
recuperaram os níveis "normais" de atividade após serem recuperadas das matrizes 3D e re-
cultivadas em monocamadas em 2D. A mais alta densidade celular mostrou-se crucial para 
promover o estabelecimento de contatos célula-célula e consequente formação de 
aglomerados multicelulares ricos em ECM endógena, e estimulou a diferenciação osteogénica 
de hMSCs. O estudo destacou claramente a importância de otimizar a densidade celular inicial 
no estabelecimento de culturas em 3D para aplicações específicas. 
Vislumbrando o potencial interesse clínico de tais agregados, foi então investigado como 
a sua formação pode ser orientada por sinais específicos da matriz. O processo de agregação 
celular envolve mecanismos de resposta a estímulos mecânicos e depende do equilíbrio entre 
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a célula-matriz e a sinalização célula-célula. Uma vez que o efeito combinado destas pistas não 
é ainda totalmente esclarecido, particularmente em 3D, foi avaliado o comportamento das 
hMSCs cultivadas dentro de hidrogéis com rigidez e composição controlada. Como 
demonstrado, a agregação das hMSCs só ocorreu em matrizes menos rígidas, tanto na 
presença como na ausência de péptidos de adesão ligados à matriz. A formação de uma rede 
de fibronectina estabilizou os contatos célula-célula dentro dos agregados, mesmo em matrizes 
não-adesivas. No entanto, as hMSCs só foram capazes de contrair substancialmente a matriz 
artificial na presença de RGD. Além disso, as matrizes menos rígidas facilitaram a proliferação 
celular e proporcionaram um ambiente permissivo para a diferenciação osteogénica das 
hMSCs, mesmo sem RGD. As interações da célula com a matriz original tornou-se menos 
importante com a progressão do tempo, enquanto a produção da nova ECM se transformou 
num fator mais crítico e determinante do destino celular. Este estudo permitiu elucidar  alguns 
mecanismos através dos quais as hMSCs sentem o seu microambiente e o usam para se 
organizarem em tecidos, e estabeleceu uma estratégia baseada em biomateriais para 
promover a formação de microtecidos compostos por ECM-MSCs em 3D. 
Depois de demonstrar que diversos fatores, tanto intrínsecos como extrínsecos à matriz, 
afetam o comportamento das hMSCs em 3D, foi idealizado o uso de pistas osteoindutivas 
como uma estratégia para guiar especificamente a sua diferenciação ao longo da linhagem 
osteoblástica. A ideia era conceber um sistema multifuncional para ser utilizado na entrega 
simultânea das hMSCs e péptidos osteoindutores. O péptido de crescimento osteogénico 
(OGP) inspirou o desenho de duas sequências peptídicas, onde o fragmento bioativo de OGP 
foi ladeado por uma ligação sensível à ação de proteases, ou pela sua sequência misturada, 
por forma a resultar numa taxa de libertação mais rápida ou mais lenta, respetivamente. Estes 
péptidos foram caraterizados e quimicamente ligados ao alginato. Os dois análogos de OGP 
libertaram fragmentos bioativos in vitro com diferentes cinéticas, o que estimulou a proliferação 
das hMSCs e a osteogénese. Hidrogéis de alginato-OGP contendo hMSCs foram testados de 
forma ectópica num modelo de xenotransplante em ratinho. Após 4 semanas, os hidrogéis de 
alginato-OGP degradaram-se mais e foram mais eficientemente colonizados por novo tecido 
vascularizado do que o controlo (sem OGP). As hMSCs produziram ECM endógena, migraram 
para fora dos hidrogéis e proliferaram. Os grupos com OGP estimularam a diferenciação 
osteogénica das hMSCs, em comparação com o controlo, e em nenhum dos grupos foi 
detetada a expressão de genes adipogénicos. Curiosamente, o análogo de OGP com a cinética 
de libertação mais lenta também estimulou a diferenciação condrogénica das hMSCs. Em 
geral, este estudo demonstrou a capacidade da plataforma proposta para direcionar o destino 
das hMSCs transplantadas in loco, e os hidrogéis de libertação de OGP emergiram como um 
sistema potencialmente útil na promoção da regeneração óssea. 
Em resumo, os resultados apresentados nesta tese forneceram novos conhecimentos 
para o desenho de matrizes 3D artificiais, capazes de direcionar o comportamento das hMSCs, 
representando um contributo para o desenvolvimento de veículos melhorados para terapias 
celulares de regeneração óssea. 
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MOTIVATION AND AIMS 
 
 
The controlled delivery of cells, namely mesenchymal stem cells (MSCs), from 
biomaterial-based vehicles can improve and accelerate functional bone formation. The carrier 
materials can transport and deliver cells into target sites, increase their survival and 
engraftment, provide a supportive ECM-like substrate to assist the 3D assembly of the newly 
formed tissue and, ideally, guide the differentiation of MSCs along the osteoblastic lineage. 
Hydrogels are amongst the most widely used carrier materials, as they can entrap and protect 
cells within a real 3D microenvironment, intrinsically present many ECM-like features, and may 
exhibit easily tunable biochemical and biophysical properties. In-situ forming hydrogels are 
attractive solutions for some applications, as they present the added benefit of injectability. 
Although this type of strategy shows great promise, clinical trials have not yet resulted in 
consistent benefits. This suggests that improved delivery systems and further understanding of 
MSCs biology and MSCs-ECM interactions is needed for optimal efficacy. 
In fact, the development of optimized hydrogel-based cell carriers requires a deep 
knowledge on how cells behave within artificial 3D matrices, and how they react to a number of 
extrinsic and matrix-intrinsic factors that differentially regulate the activities of different cell 
types. So, the aim of the first experimental part of this thesis (chapters III and IV), was to 
investigate how MSCs, which are currently recognized as a powerful cell source for bone tissue 
regeneration, react to different cues, when cultured within alginate hydrogels, one of the most 
common materials used for cell entrapment and delivery. Central questions addressed during 
this investigation were: (i) how do human MSCs (hMSCs) sense and react to cellular and matrix 
cues in 3D?; (ii) how can MSCs behaviour be dynamically instructed by the 3D matrix they 
contact with?; and (iii) how can this knowledge translate into more effective cell-based therapies 
to promote tissue regeneration?.  
For enhanced efficacy, the carrier system can also be specifically designed to co-deliver 
pro-regenerative bioactive molecules, with adequate release kinetics, in a localized and/or 
spatiotemporal manner. In the context of bone regeneration, the combination of MSCs with 
biomaterials functionalized with instructive cues can be used as a strategy to direct specific 
lineage commitment. Therefore, the aim of the second experimental part of this thesis (chapter 
V) was to synthesize new injectable alginate hydrogels functionalized with osteoinductive 
peptides. The co-delivery of such factors along with MSCs is expected to stimulate transplanted 
cells (and also host cells) activity, and thus present synergistic effects towards bone 
augmentation. 
Overall, the results presented on this thesis are expected to contribute with important 
clues for the design of optimized cell carrier materials, which might improve the therapeutic 
efficacy of transplanted cells for bone tissue regeneration.  
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THESIS OUTLINE 
 
 
The thesis has been organized into six chapters: 
Chapter I provide a brief introduction to some general concepts related with the work 
developed during this thesis. 
Chapter II is a literature review that specifically covers the functionalization of 
biomaterials with small osteoinductive moieties. It describes different strategies that have been 
used to promote substrate-mediated guidance of osteogenic differentiation of immature 
osteoblasts, osteoprogenitors and MSCs, through chemically conjugated small moieties, both in 
2D and 3D settings, including hydrogels. In each case, the selected moiety, the coupling 
strategy and the main findings of the study are highlighted. The latest advances and future 
perspectives in the field are also discussed. 
Subsequently, Chapters III, IV and V describe the performed experimental work: 
Chapter III addresses the influence of the initial cell entrapping density on the behaviour 
of human MSCs (hMSCs) cultured within alginate hydrogels, and highlights the relevance of 
optimizing this parameter when establishing 3D cultures for specific applications. It 
demonstrates that high cell densities are important for promoting the establishment of cell-cell 
contacts and the consequent formation of multicellular clusters rich in endogenous extracellular 
matrix (ECM) components, which in turn promote the osteogenic differentiation of hMSCs. 
Chapter IV provides further insights into the mechanisms by which hMSCs sense their 
microenvironment to organize into microtissues. To evaluate the effect cell-matrix and cell-cell 
signaling and especially their interplay, the behaviour of hMSCs cultured within alginate 
hydrogel matrices with tailored stiffness and density of cell-adhesion ligands was evaluated. 
The most compliant matrices promoted hMSCs aggregation and ECM production and provided 
a permissive environment for hMSCs osteogenic differentiation. 
Chapter V explores the use of osteoinductive cues as a strategy to specifically guide the 
differentiation of hMSCs along the osteoblastic lineage. Analogues of the Osteogenic Growth 
Peptide (OGP) were synthesized and chemically grafted to alginate hydrogels using linkers with 
different protease sensitivity. After in vitro characterization, the performance of functionalized 
alginate hydrogels as local depots for the co-delivery of hMSCs and OGP was analyzed in vivo, 
using a xenograft mouse model. The study demonstrates that the system can be successfully 
used to direct the fate of transplanted hMSCs at an ectopic site, suggesting that OGP-releasing 
hydrogels might be useful to stimulate bone formation by inducing osteogenesis and/or 
chondrogenesis.  
Finally, Chapter VI provides some concluding remarks, with an overall analysis of the 
preceding chapters, along with future perspectives. 
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1. INTRODUCTION 
 
 
1.1. Brief overview of bone repair mechanisms 
 
Unlike soft tissues that predominantly produce fibrous scars upon injury, the adult bone 
possesses an astounding capacity to regenerate upon damage [1]. This complex process 
recapitulates the skeleton growth during embryogenesis, and involves different cell types, 
soluble signals and matrix signals (biochemical and mechanical), acting in concert towards the 
formation of new functional bone, indistinguishable from adjacent uninjured bone tissue  [2].   
Bone repair can occur through direct (primary) and indirect (secondary) healing 
mechanisms [2]. The first process is rarely observed, as it requires a correct anatomical 
reduction of the fracture ends, without significant gap formation, and a stable fixation without 
interfragmentary strain [3]. It does not involve callus formation, and represents an attempt to 
directly re-establish an anatomically and mechanically competent lamellar bone structure. There 
is almost no periosteal involvement, and the key participating cells are osteoblasts, the bone-
forming cells, which differentiate from osteoprogenitor cells mainly supplied by blood vessels 
[2]. 
Typically, bone repair occurs through an indirect process characterized by four 
overlapping stages (Fig. 1) where endochondral and intramembranous ossification are 
combined [2]. These are: A) hematoma formation and inflammatory response, B) soft 
(cartilaginous) callus formation C) hard callus (ossified) callus formation (osteogenesis) and D) 
remodeling [4]. In what concerns the basic events occurring along the 4-stage model, it has 
been established that each phase involves specific set populations and molecular signaling, but 
as these events frequently overlap, it is difficult to make a clear delineation of each stage during 
repair [4]. 
In general terms, the first phase begins immediately after trauma, with the consequent 
disruption of blood supply and the formation of a hematoma (Fig. 1A). This initiates an 
inflammatory response, which is essential for the healing process. The blood clot serves as a 
template for subsequent callus formation and acts as a source of cytokines and growth factors, 
modulating the inflammatory process and promoting the recruitment of different pro-
regenerative cell types into the damage site [4]. One particularly relevant cell type are MSCs, 
which may derive from surrounding tissues (soft tissues, cortex, periosteum) and bone marrow, 
or even be systemically recruited as circulating MSCs from remote hematopoetic sites [3]. Still, 
their precise sources remain unclear. 
Following the formation of the initial hematoma, a fibrin-rich granulation tissue is 
assembled and progressively substituted by cartilaginous tissue, involving an endochondral 
process where MSCs differentiate into chondrocytes that proliferate and secrete new matrix 
(Fig. 1B). This results in the formation of a soft callus that bridges the fracture and restores 
mechanical stability [1] Gradually, chondrocytes became hypertrophic, their ECM starts to 
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calcify and they become apoptotic [4]. The soft callus is then progressively resorbed and 
invaded by new blood vessels. The formation of a hard callus then progresses, and the calcified 
cartilage is replaced with woven bone, as osteoblasts produce a mineralized matrix (Fig. 1C) 
[5]. 
Although the hard callus is more solid and mechanically rigid, it does not fully restore the 
biomechanical properties of normal bone. As such, the healing cascade initiates another 
resorptive phase, to remodel the hard callus and reestablish the functionality of the damage 
bone (Fig. 1D). The process involves a balance of hard callus resorption by osteoclasts, and 
lamellar bone deposition by osteoblasts, which progresses until a fully regenerated bone 
structure is achieved.  
 
 
 
Fig. 1. Schematic representation of the different stages of indirect bone healing. (A) hematoma 
formation and inflammatory response, (B) soft callus formation (chondrogenesis), (C) hard callus formation 
(osteogenesis) and (D) bone remodeling.  Adapted from Pearson Education Inc. publishing as Benjamin 
Cummings. 
 
 
When bone lesions occur, the natural ability of bone to repair/regenerate may be 
compromised by their size, location and type. Despite substantial advances in orthopedic 
surgery, different bone abnormalities still remain clinically difficult to manage. Common lesions 
include not only nonunion or delayed consolidation fractures, but also several types of bone 
defects caused by trauma, infection, prosthesis loosening or tumor resection, among others [6, 
7]. In these cases, surgical intervention is needed and there are several bone reconstruction 
strategies currently available [6]. 
In alternative to more conventional treatments, which will not be discussed here, there is 
currently great excitement over the possibility of replacing damaged tissues through the 
emerging field of regenerative medicine. Potential strategies include cell transplantation, 
implantation of acellular or cell-laden biomaterial constructs synthesized in the laboratory, and 
induction of regeneration from the body’s own cells by rendering the injury environment and/or 
host cells regeneration-competent [6, 8-11].  Presently, cell/combination therapies are mainly 
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indicated for local bone defects, but future targets also include a number of systemic metabolic 
bone diseases such as osteoporosis. 
 
 
1.2. Cell-based therapies for bone repair: mesenchymal stem cells as a promising tool 
 
Cell-based regenerative therapies offer an interesting approach to recapitulate the bone 
healing process. Most cellular therapy strategies for bone regeneration employ adult stem cells, 
like MSCs, which raise less controversial ethical considerations than embryonic stem cells [12]. 
MSCs have generated a great deal of excitement, notably for their capacity to self-renew and 
differentiate into multiple tissues, including bone, cartilage, fat, and others of mesenchymal 
origin [13]. MSCs have the capacity of homing to injured tissues [14], providing cell populations 
that regulate local cellular activity for improved repair, either by secreting key trophic factors or 
by directly participating in the assembly of new tissue [12, 15]. Their high expansion potential 
and apparent immune modulatory/suppressive effects [16] make them extremely appealing as 
‘off-the shelf’ bioproducts, to be used in both autologous and allogeneic settings. 
The presence of MSCs has been detected in different tissues, such as bone marrow [17], 
fat (adipose) tissue [18], umbilical cord blood [19], peripheral blood [20], synovial membrane 
[21], deciduous teeth [22], dental pulp [23], amniotic fluid [24], brain, skin, heart, kidneys and 
liver [25], among others. Despite sharing similar characteristics, MSCs from distinct origins differ 
in their phenotype and differentiation potential [26]. For regeneration therapies, the selection of 
the most adequate MSCs source is strongly related with issues of accessibility and/or isolation 
yield. Bone marrow MSCs, originally isolated by Friedenstein et al. in 1976 [27], are the best 
characterized and have been considered as the major source of progenitor cells for skeletal 
tissues repair. More recently, other sources requiring less invasive and easier harvesting 
procedures have been explored. Adipose tissue-derived MSCs are particularly attractive, and 
an increasing amount of data is being generated regarding their osteogenic potential [28]. In the 
case of umbilical cord blood, the isolation process is easy but results in very low yields, 
requiring extensive amplification [29].  
Irrespectively of their source, the high expansion potential of MSCs in culture [30], which 
has been consistently improved by the use of bioreactors [31], allow to obtain clinically 
meaningful cell numbers for early stage clinical trials. However, traditional expansion 
approaches raise some concerns due to the use of animal-derived supplements, mainly related 
with batch-to-batch variation and safety issues [30]. To address this limitation, several xeno-free 
cultivation strategies have been recently proposed [29, 32]. 
The International Society for Cellular Therapy has established minimal criteria to define a 
cell as a mesenchymal stem cell [33]. These include the property of plastic-adherence; the 
expression of specific phenotypic markers (presence of typical MSCs markers CD90, CD105, 
CD73 coupled with the absence of hematopoietic markers such as CD45); and the ability to 
differentiate into osteoblasts, adipocytes and chondroblasts in vitro. Osteogenic differentiation is 
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traditionally induced in the presence of β-glycerophosphate, ascorbic acid and dexamethasone 
(Fig. 2) [34]. Other osteoinductive compounds have been tested, as described in more detail in 
Chapter II. Typically, differentiated cells undergo a morphological change from spindle-shape to 
polygonal cells, express several well-recognized bone-differentiation markers and mineralize 
their ECM [34, 35]. In vivo, the osteogenic potential of bone marrow MSCs has been clearly 
demonstrated by subcutaneous implantation within a ceramic carrier in immunocompromised 
mice, a common assay for evaluating ectopic MSCs differentiation into functional osteoblasts 
[36]. 
 
 
  
Fig. 2.  Induced mesenchymal stem cells differentiation. MSCs have the capacity to differentiate into 
different lineages in vitro, namely adipogenic, chondrogenic and osteogenic. Different types of compounds 
(β-glycerophosphate, ascorbic acid and dexamethasone are depicted as examples) can be used to 
specifically induce MSCs to differentiate along the osteoblastic lineage. 
 
 
In Europe, MSCs are considered “advanced therapy medicinal products” (ATMP), but 
several scientific, technical, regulatory and safety issues still require a great deal of attention to 
set up standards for their final quality and efficacy [6]. Also, there are still many open questions 
regarding the usefulness and limitations associated to the use of MSCs in clinical practice. For 
example, intravenously administered MSCs have been shown to improve repair of multiple 
tissues, including bone, as demonstrated in preclinical testing and even in some clinical trials [6, 
37].  
Yet, the mechanism behind the observed beneficial effects remain largely unexplained 
[38], and it is not clear how infused MSCs are able to repair distal organs. On the other hand, 
localized MSCs administration to the defect site is frequently associated with rapid cell 
disappearance; low survival rates - requiring high amounts of cells to exert a therapeutic effect; 
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and poor cell engraftment. Some of these obstacles may potentially be overcome through the 
use of more effective cell delivery approaches [39]. 
 
 
1.3. Biomaterial-based vehicles for cell therapies: hydrogels as ECM mimics 
 
Biomaterial carriers that allow the local delivery of cells at the site of injury can greatly 
improve the efficacy of cell therapies. These carriers provide the transplanted cells with a 
protective microenvironment, which enhances their survival, retention and engraftment [39]. 
Moreover, these materials may act as ECM-mimics for guiding tissue repair, namely by 
modulating the behaviour and fate of transplanted cells and promoting the infiltration and 
proliferation of osteoprogenitor cells, and other relevant cell types, for integrative tissue repair 
[40]. 
Among the various types of biomaterial carriers, hydrogels are probably the most 
attractive. Hydrogels are water-swollen polymeric materials with a high water content, which 
generally possess excellent biocompatibility and high permeability allowing the diffusion of 
nutrients oxygen and cell metabolites throughout the network [40]. Moreover, their capacity to 
recreate microenvironments where cells become embedded in real 3D conditions, allows the 
structural recreation of a natural ECM scenario [41, 42].  
Importantly, within such environments, cells become exposed to a range of chemical and 
mechanical cues that modulate their behavior [9]. As recently recognized, cell-matrix 
interactions are essential determinants of cellular activity. Indeed, it is nowadays clear that, in 
vivo, the native ECM does not serve only as a scaffold to stabilize the structure of tissues, as 
initially believed, but plays a far more active and complex role in regulating cell behavior [43].  
Along with its complex role, the ECM has a correspondingly complex structure and 
composition incorporating polysaccharide-like hydrogels and numerous structural and functional 
proteins that directly interact with cells [9, 44, 45]. This is the scenario that a growing tissue 
expects to find when passing through the difficult process of regenerating, and what artificial 
scaffolds should ideally mimic. For that reason, the evolution in the design of new biomaterials 
that mimic the ECM parallels the development of knowledge of the natural matrix [46]. To 
accomplish these goals, new generations of multifunctional ECM-like biomaterials are being 
developed [46, 47]. 
In the past few years increasing efforts have also been devoted to the development of 
injectable biomaterials as an alternative for bone augmentation or replacement [48, 49]. The 
main advantage of using injectable materials is the possibility of filling bone-defects of different 
shapes and sizes using a minimally invasive surgery [50], which provides less discomfort to 
patients, undergoing a variety of orthopedic procedures, allows a faster recovery and has lower 
costs.  
There are different types of hydrogel-forming polymers, which can be generally classified 
according to their source, natural or synthetic, each presenting advantages and limitations [51]. 
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For example, protein-based or ECM-derived hydrogels can be used to create “promoting” 
microenvironments, which intrinsically encourage cell-matrix interaction due to the presence of 
endogenous bioactive domains on their composition [52]. While this may represent a benefit, it 
also makes these systems complex and ill defined, making it difficult to determine exactly which 
signals are promoting specific cellular activities [53]. Also, these materials do not afford enough 
control over their fine-biochemical and mechanical properties. 
Other types of hydrogels, both of natural and synthetic origin, also provide 3D 
microenvironments that are structurally similar to native ECMs, and are “permissive” in the 
sense that they generally preserve cell viability, but lack functional sites for cell recognition [54, 
55]. This can however be regarded as an advantage, as these materials can be used as ideal 
“bio-inert” backgrounds, which can be functionalized with bioactive motifs to elicit specific cell 
responses. Alginate hydrogels, which present these characteristics, were selected for the 
present investigation and are described in more detail in the following section. 
Hydrogels have also been frequently used as drug delivery systems [56]. Specific 
bioactive agents can be loaded into hydrogels, using different strategies involving physical or 
chemical interactions. Briefly, physical entrapment can be achieved either through drug 
absorption by pre-fabricated hydrogels, or drug trapping during hydrogel formation [57, 58]. In 
this case the main mechanisms of drug release are drug diffusion and/or matrix degradation. 
The bioactive agents can also be chemically tethered to hydrogels and then be released upon 
degradation of the matrix and/or labile linkers [59, 60]. This issue will be further discussed for 
the specific case of alginate hydrogels. 
 
 
1.4. Alginate hydrogels as vehicles for drug and cell delivery 
 
Alginate is a natural polysaccharide extracted from brown seaweeds and composed of (1-
4)-linked β-D-mannuronic acid (M units) and α-L guluronic acid (G units) monomers which vary 
in number and sequential distribution along the polymer chain [55]. Alginate chains can be 
composed by homopolymeric M blocks (MMMMMM) or G blocks (GGGGGG), and also 
composed by heteropolymeric MG blocks (MGMGMGMG) (Fig. 3).  
The sequence and composition of the monomers affect the functional properties of 
alginate. For example, alginate molecules with a high percentage of M block form more flexible 
gels, whereas alginates with a higher percentage of G blocks form stiffer gels [61]. The relative 
content of M vs. G blocks is highly dependent on the alginate source.  
In what concerns the use of alginate for biomedical applications, many of the 
disadvantages commonly associated to the use of natural polymers have been overcome. In 
fact, highly purified and well-characterized alginates developed for use in clinical and 
pharmaceutical applications are currently commercially available.  
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Fig. 3. Schematic illustration of alginate structure. (1-4)-linked β-D-mannuronic acid monomers are 
indicated by (M) and  α-L guluronic acid monomers are indicated by (G). Homopolymeric block are 
composed of G residues (GGGG) or M residues (MMMM), while heteropolymers are composed of 
alternating G and M residues (GMGM).  Adapted from [62]. 
 
 
To assist customers who are developing medical applications of ultrapure sodium 
alginates (endotoxin levels lower than 100 EU/g), some manufacturers maintain Drug Master 
Files with the US Food and Drug Administration (FDA). Within a certain category of products, 
batch-to-batch variability is negligible, namely in terms of key parameters such alginate 
molecular weight and G-to-M ratio, which could also be considered a drawback in the use of 
alginate-based biomaterials at a larger scale, namely for clinical applications.  
Alginate solutions can be easily sterilized by filtration, and hydrogels can be obtained by 
chemical and physical crosslinking methods, being the later the most common ones. 
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Ionotropic gelation occurs rapidly under physiological conditions when sodium ions from 
the α-L guluronic acid blocks, exchange with divalent cations (like Ca
2+
) present in solution, in a 
highly cooperative manner [63]. The carboxylate functional groups of subsequent G groups 
have the appropriate structure for cation binding, and this interaction leads to the formation of 
an egg-box structure (Fig. 4) [63]. The crosslinking process can be carried out under very mild 
conditions – at low temperature and in the absence of organic solvents, and hydrogels of 
different shapes can be prepared. In situ forming hydrogels can be prepared using internal 
gelation strategies, which involves the use of calcium salts with low solubility in water at neutral 
pH, such as CaCO3 and CaSO4 that can be uniformly distributed in the alginate solution without 
initiating hydrogel gelation. Decreasing the pH, using slowly hydrolyzing acidifying compounds 
such as glucone-δ-lactone, can then trigger the release of free calcium ions, thereby allowing 
the gradual crosslinking of the hydrogel network [64, 65]. The gelling time depends on different 
parameters, such as the concentration of polymer and crosslinking agents, their relative 
proportion, and the temperature, among others. This way, in a clinical scenario, the injection of 
fluid gel-precursor solutions that conform to the defect shape and solidify at the target site is 
possible. 
The properties of alginates as delivery systems have been widely investigated. Several 
proteins, including growth factors [66] and enzymes [67], and also cells, have already been 
successfully incorporated in alginate gels, retaining a high percentage of biological activity or 
viability. 
Although alginates hydrogels present numerous attractive features, their use as cell 
scaffolds presents additional requirements. It has been previously reported [55] that attachment-
dependent cells are unable to specifically interact with alginate hydrogels, which promote 
minimal protein adsorption due to their high hydrophilic nature.  
A way to circumvent this apparent limitation is the incorporation of the cell-adhesive 
oligopeptide arginine-glycine-aspartic acids (RGD), as initially proposed by Rowley et al [55]. 
This motif was identified almost two decades ago by Pierschbacher and Rouslahti as the 
minimal essential cell-adhesion sequence in fibronectin (Fn) [68]. RGD coupling to alginate was 
performed through covalent modification utilizing standard aqueous carbodiimide chemistry [55].  
Briefly, 1-ethyl-(dimethylaminopropyl) carbodiimide (EDC) was used to form amide 
linkages between the terminal amine on the peptide and the carboxylate on the alginate as 
depicted schematically in Fig. 5. The compound N-hydroxysulfosuccinimide (sulfo-NHS) was 
used as a co-reactant to stabilize the reactive EDC-intermediate (O-acylisourea intermediate) 
against a competing hydrolysis reaction.  
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Fig. 4. Model of egg-box structure. Link between paired -L-guluronic acid sequences of the alginate 
and divalent ions (Ca
2+
 is depicted as example). Adapted from [61]. 
 
 
 
Another important modification of alginate hydrogels, which greatly improved their 
properties as ECM mimics, was the incorporation of enzyme-susceptible groups to render them 
degradable by cell-secreted proteases [69, 70]. Alginate hydrogels were partially crosslinked 
with the matrix metalloproteinase (MMP)-cleavable peptide PVGLIG (proline-valine-glycine-
leucine-isoleucine-glycine) combined with RGD peptides. The cleavable peptide allowed cells to 
overcome the biophysical hydrogel resistance while RGD provided for integrin-mediated cell 
adhesion. This work showed that entrapped MSCs interacted dynamically with the MMP-
sensitive hydrogels, being also able to interact with neighboring cells emphasizing the 
importance of the microenvironment in MSCs’ behavior (Fig. 6). The sequence selected for that 
study, which also explored in the present work (PVGLIG - the arrow indicates the cleavage 
site) is susceptible to cleavage by MMP-2, MMP-9, MMP-13 and MMP-14, as previously 
demonstrated [70], and was originally deduced from a combinatorial library of MMP-sensitive 
oligopeptides [71, 72]. 
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Fig. 5. Reaction scheme of peptide coupling to alginate molecules using carbodiimide chemistry. 
EDC added to alginate reacts with carboxylic acid groups forming an amide bond where the terminal 
amine of the peptide link. Adapted from [55]. 
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Fig. 6. MMP-degradable alginate hydrogels. Alginate matrices functionalized with crosslinking MMP-
sensitive (PVGLIG) and tethered cell-adhesion (RGD) peptides, which not only promote MSCs adhesion, 
but also enable matrix degradation through cell-driven proteolytic mechanisms [69].  
 
 
1.4.1. Alginate functionalization with osteoinductive peptides and release mechanisms 
 
In this thesis, the functional modification of alginate with osteoinductive peptides, for 
subsequent in vivo release was investigated. The idea was to develop a system where 
osteoinductive peptides could be co-delivered with MSCs to induce their differentiation along 
the osteoblastic lineage, and remain locally available, in close proximity of target cells at the 
injury site, for prolonged periods of time.  
As explained in detail in chapter II, different types of small moieties have been proposed 
as osteoinductive agents, and some of them have already been conjugated with alginate 
hydrogels [59, 73]. For this study, the osteogenic growth peptide (OGP) was the one selected, 
due to a number of reasons, which include its interesting bioactive properties and its small size 
that facilitates coupling and is less likely to interfere with the hydrogel crosslinking process. 
OGP is a naturally occurring tetradecapeptide identical to the C-terminal amino acid sequence 
89-102 (H-Ala-Leu-Lys-Arg-Gln-Gly-Arg-Thr-Leu-Tyr-Gly-Phe-Gly-Gly-OH) of histone H4 (H4) 
[74]. It can be found free or combined with OGP binding proteins (OGPBPs), mainly as an 
inactive complex with α2-macroglobulin (α2M) [75]. Following its dissociation and proteolytic 
cleavage, it generates the C-terminal pentapeptide H-Tyr-Gly-Phe-Gly-Gly-OH (or OGP10-14) 
[76], which is the minimal OGP-derived sequence that retains the full mitogenic activity of OGP 
[77].  OGP10-14 interacts with a yet unidentified receptor to activate an intracellular Gi-protein-
MAP kinase signaling pathway, a relatively early step in the mitogenic signaling cascade MAP 
Kinases (Fig. 7) [78]. 
OGP is a peptide with several functions. In vivo it increases bone mass, bone formation 
and trabecular bone density and hematopoiesis [79, 80]. It has also been demonstrated that 
OGP10-14 induces balanced increase in white blood cell (WBC) count and overall bone marrow 
cellularity [81], including the engraftment of bone marrow transplants. It also regulates the 
expression of transforming growth factors, insulin like growth factor, and basic fibroblast growth 
factor. In cultured osteoblasts, OGP10-14 regulates proliferation, alkaline phosphatase activity, 
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and matrix mineralization [82], via an auto-regulated feedback mechanism. Moreover, OGP10-14 
stimulates the differentiation of progenitor cells into osteoblasts while concurrently inhibits 
adipocyte formation [83]. 
 
 
  
Fig. 7. OGP activation. Model of OGP activation of Gi protein-MAP kinase signaling cascade and 
functional domains of OGP. Adapted from [84]. 
 
 
When very small molecular-weight drugs, such as peptides, are loaded into alginate 
hydrogels simply by physical entrapment, the diffusion-controlled release kinetics is generally 
too fast. If a more sustained release is to be attained, it might be necessary to conjugate both 
components via stronger interactions such as chemical bounds. So, in this study, OGP was 
covalently grafted to alginate by carbodiimide chemistry as described previously. Although 
generally irreversible in nature, the covalent bonding may also be used for delivery purposes, if 
the carrier is biodegradable or if a labile drug-polymer linker is used. In the specific case of 
traditional alginates, the first strategy is often inadequate since their degradation in the human 
body is slow and unpredictable [85]. Moreover, the second approach generally provides a 
higher degree of versatility and efficacy, as very selective triggering mechanisms can be chosen 
to enable drug release in response to specific stimuli, under defined locations and/or conditions. 
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One interesting strategy is the use of metabolically cleavable linkers, often peptides, 
which are sensitive to the action of specific enzymes, particularly proteases. In this perspective, 
matrix metalloproteinases (MMPs) are particularly attractive as MMPs actively participate in 
ECM remodeling and degradation, having a key role in wound healing and tissue regeneration, 
and some are constitutively expressed by both naïve and differentiated human mesenchymal 
stem cells [70, 86]. For these reasons, they have been selected as target proteases in the 
present study, and the previously described PVGLIG sequence inspired the design of 
proteolytically-degradable linkers, which were used for the preparation of MMP-responsive 
alginate hydrogels for OGP delivery. In such OGP-functionalized alginate hydrogels, the rate of 
OGP release will depend on the cleavage kinetics of the peptide linker, the rate of diffusion of 
the active fragment, and the rate of matrix degradation.  
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ABSTRACT 
 
Adult mesenchymal stem cells (MSCs) are currently recognized as a powerful cell source for 
regenerative medicine, notably for their capacity to differentiate into multiple cell types. The 
combination of MSCs with biomaterials functionalized with instructive cues can be used as a 
strategy to direct specific lineage commitment, and can thus improve the therapeutic efficacy of 
these cells. In terms of biomaterial design, one common approach is the functionalization of 
materials with ligands capable of directly binding to cell receptors and trigger specific 
differentiation signaling pathways. Other strategies focus on the use of moieties that have an 
indirect effect, acting, for example, as sequesters of bioactive ligands present in the 
extracellular milieu that, in turn, will interact with cells. Compared with complex biomolecules, 
the use of simple compounds, such as chemical moieties and peptides, and other small 
molecules can be advantageous by leading to less expensive and easily tunable biomaterial 
formulations. This review describes different strategies that have been used to promote 
substrate-mediated guidance of osteogenic differentiation of immature osteoblasts, 
osteoprogenitors and MSCs, through chemically conjugated small moieties, both in two- and 
three-dimensional set-ups. In each case, the selected moiety, the coupling strategy and the 
main findings of the study were highlighted. The latest advances and future perspectives in the 
field are also discussed. 
 
 
 
 
 
 
 
 
Keywords: Biomaterials; Bone regeneration; Biofunctionalization; Small moieties; 
Osteogenesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
26 
 
1. INTRODUCTION 
 
Stem cells, in particular adult mesenchymal stem cells (MSCs), are currently recognized 
as a promising cell source for tissue engineering (TE) applications and cell-based therapies, 
namely for bone repair and regeneration. Under appropriate in vitro conditions, in the presence 
of morphogens and specific chemicals, MSCs can be induced to differentiate along several 
mesodermal lineages, including osteoblastic [1]. Moreover, in vivo, the osteogenic potential of 
MSCs has been clearly demonstrated by subcutaneous implantation of MSCs within a ceramic 
or polymer carrier in immunocompromised mice, a common assay for evaluating ectopic MSCs 
differentiation into functional osteoblasts [2, 3]. 
In view of the current limitations associated with bone grafting procedures, the 
combination of MSCs with adequate vehicles or scaffolding materials has been pursued as a 
therapeutic strategy to promote bone repair in response to injury, which still represents a major 
challenge and is a global health problem. Over the past years, biomaterials have evolved from 
essentially ‘‘bioinert’’ materials into sophisticated substrates, with the capability to instruct cells 
and tune their behavior. In this context, being able to drive MSCs’ fate in a controlled manner, 
namely by activating their differentiation into osteoblasts, is clearly relevant [4].  
The effect of a variety of biochemical and mechanical cues [5], as well as other cues, 
such as cell shape and size and cell–cell contacts [6–9], on osteogenic differentiation has been 
extensively investigated. With respect to biochemical cues, which are covered in this review, 
studies have focused not only on the use of prototypical signaling molecules such as growth 
factors (GFs), extracellular matrix (ECM) proteins and hormones, but also on a wide variety of 
small compounds of diverse chemical nature.  
In the vast majority of available studies, these cues have been presented to cells and 
tissues in a soluble form, but their effect in an immobilized form and, in particular, associated 
with biomaterials has also been extensively investigated. Different immobilization strategies can 
be used to combine bioactive molecules with a substrate, including covalent bonding, physical 
adsorption and entrapment (Fig. 1).  
 
This review only covers examples involving the establishment of chemical bonds between 
the moieties and the material, which generally provides better control over their presentation in 
terms of density and orientation, and improves stability [10]. Compared with more complex 
biomolecules, approaches involving the use of smaller and simpler compounds can be 
advantageous by leading to less expensive and easily tunable biomaterial formulations [11]. 
These approaches are reviewed herein, and compounds have been organized into three major 
groups, according to their nature: (i) chemical moieties; (ii) peptides; and (iii) other small 
molecules. 
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Fig. 1. Different (A and B) physical- or (C–E) chemical-based strategies can be used to immobilize a 
bioactive compound onto a biomaterial, such as: (A) adsorption; (B) entrapment; (C and D) covalent 
binding; and (E) crosslinking. Even when chemical methods are used, the compound can be subsequently 
released, if desirable, upon degradation of the material and/or the linker (D). 
 
 
 
The modification of biomaterials with specific functional groups is probably the most 
straightforward strategy to induce material driven control over cell behavior. In most of the 
described studies, chemical groups of different character, broadly categorized as hydrophobic, 
hydrophilic, charged or uncharged, have been selected to convey a wide range of properties to 
the material surface. In a way, these moieties capture chemical features of the native ECM, as 
all of them are inherently present in living systems [11, 12].  
The selection of the functional properties that are the most akin to specific native 
microenvironments can be pursued. For example, carboxylic acid groups are a prevalent 
chemical functionality of cartilaginous matrices, which are rich in glycosaminoglycans; 
negatively charged phosphate groups are present in the mineral phase of hard tissues, such as 
bone; and hydrophobic moieties can be associated with adipose tissues, as adipocytes are rich 
in lipids and secrete them into their extracellular milieu [11, 12].  
Mechanistic studies using model surfaces, such as self-assembled monolayers (SAMs), 
provide a valuable tool for investigating how the presentation of functional groups can be used 
to control MSCs differentiation. Although SAMs cannot be used as implant materials, the 
knowledge gathered from such studies can be translated into the surface modification of 
scaffolds for tissue engineering, leading to more interactive and efficient materials that are able 
to guide the differentiation pattern of attached stem cells.  
As described in Section 2, several in vitro studies have demonstrated that surface 
chemistry can not only modulate short-term cell functions, such as adhesion and morphology 
(Fig. 2), but also affect long-term cellular functions such as differentiation, which is remarkable, 
given that most cells rapidly remodel their underlying matrix [13,14].  
 
 
 
 
28 
 
 
 
Fig. 2. (A) SAMs have been widely used as model surfaces to perform mechanistic studies on cell 
behavior. These studies clearly demonstrated that the surface chemistry modulates MSCs adhesion and 
morphology and, ultimately, differentiation. (B) In hydrophilic (OH) SAMs, human MSCs exhibit a more 
spread-out shape and a better organized actin cytoskeleton than in (C) hydrophobic (CH3) SAMs [15]. 
 
 
The molecular design of cell-instructive biomaterials decorated with peptide cues has 
also been fostered over the last decade or so [16–30]. The rationale for this strategy relies on 
the inherent bioactivity of such compounds. In fact, molecular recognition is highly dependent 
on specific amino acid sequences present in peptides and proteins, which regulate key 
biological and physiological processes, thus modulating cellular function and coordinating 
intercellular communication. The use of synthetic analogues of peptide sequences from 
biologically relevant proteins presents obvious advantages over the use of the full-length 
protein. The latter exhibit intrinsic bioactivity, but may also concomitantly present other binding 
sites for non-targeted biological ligands that may trigger unwanted, and often interfering, cellular 
responses. Moreover, whole proteins are much more sensitive and complex to use, are more 
expensive, and present greater risks of immunogenicity [28]. Peptides are commonly non-toxic, 
as they are composed of naturally occurring or metabolically acceptable amino acids. However, 
although generally they do not cause severe immune responses, this possibility must be taken 
into account, particularly for peptides with longer sequences.  
One of the first peptidic sequences to be used for biomaterial functionalization, which is 
still among the most widely used, is the prototypical cell adhesion sequence Arg-Gly-Asp 
(RGD). This motif was identified almost two decades ago by Pierschbacher and Rouslahti [31] 
as the minimal essential cell adhesion sequence in fibronectin (Fn), and shortly after was tested 
in a covalently immobilized form [32]. Different studies have addressed the effect of RGD 
surface density and accessibility (frequently controlled with the use of spacers), as these 
parameters are essential to guarantee that the peptide bioactivity is preserved [33, 34]. 
Although not discussed in detail herein, the density and distance are clearly important issues 
when considering covalent bounding of any type of bioactive molecule. For example, the RGD 
nanospacing has been found to regulate specific cell adhesion [35, 36]. Based upon a unique 
technical platform to fabricate RGD micropatterns and nanopatterns on PEG hydrogels [37–39] 
in their group, Wang et al. [40] recently examined MSCs differentiation on RGD nanopatterns 
with varied nanospacings. Their stimulating finding is that RGD nanospacing regulates stem cell 
differentiation, including osteogenesis, beyond cell adhesion. In fact, while it has been primarily 
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used as an adhesive ligand, many studies have demonstrated that RGD is in itself a mild 
promoter of osteogenic differentiation [25, 41–45].  
However, RGD is not selective for a specific integrin, but triggers non-biased cell 
attachment. Moreover, in vivo data on the ability of RGD-modified materials to promote 
osseointegration and bone formation are contradictory and, in general, rather disappointing [46]. 
Therefore, for bone-related applications, other cell adhesion peptides have been proposed that 
selectively target integrin signaling cascades implicated in osteogenesis, which demonstrated 
improved performance.  
The most highly expressed integrins in osteoblastic-like cells belong to the b1 sub-family 
of integrins [46]. Although data reporting the expression of the specific alpha subunit by 
osteoblasts has been less consistent, it is well established that the α2β1 integrin is implicated in 
pro-osteogenic pathways and specifically binds to regions of collagen type I, the most abundant 
matrix component in bone [46]. Nevertheless, the modification of biomaterials with RGD-like 
peptides to promote cell adhesion has been often recurrent, as cell anchorage is a prerequisite 
for the survival of several cell types [47, 48]. Advancements in terms of the grafting strategies 
and improved ligands have been reported. For example, techniques to covalently bind RGD into 
both hydrophobic and hydrophilic blocks have been recently set up, and the binding sites have 
been found to influence the cell adhesion efficacy [49].  
A new and very potent peptide ligand combining both cyclic RGD and linear oligolysine 
has been designed to promote both specific and nonspecific cell adhesion [50]. Notably, many 
studies have shown that, when RGD and other osteoinductive peptides are co-grafted onto a 
substrate, they might actually operate synergistically to enhance osteogenic differentiation and 
mineralization of osteoprogenitor cells [21, 51]. Presumably, as some authors have suggested, 
the increased adhesion and spreading of cells onto substrate promoted through binding to RGD 
motifs will in turn favor the interaction of the other peptides with specific cell surface receptors, 
potentiating their action. Other Fn- derived peptide fragments have shown higher specificities 
for key integrins, such as α5β1, with important roles in the control of MSCs osteogenic 
differentiation [46, 52]. In fact, independently of the activation state of α5β1 integrins, RGD 
alone seems to be insufficient to promote binding, even if it serves to activate and align the 
α5β1 – Fn interface, and the simultaneous presence of the PHSRN synergy site is required to 
provide the mechanical strength of the bond [53].  
To specifically promote osteoblastic differentiation and matrix mineralization, different 
peptide sequences derived from the active domains of typical bone ECM proteins, such as 
collagen type I (COL-I), osteopontin (OPN), osteocalcin (OCN) and bone sialoprotein (BSP), 
have been suggested. Peptides derived from bone-related GFs (such as bone morphogenetic 
proteins, BMPs) and peptide/protein hormones with recognized anabolic effects in bone (such 
as the parathyroid hormone, PTH) have also been suggested. Most of these peptides are 
expected to directly interact with cell receptors, activating particular signaling pathways similarly 
to their parental proteins. Alternatively, the immobilized peptides can have an indirect action, by 
promoting the non-covalent sequestering of key biomolecules present in the extracellular milieu 
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that, in turn, will exert their bioactivity [54–56]. In a way, these ‘‘indirect’’ strategies set up a new 
paradigm in biomaterials design, in the sense that these sequestered signaling compounds are 
not directly presented by the biomaterial. In addition, peptides themselves are paving the way 
as new biomaterials.  
This is the case of a new class of ‘‘smart’’ peptides, which self-assemble into nanofibers 
and create self-supporting hydrogels that can be used to culture cells under three-dimensional 
(3-D) conditions. These self-assembling (SA) peptides have been broadly proposed for the 
therapeutic regeneration of different tissues, including bone [57, 58]. The bioactivity of these 
peptides can be molecularly tailored by changing their amino acid composition. In a common 
approach, the original SA sequence is extended, generally at one of its termini, with specific 
bioactive domains.  
Finally, there are a vast number of other classes of small compounds, including 
dexamethasone and statins, which have also been used as osteoinductive compounds, and 
these are described briefly here. Collectively, the examples provided in this review are intended 
to be illustrative rather than inclusive. Importantly, for these compounds to have impact on the 
field, they must be suitable for use in a wide variety of biomaterials for bone regeneration. As 
described throughout the text, by selecting appropriate chemical routes, all these small 
molecules can in theory be used in the functionalization of different classes of materials, 
including polymers, ceramics, metals and composites, and processed in a variety of ways, such 
as films, membranes, microparticles, porous TE scaffolds and hydrogel-based cell-
encapsulation systems (Fig. 3).  
Polymers are the most common material class as they are quite versatile, offering a huge 
diversity in terms of nature, properties and composition. Additionally, they are generally easy to 
functionalize, as they intrinsically present adequate reactive groups to directly engage in 
different chemical modification schemes. Depending on the original material chemistry, pre 
modification steps to introduce adequate reactive groups might be needed, prior to 
functionalization with bioactive moieties. On the other hand, the bioactive moieties themselves 
might be directly reacted to the material or be previously modified. For example, in the case of 
peptides, the simplest grafting procedures involve a direct coupling via peptide N-terminal and 
C-terminal groups, or thiol groups present in terminal cystein residues. More complex 
procedures require the pre-derivatization of peptides with different coupling functionalities, such 
as azides and acryloyl groups. In special cases, such as SA peptides or recombinant proteins, 
bioactive amino acid sequences are directly incorporated during biomaterial synthesis.  
Table 1 presents some examples of functionalization strategies employed in the covalent 
modification of different biomaterials with peptides. Throughout this review, the different 
chemical routes used for the functionalized of biomaterials with different small moieties are 
described in detail. Within each category of materials, examples describing both surface 
modifications (when performed after substrate/scaffold formation) and bulk modifications (when 
performed before scaffold formation) are provided. 
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Material 
Material 
reactive group 
Reactive group 
modification 
Peptide 
reactive group 
Reactive group 
modification 
Material-peptide 
coupling reaction 
Ref. 
Ceramics      
HA/β-
TCP 
Hydroxyl 
OH– 
Silanization to 
create NH2- 
followed by 
reaction with 
PEG 
disuccinimidyl 
succinate 
NH2– – 
NHS ester–NH2 
coupling 
[59] 
HBPs 
Hydrazine 
N2H4– 
– 
OH– 
(N–terminal 
Ser) 
Oxidation to 
create CHO– 
Hydrazone linkage [60] 
SkeliteTM 
Hydroxyl 
OH– 
Silanization to 
create NH2- 
followed by 
succinylation to 
create a NHS 
ester 
NH2– – 
NHS ester–NH2 
coupling 
[61] 
Synthetic polymers      
PEG 
Hydroxyl 
OH– 
Acrylation to 
create 
H2C=CH–
C(=O)– 
S– 
(N–terminal 
Cys) 
– 
Thiol-Acrylate 
coupling 
[62] 
PET Carbonyl 
Oxidation to 
create 
COOH- 
NH2– – 
Carbodiimide 
chemistry 
(EDC/NHS) 
[63] 
pACAA 
Carboxyl 
COOH- 
– NH2– – 
Carbodiimide 
chemistry 
(EDC/NHS) 
[64] 
PLEOF 
Fumarate 
Incorporation of 
propargyl 
acrylate during 
hydrogel 
formation 
NH2– 
Derivatization with 
PEG–N3 during 
synthesis 
Click chemistry 
[21, 
65] 
Aldehyde 
CHO– 
– NH2– 
Derivatization with 
aminooxy group 
during synthesis 
Oxime ligation [65] 
PLGA-
(PEG-
ASP)n 
Amine 
NH2– 
– COOH– – 
Carbodiimide 
chemistry 
[66] 
PLGA 
Carboxyl 
COOH– 
Derivatized with 
hydrazide by 
carbodiimide 
chemistry 
OH– 
(N–terminal 
Ser) 
Oxidation to 
create CHO– 
Hydrazone linkage [67] 
PEU –CH2–  
N– and C–
termini 
Symmetrically 
functionalized with 
Lys grafted w/ 
vinyl groups 
during synthesis 
UV-activated 
reaction of 
−CH=CH2 with 
–CH2– 
[68] 
Natural polymers      
Silk 
fibroin 
Carboxyl 
COOH– 
– NH2– – 
Carbodiimide 
chemistry 
(EDC/NHS) 
[30] 
Alginate 
Carboxyl 
COOH– 
– NH2– – 
Carbodiimide 
chemistry 
(EDC/NHS 
or EDC) 
[17, 
69] 
[70] 
Agarose CH– – NH2– 
Linked to the 
NHS-ester of 
heterobifunctional 
sulfo-SANPAH 
UV-activated 
reaction of 
sulfo-SANPAH 
with CH– 
[71] 
 
 
 
Table 1. Examples of functionalization strategies to covalently modify different biomaterials with peptides. 
 
 
Cys – cysteine; HA/b-TCP – hydroxyapatite/beta-tricalcium phosphate; HBPs – hydrazine-bisphosphonates; Lys – 
lysine; OPF – oligo[poly(ethylene glycol) fumarate; pACAA – poly(acrylic acid-co-acrylamide); PCL – polycaprolactone; 
PEG – polyethylene glycol; PET – polyethylene terephthalate; PEU – polyether urethane; PLEOF – poly(lactide-co-
ethylene oxide fumarate); PLG – poly(lactide-co-glycolide); SAMs – self-assembly monolayers; SAP – self-assembling 
peptide. 
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Fig. 3. Osteogenic differentiation of MSCs cultured in different types of materials, namely: (A) 2-D surfaces 
(tissue culture polystyrene); (B) 3-D porous scaffolds (chitosan sponge); and (C) 3-D hydrogel matrices 
(alginate microspheres). Upon incubation under standard osteoinductive conditions, differentiated MSCs 
express high levels of ALP activity (pink staining; A2, B2, C2), a common osteoblastic phenotypic marker. 
 
 
2. OSTEOINDUCTIVE CHEMICAL GROUPS  
 
 
2.1. Surface-immobilized chemical groups 
 
SAMs have emerged as an important tool to investigate the effect of specific surface 
chemistries on stem cell differentiation due to their controllable surface properties [72]. SAMs 
represent a class of well-ordered organic substrates formed by the adsorption of an active 
surfactant on a solid surface [73, 74]. SAMs formed via chemisorption of alkanethiolates onto 
gold-coated substrates are currently considered to be the best available class of model organic 
surfaces, allowing significant control over chemical properties of the underlying substrate [14, 
72, 75, 76]. A key advantage of this system is the simple creation of well-defined and 
reproducible surfaces presenting a wide range of chemical moieties, which allow the control of 
protein–surface and cell–surface interactions [14, 77]. Although SAMs can only be used as 
model surfaces, results from these studies have been laying the groundwork for more complex 
studies with ‘‘real’’ implant biomaterials towards the identification of surface chemistries that are 
optimal to achieve the fine control over MSCs differentiation in clinical applications. 
Most of the published studies have demonstrated that cell interactions with surfaces are 
indirectly mediated by the characteristics of a pre-adsorbed protein layer, and the pattern of 
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protein adsorption has been correlated with the underlying surface chemistry [15, 73, 78–94]. In 
fact, when a surface comes into contact with a protein-rich physiological medium, it 
instantaneously becomes coated with layers of adsorbed proteins, which will in turn direct the 
binding of cell adhesion receptors. The type, amount, conformation and surface distribution of 
adsorbed proteins modulate focal adhesion formation and intracellular signaling cascades, 
eventually leading to changes in initial adhesion and the long-term differentiation of cells [15, 
85]. Here, a selection of mechanistic studies performed with SAMs and other model surfaces is 
provided, where it was possible to identify chemical functionalities that were claimed to 
effectively promote or enhance osteogenic differentiation of MSCs, either in basal or pro-
osteogenic conditions. Table 2 summarizes the main findings of the described studies. Phillips 
and co-authors analyzed [14] SAMs functionalized with four different functional groups, namely 
methyl (–CH3,), hydroxyl (–OH), carboxyl (–COOH) and amino (–NH2), and were able to 
demonstrate that the surface chemistry has an effect on the pattern of Fn adsorption, which in 
turn modulates the osteogenic differentiation of human MSCs (hMSCs). Differences in Fn 
conformation promoted different integrin–ligand interactions and the consequent activation of 
different intracellular signaling pathways [85]. In particular, NH2-SAMs pre-coated with Fn 
promoted the strongest induction of hMSCs differentiation along the osteoblastic lineage under 
osteoinductive medium. On this surface, mineralized nodules were primarily observed, alizarin 
red staining for calcium showed the greatest enhancement, and Runx2, BSP and OCN 
expression were significantly up-regulated comparing to control surfaces (gold-coated tissue 
culture polystyrene, TCPS). It is noteworthy that, although the other functionalities also showed 
some evidence of osteoinductivity, they only affected the global magnitude of one or two 
phenotypic markers. In fact, only in NH2-SAMs was it possible to demonstrate how a single 
surface variable predicts the most profound effect on lineage commitment. Using silane-
modified glass surfaces as models, Curran et al. [13] investigated the effect of the same 
chemical groups and also thiols (–SH) on hMSCs behavior. Again, hMSCs cultured on positively 
charged NH2 surfaces were shown to be more likely to differentiate along the osteogenic 
lineage, rather than maintaining an undifferentiated phenotype or differentiating into other cell 
types. After 7 days, hMSCs cultured on these surfaces showed higher levels of viable cells 
adhering and also an increase in mRNA expression of Cbfa-1 (bone transcription factor) 
compared to day 1, and decreases in COL-I, COL-II, transforming growth factor b (TGF-β) and 
ornithine decarboxylase (a proliferation marker). Significantly, in this particular study, cells were 
cultured in basal growth medium, without soluble osteoinductors, allowing a direct correlation 
between surface chemistry and cell behavior. Although not studied in detail, the pattern of 
protein adsorption to NH2 surfaces, and particularly the presence of adsorbed vitronectin, might 
have contributed to early osteogenic signaling, as suggested by the authors. Unfortunately, the 
unexpected decrease in COL-I expression were not discussed. The same authors subsequently 
performed a similar study in which hMSCs behavior was monitored for a longer period of time 
(28 days) in the presence of basal and osteoinductive media [12]. The results from this study 
are somewhat confusing, as all the surfaces up-regulated at least one osteogenic gene at 
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certain time points. In accordance with the previous results, however, NH2 surfaces were the 
ones that promoted and maintained cell osteogenic differentiation better overall, both at the 
gene and protein levels, in the presence and absence of biological stimuli. Interestingly, SH 
surfaces also had a positive effect on osteogenesis, with the up-regulation of OCN and Cbfa1 
compared to control samples being observed at different time points, both in the presence and 
absence of biological stimuli. This was surprising, since in the previous study [13] –SH surfaces 
resulted in the decreased expression of proliferation and osteogenic markers after 1 week of 
culture in basal conditions, though this issue was not discussed.  
A number of other chemical functionalities have been investigated with regard to their 
ability to promote osseointegration. For instance, using the H3PO4/P2O5/Et3PO4/hexanol 
method, Granja et al. [95] grafted phosphate functionalities onto regenerated cellulose surfaces 
to enhance its bioactivity, inspired by the role of phosphoproteins in biomineralization. They 
demonstrated in vitro that the calcium salt of cellulose phosphate induces the mineralization of 
the surface, but the highly negatively charged surfaces promoted poor attachment, proliferation 
and differentiation of human bone marrow stromal cells [96].  
This influence of chemical functionality and surface charge seems to be in agreement 
with the previously discussed effect of positively charged SAM surfaces. In vivo, phosphorylated 
surfaces promoted slightly better osseointegration than non-modified surfaces [96]. 
 
 
2.2. Bulk-immobilized chemical groups 
 
Murphy et al. [97] proposed a chemical method for the preparation of silk fibroin 
derivatives with tailored structure and hydrophilicity, carrying different chemical groups, both 
hydrophilic (carboxyl, amino and sulfonic acid) and hydrophobic (ketone and heptyloxy). The 
diazonium coupling chemistry was chosen to target the tyrosine residues, as these are 
homogeneously distributed along the protein molecules and are present in sufficient amounts 
[97]. hMSCs were cultured at the surface of modified-silk (azo-silk) films and, after 1 week of 
culture under osteoinductive conditions, higher expression of alkaline phosphatase (ALP) and 
COL-I was observed in all silk derivatives compared to non-stimulated cultures. Surprisingly, the 
variation in the functional groups attached to the silk did not differentially affect the pattern of 
hMSCs differentiation. The authors did not provide an explanation for this, but proposed future 
studies to investigate whether azo-silk derivatives with higher surface charge (carboxylic and 
sulfonic acid) could enhance mineralization.  
The effect of phosphoesters on hMSCs differentiation was evaluated in a poly(ethylene 
glycol) (PEG) dimethacrylate-based cell encapsulation system [98]. Phosphate-containing 
hydrogels were obtained via photopolymerization of the macromer precursor PEG-di-
[ethylphosphatidyl (ethylene glycol) methacrylate], which incorporates PO4-containing 
degradable polyester linkages [98, 99]. Co-gels were prepared by combining PhosPEG with 
PEG. Compared to PEG gels, and in the absence of growth factors or other inducers, 
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PhosPEG–PEG co-gels increased the gene expression of bone-specific markers (COL-I, ALP 
and osteonectin (ON)), secretion of bone-related matrix (ON and OCN) and mineralization (both 
in a cellular and cellularized gels). In this case, the phosphate moieties in the hydrogel 
backbone played multiple key roles, as they not only acted as osteoinductive moieties, but also 
provided a site for ALP-responsive scaffold degradation, which, in turn, produced functional 
groups that promoted autocalcification. 
Benoit et al. [11] tested the effect of amino, t-butyl, phosphate (PO4), fluoro and 
carboxylic acid groups on hMSCs differentiation, also with the aim of developing PEG-based 
cell-encapsulating hydrogel systems. In a first stage, hMSCs were cultured on arrays of 
functionalized-PEG spots, as a 2-D screening platform. Some selected groups, and in particular 
PO4 groups, shown to induce osteogenesis, were then tethered to 3-D PEG hydrogels, and their 
effect on the differentiation of encapsulated hMSCs was evaluated. These, PO4-PEG hydrogels 
were prepared by photopolymerization of PEG monomers with ethylene glycol methacrylate 
phosphate [11,100,101]. Importantly, hydrogels were designed to have different chemistries, 
and hence different charges and hydrophilicities, but comparable matrix properties, such as 
stiffness and swelling [11]. In addition, 3-D cultured cells were trapped in a rounded 
morphology, irrespectively of the material chemistry, in an attempt to eliminate confounding 
factors and show how a synthetic matrix could modulate hMSCs commitment solely through 
interactions with small chemical groups. As predicted from the 2-D studies, 3-D encapsulation of 
hMSCs in PO4-PEG hydrogels led to osteogenic differentiation in the absence of inducers, as 
suggested by the up-regulation of Cbfa1 expression and the secretion of a COL-I and OPN-rich 
ECM [11].  
In a previous work, the same group had demonstrated improved viability of hMSCs 
encapsulated in PO4-PEG, as compared to unmodified PEG, as the former promoted the 
formation of an apatite-like mineral phase that sequesters OPN, which in turn mediates cell–gel 
interactions [100,101].  
Recently, the authors tried to uncover the mechanisms that underlie the effect of PO4-
PEG on osteogenesis [102]. hMSCs were shown to attach and spread at the surface of PO4-
PEG hydrogels only in the presence of serum proteins, and cell attachment to adsorbed matrix 
components (Fn and COL-I) was partially mediated by integrins β1 and β3. Inhibition of focal 
adhesion kinase (FAK) phosphorylation resulted in down-regulation of the expression of 
osteogenic markers, suggesting the involvement of an outside-in signaling pathway.  
Collectively, these examples clearly demonstrate that the presence of small molecules, in 
this case negatively charged phosphate groups, promoted a specific pattern of ECM protein 
adsorption, which in turn directed hMSCs differentiation down the osteogenic lineage without 
using induction medium. 
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Table 2. Effect of different chemical groups on hMSCs osteogenic differentiation in vitro. 
 
ALP – alkaline phosphatase; BM – Basal medium; Col-I – collagen type I; hMSCs – human mesenchymal stem cells; 
OM– osteoinductive medium; PEG – poly (ethylene glycol); SA – self-assembly;  – decreased;  – increased. 
* According to the expression of osteogenic markers (OCN; Cbfa1) at the protein level as analysed by 
immunocytochemistry. RT-PCR results were not included due to their complexity. 
 
 
3. OSTEOINDUCTIVE PEPTIDES  
 
The general use of osteoinductive peptides in bone regeneration has been recently 
reviewed by Jabbari [103]. The use of ECM-derived and GF-derived peptides for implant 
functionalization to promote osseointegration and enhance bone healing within large defects 
has also been reviewed by Shekaran and García [46]. Although several recent reports exist 
uncovering the potentialities of new osteoinductive peptides, including collagen-binding peptides 
from BSP [104], peptides based on the prodomain region of BMP-7 [105], neuropeptides 
[106,107] and amelogenin-derived peptide sequences present in enamel matrix proteins [108], 
no studies using such peptides in a covalently immobilized form have been found. Here, an 
overview of studies exploring the effect of scaffold-grafted peptides on osteogenic differentiation 
Chemical 
group 
Surface 
properties 
Substrate Main observed effects Ref. 
– CH3 Hydrophobic 
SA of alkanethiols on gold 
(pre-coated with Fn) 
Supported hMSCs differentiation in 
OM (similar to control) 
[14] 
SA of alkoxysilanes on Glass 
Supported hMSCs differentiation in 
OM (similar to control) * 
[12, 13] 
Silk fibroin 
Supported hMSCs differentiation in 
OM (similar to control) 
[97] 
– OH 
Hydrophilic 
Neutral 
SA of alkanethiols on gold 
(pre-coated with Fn) 
of Runx2 mRNA in OM [14] 
SA of alkoxysilanes on Glass 
of COL-I mRNA in BM [13] 
Did not support hMSCs 
differentiation in BM and OM (< 
control) * 
[12, 13] 
– COOH 
(– COO
-
) 
Hydrophilic 
Negative 
SA of alkanethiols on gold 
(pre-coated with Fn) 
of Runx2 mRNA in OM 
 mineralization 
[14] 
SA of alkoxysilanes on Glass 
of COL-I mRNA in BM [13] 
Did not support hMSCs 
differentiation in BM and OM (< 
control) * 
[12, 13] 
Silk fibroin 
Supported hMSCs differentiation in 
OM (similar to control) 
[97] 
– NH2 
(– NH3
+
) 
Hydrophilic 
Positive 
SA of alkanethiols on gold 
(pre-coated with Fn) 
Runx2, OCN mRNA in OM, 
 mineralization 
[14] 
SA of alkoxysilanes on Glass 
of Cbfa and COL-I in BM [13] 
Promoted hMSCs differentiation in 
BM and OM (> control) * 
[12, 13] 
Silk fibroin 
Supported hMSCs differentiation in 
OM (similar to control) 
[97] 
– SH 
Hydrophilic 
Neutral 
SA of alkoxysilanes on Glass 
of COL-I and Cbfa1 mRNA in BM [13] 
Promoted hMSCs differentiation in 
BM and OM (> control) * 
[12, 13] 
– SO3H 
(– SO3
-
) 
Hydrophilic 
Negative 
Silk fibroin 
Supported hMSCs differentiation in 
OM (similar to control) 
[97] 
– C=O Hydrophobic Silk fibroin 
Supported hMSCs differentiation in 
OM (similar to control) 
[97] 
– PO3 
(– PO4
-
) 
Hydrophilic 
Negative 
PEG 
of several osteogenic markers at 
gene and protein levels in BM 
[11, 100-102] 
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and bone healing is provided. All peptide sequences are written, according to the usual 
standards, from the N-terminus to the C-terminus. A compilation of covalently immobilized 
peptide sequences tested as osteoinductors is presented in Table 3.  
 
 
3.1. BMP-derived peptides 
 
BMPs are a group of 18 proteins belonging to the TGF-β family. Among them, BMP-2, -7 
and -9 are the ones involved in the development of the skeleton and bone formation and 
remodeling [109–111]. They interact with the BMPR-type I and BMPR-type II cell receptors, 
which activate different signaling pathways. One of them involves the activation of LIM kinase-1 
and has implications on cytoskeleton dynamics [112]; the other involves activation of Smad1/5/8 
and its translocation into the nucleus, where it regulates the expression of some osteogenic 
genes [113–116]. In the case of BMP-2, the majority of its peptide derivatives was obtained 
from the ‘‘wrist’’ and ‘‘knuckle’’ epitopes of the parental protein, and preferentially interact with 
type I and type II cell surface receptors, respectively [110,117–119]. BMPs are potent 
osteoinductive agents, but their clinical use is often limited by their short biological half-life, rapid 
local clearance, propensity for side effects and high cost [120]. Some of these limitations can be 
partially overcome by the use of BMP-derived peptides, particularly when used in association 
with biomaterials. 
 
 
3.1.1. Surface immobilization of BMP-derived peptides 
 
Using SAMs, Moore and colleagues [51] investigated the synergistic and concentration-
dependent effects of the peptides RGD and KIPKASSVPTELSAISTLYL (73–92 residues of the 
knuckle epitope of BMP-2) [19] on bone marrow stromal cells (BMSCs). Both peptides were 
derivatized with azide (N3-GRGDS and N3-KIPKASSVPTELSAISTLYL) and grafted onto alkyne-
SAMs by click chemistry, alone or combined at a 1:1 M ratio, in gradients of 0–140 pmol cm
–2
. 
Human BMSCs were seeded onto peptide-modified surfaces and cultured in the absence of 
osteoinductive supplements for 21 days. Runx2 expression increased in the presence of the 
BMP-2 peptide, when grafted at 80–120 pmol cm
–2
, but not in the presence of RGD alone. 
When both peptides were present (1:1, total of 130 pmol cm
–2
) there was a synergistic 
enhancement of BSP expression and some signs of mineralization. This study reinforced the 
idea that, by providing cell-attachment sites, RGD peptides improve the interaction of BMP-2 
peptide with its receptors. Unexpectedly, cell proliferation and BSP expression also increased in 
the presence of COOH groups alone (200 pmol cm
–2
), which seems to contradict previous 
reports [11]. It was hypothesized that COOH groups might interact electrostatically with 
exogenously expressed proteins, including BMP-2, and increase their accessibility.  
Zouani and colleagues [63] tested a very similar BMP-2 derived sequence 
(RKIPKASSVPTELSAISMLYL) and also two other sequences, derived from BMP-7 
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(RTVPKPSSAPTOLNAISTLYF, residues 89–117) and BMP-9 (RKVGKASSVPTKLSPISILYK, 
residues 68–87). RGD peptides were also used to promote cell adhesion. Peptides were grafted 
through their terminal amines to the COOH groups of oxidized poly (ethylene terephthalate) 
(PET) by carbodiimide chemistry at the same initial concentration (10
-3
 M). Murine pre-
osteoblastic MC3T3-E1 cells were cultured on PET surfaces in osteoinductive medium. 
Throughout the first 12 h, however, cells were maintained without serum to avoid its proteins 
from interfering in the initial BMP peptide–cell interaction, which is something that cannot be 
replicated in an in vivo environment. After 24 h, several osteogenic markers were shown to be 
up-regulated in all BMP–RGD–PET surfaces, namely Runx-2, BSP, OPN and ALP, as 
compared to oxidized PET and RGD–PET, suggesting that BMP peptides effectively interacted 
with cell membrane receptors. Unsurprisingly, BMP-2 presenting surfaces were the more 
osteoinductive ones, which was further confirmed by an increased production of endogenous 
ECM. These differences were correlated with cell morphology. Moreover, BMP-presenting 
surfaces, and especially those with BMP-2, increased the mRNA expression of different GFs 
(BMP-2, TGF-β1 and VEGF), BMP receptors and OCN during 72 h of culture, as well as the 
extent of mineralization after only 5 days of culture. Overall, these results confirm the possible 
advantages that BMP-2 peptides may present over other peptides.  
More recently, the interplay between biochemical (BMP-2 peptides) and mechanical cues 
on hMSCs differentiation was addressed by the same group [64]. RGD and 
RKIPKASSVPTELSAISMLYL were grafted onto poly (acrylamide-co-acrylic acid) (pACAA) 
surfaces of different stiffnesses through carbodiimide chemistry. hMSCs sensed the different 
mechanical environments, committing into muscle-like and osteoblast-like cells on RGD–pACAA 
surfaces with 15 and 48 kPa stiffnesses, respectively, after 96 h of culture. The authors were 
able to show that the effect of biochemical stimuli may overlap those of mechanical ones 
(whenever stiffness >13 kPa), as hMSCs only differentiated along the osteogenic lineage when 
BMP-2 peptides were present. However, osteogenic differentiation was inhibited on the softer 
BMP-2 surfaces (0.76–3.21 kPa), which presumably did not promote a favorable F-actin 
cytoskeleton reorganization, which is essential for BMP-induced Smad1/5/8 phosphorylation 
and nuclear translocation, as the authors also demonstrated. The results from this study 
contribute to uncovering the key role of matrix mechanical properties during osteogenesis and, 
importantly, their coordination with the biochemical environment.  
He and colleagues [21] tested the same BMP-2 sequence, KIPKASSVPTELSAISTLYL, in 
the form of an azide-functionalized PEGylated peptide (Az-mPEG–BMP), which was grafted 
onto RGD-modified or unmodified hydrogels of poly(lactide-co-ethylene oxide fumarate) 
(PLEOF) by click chemistry. The final peptide concentrations used on cell studies were 1.6 pmol 
cm
–2
 for RGD and 5.2 pmol cm
–2
 for BMP-2, respectively. Under osteoinductive conditions, ALP 
activity and mineralization of rat BMSCs were similar in BMP2–PLEOF and RGD–PLEOF 
hydrogels, but when both peptides were present they acted synergistically to enhance cell 
differentiation. In a more recent study [65], the OPN-derived sequence SVVYGLR (OPD 
peptide), which corresponds to residues 162–168 of OPN and is known to influence 
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vasculogenesis [121], was used as a third peptide. For orthogonal grafting, the RGD–PLEOF 
hydrogel was first conjugated with propargyl acrylate to create alkyne moieties and with 4-
pentenal to create aldehyde moieties, then reacted with Az-mPEG–BMP and aminooxy-mPEG–
OPD peptides by click reaction and oxime ligation, respectively. The final peptide 
concentrations used on cell studies were 13.8 pmol cm
–2
 for OPD and 5.4 pmol cm
–2
 for BMP-2. 
Rat BMSCs were seeded on top of hydrogel disks and cultured in osteoinductive medium 
supplemented with vasculogenic factors for 28 days. The tested groups included hydrogels with 
RGD, RGD + BMP2, RGD + BMP2 + mOPD (a mutated OPD) and RGD + BMP2 + OPD 
peptides. The RGD hydrogels co-functionalized with OPD and BMP-2 yielded the best results in 
terms of ALP activity, mRNA expression of OPN and OC, and extent of mineralization. 
Moreover, both peptides were essential for the expression of vascular markers such as 
PECAM-1, α-SMA and VE-cadherin. In summary, the three peptides (RGD + BMP2 + OPD) 
acted cooperatively to provide a favorable microenvironment for concomitant BMSCs 
osteogenesis and vasculogenesis.  
Lin et al. [66] changed the terminal residues (underlined) of the previously described 
BMP-2 peptide, and showed that the sequence S
[PO4]
 KIPKASSVPTELSAISTLYLDDD 
(designated by P24) was able to induce bone formation. P24 has a high content of D and 
(phosphorylated) S that might promote apatite nucleation and enhance mineralization. The 
peptide was coupled by carbodiimide chemistry through its terminal COOH groups to the amine 
groups of a biodegradable copolymer of poly(lactic-co-glycolic acid) (PLGA) with segments of 
PEG and aspartic acid units (PLGA–(PEG–Asp)n) [66,122]. The incorporated PEG and Asp 
increased the polymer hydrophilicity and provided anionic functional groups that acted as 
peptide-binding sites. The aim was to use the P24-modified scaffolds as a delivery system for 
the sustained release of P24. In vitro, in osteoinductive medium, the ALP activity and 
mineralization pattern of rat BMSCs cultured on P24-modified scaffolds were increased 
compared to on unmodified membranes. Moreover, these scaffolds promoted ectopic bone 
formation upon subcutaneous implantation in rats. Their performance was significantly better 
than that of the other groups (unmodified scaffolds or gelatin sponges), as demonstrated by 
radiographic and histological examination, Western blotting and reverse transcriptase-
polymerase chain reaction (COL-I and OPN). 
 
 
3.1.2. Bulk immobilization of BMP-derived peptides 
 
One successful demonstration of ectopic bone formation using a covalently immobilized 
BMP-2-derived peptide was provided by Suzuki and colleagues in 2000 [17]. The authors 
prepared covalently crosslinked alginate hydrogel scaffolds by reacting 1-ethyl-
(dimethylaminopropyl)-carbodiimide (EDC) and sodium alginate in aqueous solution, followed 
by freeze-drying. The peptide, with the sequence NSVNSKIPKACCVPTELSAI, was grafted onto 
alginate COOH groups by carbodiimide chemistry. A control material was prepared by mixing 
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the same amount of peptide with alginate but without the coupling agent, resulting in simple 
entrapment (10 mg of alginate with 180 μg of peptide). Both materials were implanted for 3 and 
8 weeks in the calf muscle of Wistar rats. The formation of new bone tissue and vascular 
channels was only observed in the group with the covalently grafted peptide, highlighting the 
advantages of this type of immobilization. Surprisingly, given that alginate is non-cell adhesive, 
good results were obtained even in the absence of RGD peptides. The authors highlighted the 
importance of further characterizing the time course and dose–response dependence of the 
observed effects, but no subsequent studies using this exact peptide sequence have been 
found.  
In a subsequent study, Saito and co-workers [70] tested the slightly different sequence 
KIPKASSVPTELSAISTLYL (already described above). In its soluble form, this peptide was 
shown to increase ALP activity in the murine multipotent stromal cell line C3H10T1/2, and 
interact with both types of BMP receptor [19]. Peptide–alginate hydrogel scaffolds were 
prepared using the methodology described above, and implanted in the same animal model (3 
mg of alginate with 75 μg of peptide) [70]. Collagen gels impregnated with recombinant BMP-2 
(3 mg of collagen with 3 μg of protein) were used as a control. While the peptide–alginate gel 
showed prolonged formation of a calcified bone-like tissue for up to 7 weeks, with large 
numbers of osteoblasts, the control exhibited maximal calcification after 3 weeks, which 
progressively disappeared, probably being absorbed by osteoclasts, which were present in 
large amounts. Apparently, in contrast to the impregnated protein, the grafted peptide remained 
active at the implant site, exerting a continuous local effect. The differences between the 
materials (alginate vs. collagen) and the quite different molar amounts of peptide vs. protein 
implanted were not, however, taken into account when the results were discussed.  
Using a different rationale, Lee and co-workers [58] tested the osteoinductive effect of 
several domains from human BMP-2, corresponding to residues 1–25, 26–50, 51–75 and 76–
110. The segment 26–50, which provided the best results in terms of cell adhesion, was further 
segmented into short 4–5 amino acid sequences (VGWN, DWIVA, PPGYH, AFYCHG, and 
ECPFP), and out of these the sequence DWIVA was the one that presented the highest binding 
activity to BMP receptors type IA and II. A hydrophobic aliphatic tail (C16) tail was attached to 
DWIVA, via an amide bond, to create a self-assembling peptide (SAP). In the presence of 
calcium, this amphiphile self-assembles into a nanofibrous hydrogel with surface-exposed 
DWIVA (or DFMLG, a control non-bioactive sequence). hMSCs were entrapped within this 
hydrogel and cultured under osteoinductive medium. Higher levels of phosphorylated Smad, 
ALP activity and mineralization were found in cells cultured within the DWIVA-SAP hydrogels, 
as compared to the control. Similar results were obtained when cells were treated with even 
higher concentrations of free peptide (1.67 vs. 0.7 mM), indicating that the bioactivity of DWIVA 
is retained upon immobilization. 
 
 
 
41 
 
3.2. Collagen type I-derived peptides 
 
The most highly expressed integrins in osteoprogenitors and osteoblasts belong to the β1 
sub-family, being predominant mediators of cell adhesion in these cells [46]. The α2β1 integrin 
is highly expressed on osteoblasts, being one of the major adhesion receptors for COL-I [123]. 
The interactions between this integrin and its ligand activate focal adhesion kinases, and initiate 
key pathways for the induction of osteoblastic differentiation and matrix mineralization [28,124]. 
Based on this, COL-I-derived peptides have been used as cell adhesion mediators to ultimately 
induce osteogenic differentiation, as previously pointed out. 
 
 
3.2.1. Surface immobilization of COL I-derived peptides  
 
Wang and co-workers [61] selected the bone and cartilage synthetic peptide (BCSPTM-1), 
derived from human COL-I, with the sequence NGLPGPIGP. BCSPTM-1 was chemically bound 
to a commercial ceramic surface (SkeliteTM) in three steps. First, amine moieties were created at 
the ceramic surface by grafting (3-amino-propyl) triethoxysilane (APTES) to free hydroxyl 
groups through silanization. Then, through succinylation, amine functionalities were converted 
into esters, to which peptides where grafted via their terminal amines. Rat calvaria cells were 
first cultured for 3 days with 0.28 mM of ascorbic acid and then seeded on peptide-bound 
ceramic surfaces with different peptide densities for 10 days. The specific ALP activity on these 
surfaces was nearly three-fold higher than in control non-modified ceramics, being the 
maximum activity achieved at a peptide density of 0.87 nmol cm
–2
. 
 
 
3.2.2. Bulk immobilization of COL I-derived peptides  
 
A more complex triple helical sequence with the COL-I-derived motif GFOGER has also 
been proposed. GFOGER corresponds to residues 502–507 of the α1 chain of COL-I and 
selectively binds to α2β1 integrin [125]. Promising results were obtained when this peptide was 
used to non-covalently coat titanium surfaces. Compared to untreated Ti, GFOGER-Ti triggered 
osteoblastic differentiation and mineral deposition in vitro, and enhanced osseointegration in 
vivo [28]. Good osseointegration was also observed when the same peptide was adsorbed at 
the surface of polycaprolactone scaffolds [126]. However, the effect of GFOGER has not been 
compared with other peptides, such as RGD, in any of the studies mentioned. In a subsequent 
work, GFOGER was covalently coupled to agarose hydrogels to evaluate its effect on the 
regulation of 3-D chondrogenesis [71]. The prototypical RDG sequence and the Fn-derived 
sequence FnIII7-10, which binds to a5b1 integrin, were also tested [71]. Peptides were grafted 
onto agarose hydrogels in a two-step reaction. First, their primary amines were reacted with 
NHS-ester groups of the crosslinker sulfo-SANPAH. The crosslinker was then mixed with 
agarose, and its photoreactive groups were activated by ultraviolet radiation for conjugation to 
 
 
42 
 
agarose CH groups. BMSCs were cultured within peptide–agarose hydrogels (with 1 μM FnIII7-
10, 15 μM GFOGER or 100 μM RGD) for 1 week. BMSCs osteogenic differentiation was 
assessed under basal conditions by looking to the mRNA expression of COL-I and OCN. It was 
demonstrated that RGD peptides, but not GFOGER or FnIII7-10, increased COL-I. Moreover, 
the GFOGER and RGD peptides enhanced OCN at similar levels, whereas FnIII7-10 inhibited 
its expression. In general, the overall effect of GFOGER was not superior to that of RGD. 
However, the differential effects of the various ligands in osteogenesis were not studied in 
detail, as that was beyond the scope of the study.  
 
 
3.3. Small integrin-binding ligand N-linked glycoproteins (SIBLING)-derived peptides  
 
The ECM of bone and dentine is rich not only in collagenous but also in non-collagenous 
proteins, including those belonging to the SIBLING family [127]. This family of proteins is 
involved in the process of bone mineralization, and includes matrix extracellular 
phosphoglycoprotein (MEPE), OPN, BSP, dentin matrix protein 1 and dentin 
sialophosphoprotein [128]. Although these phosphoproteins are distinct in their structures, they 
also share some similarities, such as presenting RGD-like motifs, glutamic acid-rich sites known 
to induce hydroxyapatite nucleation, and collagen-binding domains [127,129]. 
 
 
3.3.1. BSP-derived peptides 
 
BSP is the major non-collagenous protein in bone, and it shows a high degree of 
specificity in osteoblastic-like cell attachment [130,131]. It is considered as a major nucleator of 
hydroxyapatite crystal formation, and its expression correlates with the onset of matrix 
mineralization [132]. BSP is present in the bone matrix at late stages of osteoblast 
development, being primarily localized around mature osteoblasts and osteoblasts trapped in 
newly formed matrix [133]. 
 
 
3.3.1.1. Surface immobilization of BSP-derived peptides.  
Rezania and colleagues [29,134] tested the effect of the BSP-derived peptide 
CGGNGEPRGDTYRAY (pRGD) on rat calvaria cells. Peptides were grafted onto maleimide-
functionalized quartz surfaces through thiol groups present in terminal C residues. Different 
peptide densities, ranging from 0.01 to 3.6 pmol cm
–2
, were tested. After 3 weeks of culture in 
mineralization medium (basal medium supplemented with ascorbic acid and β-
glycerophosphate), enhanced mineralization was observed in cells exposed to ligand 
concentrations of 0.62 pmol cm
–2
 or higher, as compared with lower concentrations or control 
surfaces (with RGE in place of RGD). However, the mechanisms by which the initial 
engagement of adhesive ligands mediated the long-term effect were not elucidated. These 
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mechanisms were more recently investigated by Drevelle and colleagues [135] using the same 
peptide, but this time immobilized on polycaprolactone (PCL). The peptides, pRGD or control 
pRGE, were linked through their C-termini to PCL films previously functionalized with 
ethaneamine hydrochloride. In serum-free medium, MC3T3-E1 osteoblasts were only able to 
spread on pRGD–PCL. Additionally, only on those surfaces cells presented an organized 
cytoskeleton, activated intracellular FAK signaling and responded to BMP-2 by activating their 
canonical Smad pathway. More recently, the same group tried to elucidate how MC3T3-E1 cells 
cultured in the presence of these peptides respond to BMPs, in terms of signal transduction and 
differentiation. Cells were cultured on PCL substrates in serum-free medium, and were treated 
with 0.38 nM of BMP-2 and/or BMP-9 [136]. Treatment with both BMPs similarly affected the 
kinetics of MAPK activation, but their effects on Smad activation and b-catenin stabilization 
were different. In terms of cells osteogenic differentiation, both BMPs increased Dlx5, osterix 
and OCN transcripts, and also ALP activity, compared to unstimulated samples. This study shed 
some light on the mechanisms that underlie the effect of biomimetic materials on cells response 
to GFs. 
 
 
3.3.2. MEPE-derived peptides 
 
Similarly to other proteins from the SIBLING family, MEPEs also play a key role in 
phosphate regulation, bone mineralization and osteogenesis. MEPEs contain not only RGD-like 
motifs, but also the amino acid sequence SGDG known to promote glycosaminoglycan (GAG) 
attachment [137]. MEPE expression has been predominantly found in osteoblasts. Most of the 
studies to date have used this peptide in a soluble form [137–139]. 
 
 
3.3.2.1. Surface immobilization of MEPE-derived peptides.  
Only recently, Acharya and co-workers [59] immobilized a MEPE-derived peptide, with 
the sequence TDLQERGDNDISPFSGDGQP, at the surface of hydroxyapatite/β-tricalcium 
phosphate (HA/β-TCP) particles to induce bone regeneration in local defects. The 
immobilization strategy comprised two steps. First, OH groups on the ceramic surface were 
silanized to create amine moieties, which were PEGylated with PEG disuccinimidyl succinate. 
Peptides were then coupled through the N-terminal to the PEG linker. It is noteworthy that, 
although the peptide immobilization was demonstrated, the effectively grafted amount was not 
quantified. Peptide-functionalized ceramic particles were combined with a fibrin vehicle and 
implanted into calvarial defects created in mice. Eight weeks later, the composite was recovered 
and increased new bone formation was observed in peptide-modified HA/β-TCP particles 
compared to unmodified ones, as indicated by microcomputerized tomography and hematoxilin 
& eosin staining. The newly formed bone was actively remodeled by osteoclasts. Overall, this 
multifunctional peptide combining RGD with a motif that promotes GAG attachment showed 
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great potential for in vivo bone regeneration strategies. Nevertheless, future studies to elucidate 
the underlying mechanisms and its effect on MSCs differentiation should be addressed.  
 
 
3.3.3. OPN-derived peptides  
 
OPN is a glycosylated phosphoprotein expressed by different cell types, but prominently 
localized in the ECM of mineralized tissues, such as bone, being involved in the regulation of 
their formation and remodeling [140,141]. OPN is able to bind not only to cells via a RGD 
sequence that recognizes the α4β1 integrin, but also to other ECM components via less 
characterized peptide sequences [142]. As previously pointed out, similarly to other 
phosphoproteins, OPN has the capacity to complex to collagen fibrils and induce bone 
mineralization. This interaction involves a specific region, called collagen-binding motif [143].  
 
 
3.3.3.1. Surface immobilization of OPN-derived peptides.  
Shin et al. [18, 20,144] have been studying the effect of OPN-derived peptides on MSCs 
behavior using oligo (poly (ethylene glycol) fumarate) (OPF) macromers with alternating PEG 
chains and fumarate groups. Two cell adhesion peptides have been covalently grafted onto 
OPF, namely RGD and the DVDVPDGRGDSLAYG (ODP) sequence derived from rat OPN. To 
prepare peptide-modified hydrogels, each peptide was acrylated and reacted with acryloyl-
PEG–NHS at different concentrations (0.1, 1.0 or 2.0 μmol g
–1
 of hydrogel). In an initial study, 
osteoblasts were shown to be able to attach and proliferate on ODP-modified and RGD-
modified hydrogels at similar rates [20]. For differentiation studies, rat MSCs were seeded on 
top of both peptide-modified hydrogels and cultured under osteoinductive conditions [144].When 
compared to unmodified hydrogels and TCPS surfaces, ODP hydrogels enhanced the 
differentiation and mineralization of MSCs, as verified by higher ALP activity, OPN secretion 
and calcium deposition, in a concentration-dependent manner. However, the effect ODP in 
enhancing osteogenic differentiation was not different from the effect of RGD. Lee et al. [69] 
tested different fragments from human OPN, and identified the sequence 
GLRSKSRRFRRFDIQYFDATDEDITSHM (CBM, residues 150–177) as the region presenting 
the highest binding affinity to collagen. Within this sequence, the amino acids D and E are the 
ones responsible for calcium binding, which in turn promotes mineralization [130]. CBM was 
grafted onto alginate by carbodiimide chemistry (0.007–35 mg of CBM per g of alginate) and the 
collagen-binding ability of CBM was apparently maintained in peptide–alginate hydrogels. 
hMSCs were cultured on top of CBM-modified hydrogels, control peptide-modified hydrogels 
(residues 53–80, with the lowest collagen affinity) and non-modified gels for 28 days, and the 
cell response was analyzed. Cells adhesion, spreading and proliferation were improved on 
CBM–alginate. Differentiation assays were performed using hydrogels with 700 μg of peptide 
per mg of gel, under standard induction medium, for 28 days. The best results were obtained 
with CBM–alginate, as shown by the enhancement of ALP activity compared with control 
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peptide-modified hydrogels, and by the expression of activated Smad. Importantly, when 
implanted in rabbit calvarial defects for 4 weeks, the CBM–alginate hydrogel induced 
significantly more new bone formation than unmodified alginate. Although the role and biologic 
activity of the OPN collagen-binding motif have not yet been well established, this study 
suggests its applicability as an active component for clinical bone regeneration procedures. 
 
 
3.4. PTH-derived peptides 
 
PTH is an 84-amino-acid hormone that acts as a regulator of calcium homeostasis and 
plays important roles in bone remodeling. PTH1–34 is a truncated peptide with 34 amino acids 
derived from the N-terminus of PTH that retains most of its bioactivity. Currently, PTH1–34 
(commonly referred to as teriparatide) is used as an anabolic agent in the systemic treatment of 
osteoporosis. However, depending on the dose and administration regimen, it can also have 
catabolic effects. Moreover, multiple mechanisms of action and target cell types are involved in 
PTH1–34-stimulated bone repair, as recently reviewed by Takahata et al. [145]. A few studies 
have addressed the effect of immobilized PTH1–34 in local therapies and bone TE strategies. 
  
 
3.4.1. Surface immobilization of PTH-derived peptides 
 
In one of the first available studies, PTH1–34 was covalently coupled to silk films [30] by 
carbodiimide chemistry, at an estimated final density of 20 pmol cm
–2
. However, no positive 
effects in terms of differentiation of osteoblast-like cells (Saos-2) were demonstrated when 
compared to RGD-modified silk. Sharon and Puleo [67] reported a strategy for the controlled 
immobilization of bioactive PTH1–34 through attachment to a biodegradable polymer (PLGA) via 
its N-terminus. The N-terminal serine residue of the peptide was first oxidized to yield a single 
aldehyde moiety, which was then specifically bound to hydrazide–PLGA, forming a hydrazone 
bond. Dihydrazide spacers with different lengths were tested, and the accessibility of the 
tethered peptide was shown to increase with spacer length, as probed with antibodies directed 
to both the N- and C-terminus of the peptide. The longest spacers also increased the bioactivity 
of immobilized PTH1–34, compared to randomly bound or adsorbed peptide, showing a higher 
stimulation of intracellular synthesis of cAMP by pre-osteoblastic MC3T3-E1 cells. In a more 
recent study by Yewle et al. [60], oxidized PTH1–34 was conjugated via the N-terminal aldehyde 
to single molecules of hydrazine bisphosphonates (HBPs), which present a high bone-binding 
affinity. The PTH–HBP conjugates were immobilized on bone wafers, to simulate the bone 
surface, and the bioactivity of PTH1–34 was demonstrated as described in the previous study. 
The selective conjugation of PTH1–34 with HBPs increased its affinity to bone and improved its 
interaction with cells once delivered. Although these results are quite interesting, the effects of 
conjugated PTH1–34 are yet to be investigated further in more specific in vitro osteogenesis 
assays, or in terms of in vivo bone formation. 
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3.4.2. Bulk immobilization of PTH-derived peptides 
 
The beneficial effects of PTH locally delivered into bone defects were recently 
demonstrated in an elegant work by Arrighi et al. [146]. The strategy consisted on derivatizing 
fibrin matrices with an engineered active fragment of PTH1–34, using a plasmin-sensitive 
substrate sequence as a linker (pl). Once in vivo, the enzymatic cleavage of the linker by 
endogenous plasmin results in cell-driven release of PTH1–34 in situ. The fusion peptide 
(TGplPTH1–34) was obtained by linking the N-terminus of the PTH1-34 to the coagulation 
transglutaminase (TG) factor XIIIa, which covalently crosslinks the peptide into the fibrin 
network during polymerization. The TGplPTH1–34 pro-drug is inactive, preventing the eventual 
activation of osteoclasts at the time of injection when the local concentration of PTH1–34 is high 
[147], but it converts into fully functional PTH1–34 upon plasmin-induced proteolytic cleavage. In 
vivo studies were performed using epiphyseal drill defects created in sheep, which were filled 
with TGplPTH1–34-derivatized (50–1000 μg ml
–1
) or non-derivatized fibrin gels. Bone formation 
was observed in the presence of PTH in a dose-dependent fashion, demonstrating a strong 
healing potential, with evidence of both osteoconductive and osteoinductive mechanisms. The 
same group started clinical trials in humans to investigate the therapeutic efficacy of this PTH-
fibrin matrix in bone healing. In another study, Jung et al. [62] used an RGD-modified PEG-
based matrix containing covalently bound PTH1–34 peptides. To prepare functionalized PEG 
hydrogels, cys-PTH1–34 and cys-RGD were both added to a four-arm PEG-acrylate solution, and 
cysteine thiol groups were allowed to react with the PEG-acrylate. Afterwards, this solution was 
combined with another solution of linear PEG-dithiol and the gelling mixture was loaded into a 
syringe for surgical application. The final concentrations of each peptide in the PEG hydrogels 
were 20 μg ml
–1
 (PTH1–34) and 350 μg ml
–1 
(RGD). The RGD–PTH1–34–PEG matrix and different 
controls were implanted in canine alveolar bone defects. Histomorphometric analysis after 4 
and 12 weeks revealed that the PTH1–34 group presented enhanced bone formation when 
compared with PEG alone or empty defects, with similar results being obtained with autogenous 
bone. However, the effect of RGD–PEG without PTH1–34, which would be an important control, 
was not evaluated. 
 
 
3.5. Osteogenic growth peptide (OGP) and OGP-derived peptides 
 
OGP is a naturally occurring tetradecapeptide identical to the C-terminal amino acid 
sequence (residues 89–102, ALKRQGRTLYGFGG) of histone H4 (H4), which is naturally 
present in human plasma at micromolar concentrations [148–151]. Chen and co-workers [152–
154] demonstrated that the C-terminal sequence of OGP (residues 10–14, YGFGG, hereafter 
designated as OGP10–14) corresponds to the bioactive portion of OGP that directly interacts with 
the cell surface. Upon intravenous administration in animals, both peptides were shown to 
promote increased bone mass and promote fracture healing [148,150,151]. In vitro, soluble 
OGP peptides were shown to increase osteoblasts and MSCs proliferation and to promote 
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osteogenic differentiation in a biphasic concentration-dependent manner [155]. The use of 
physically [156,157] and chemically immobilized OGP has been explored in a few works.  
 
 
3.5.1. Surface immobilization of OGP and OGP-derived peptides  
 
To clarify the effect of concentration and bioavailability of surface-immobilized OGP, 
Moore and colleagues [158] performed a systematic study using SAMs. OGP and OGP10–14 
derivatized with azide at the N-terminal were grafted by click chemistry onto SAMs 
functionalized with alkyne gradients [158]. Along the gradients, the density of grafted peptides 
ranged from 0 to 140 pmol cm
–2
. MC3T3-E1 cells were cultured on these substrates for up to 7 
days in serum-free medium. From day 0 to day 3, immobilized OGP increased cells proliferation 
independently of concentration. It is possible that OGP activity was dependent on the cleavage 
of the bioactive (10–14) sequence that, once free, subjected all cells to similar OGP10–14 
concentrations. Also, there was probably a concomitant effect of cell-secreted OGP. A positive 
effect of OGP10–14 was only observed at a lower density (40 pmol cm
–2
). Globally, the outcome 
of immobilized OGP was considered to be small compared to other immobilized GFs described 
in the literature. In another study, the effect of OGP on gene expression of osteogenic markers 
was only investigated in cells treated with soluble peptides (at 10
-7
 M). From day 3 to day 7, 
both peptides increased the expression of COL-I while decreasing the expression of Runx2, 
apparently indicating a transition of MC3T3-E1 cells from a proliferative to a maturation phase 
[159]. 
 
 
3.5.2. Bulk immobilization of OGP and OGP-derived peptides 
 
OGP was also used to functionalize the SAP AcN-RADARADARA-DARADA-CONH2 
(RADA16), through direct solid-phase synthesis extension at the C-termini (Ac 
(RADA)4GGALKRQGRTLYGF-CONH2) [22]. Its effect was compared to that of unmodified 
RADA16, and of RADA16 functionalized with either an OPN-derived motif (Ac(RADA) 
4GGDGRGDSVAYG-CONH2) or a double RGD-containing sequence 
(Ac(RADA)4GPRGDSGYRGDS-CONH2). Gel-precursor solutions were prepared (1 wt.%) by 
mixing unmodified with modified RADA16 at a ratio of 1:1, and MC3TE-E1 cells were cultured 
on top of the hydrogels in OM. After 2 weeks, the cell proliferation rate in all modified peptides 
was higher than that of pure RADA16. ALP activity and OCN expression were also increased, 
especially when PRG was used. Although this study demonstrated the effectiveness of 
immobilized OGP in enhancing cellular proliferation and differentiation, the bio-functional region 
of the peptide was apparently used in a truncated form (YGF) that, according to previous 
studies, is not fully active [154]. In a recent study, OGP10–14 was used as a crosslinker in amino 
acid-based poly (ester urea) (PEU) scaffolds [68]. OGP10–14 was symmetrically functionalized 
with K residues at both termini (KYGFGGK), with reactive vinyl groups grafted onto K side 
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chains. It was then used (at 0.5% and 1%) to photochemically crosslink phenylalanine or 
leucine-based PEU scaffolds, enhancing their mechanical properties in a concentration-
dependent manner. The proliferation of MC3T3-E1 cells cultured on PEU scaffolds was slightly 
increased in the presence of OGP10–14 at both concentrations. As the peptide was immobilized 
through both ends, the release of bioactive OGP10–14 into the medium upon enzymatic cleavage 
is improbable, suggesting that it retains bioactivity even in an immobilized form. Upon 
subcutaneous implantation in rats (12 weeks), all scaffolds degraded to some extent, but no 
signs of mineralization were observed in any of the samples. This was attributed to a number of 
factors, including the implantation site, the absence of porosity and transplanted stem cells, and 
the time frame of the study. Overall, a positive bioactive effect of OGP10–14 has not been clearly 
demonstrated. 
 
 
3.6. Heparin-binding peptides 
 
GAG chains of heparin and heparan sulphate (HS), which occur in the form of 
proteoglycans (PGs), are important components of the ECM, with the ability to bind to and 
release GFs, protecting them from degradation, increasing their local concentration and 
regulating their availability [68]. Several types of cells secrete PGs, including hMSCs. 
Interestingly, when hMSCs are cultured under basal conditions, PGs are primarily located 
intracellularly, being secreted into the extracellular milieu when cells are cultured in 
osteoinductive medium [160]. At the cell surface, HS-PGs, along with other PGs, regulate GF 
activity and morphogenic gradients, being implicated in multiple biological processes. In 
particular, they have been shown to be involved in fibroblast growth factor type 2-mediated 
[161] and BMP-mediated [160] differentiation of MSCs along the osteoblastic lineage. Based on 
their pivotal biological role, a number of methods to incorporate GAGs and PGs into synthetic 
biomaterials have been proposed [54]. One such example is the functionalization of 
biomaterials with HBPs, which are able to sequester cell-secreted PGs. These non-covalently 
immobilized PGs can then modulate cell behavior, similarly to what happens within the natural 
ECM. Cell surface HS–PG receptors also interact with heparin-binding domains present in 
adhesion proteins, acting cooperatively with RGD domains in mediating adhesion, and assisting 
the assembly of focal adhesions and actin fibers [133].  
 
 
3.6.1. Surface immobilization of heparin-binding peptides  
 
Rezania and Healy [133] produced model surfaces with different ratios of the consensus 
heparin-binding domain FHRRIKA and an RGD-like sequence, both present in BSP, using a 
heterobifunctional crosslinker to couple the peptides to amine-functionalized quartz substrates. 
The behavior of rat calvaria osteoblast-like cells when cultured on these peptide-modified 
surfaces was examined, namely in terms of matrix mineralization by Von Kossa staining. The 
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presence of the HBP enhanced mineralization compared to RGD alone, although the effect of 
grafted RGD proved to be dominant over that of FHRRIKA.  
Hudalla and co-authors showed that SAMs modified with the bioinspired heparin-binding 
sequence GGGKRTGQYKL were able to sequester serum-borne heparin [55], and designed a 
SAM-based cell culture platform to study the influence of endogenous heparin and GFs on 
hMSCs behavior [56]. Mixed SAMs with the ability to specifically sequester heparin and resist 
non-specific adsorption were formed using tri (ethylene glycol) (HS-EG3) and carboxyl-
terminated hexa (ethylene glycol) (HS-EG6-COOH) alkanethiolates. HBP or scrambled peptides 
(SP) and RGD were immobilized onto SAMs by carbodiimide reaction with COOH groups [56]. 
Using HBP–RGD-SAMs, the authors provided some preliminary evidence that hMSCs 
osteogenic differentiation was enhanced by sequestered heparin, in a BMP-dependent manner. 
In fact, under osteoinductive medium, the expression of ALP activity significantly increased in 
HBP–RGD-SAMs compared to control SP–RGD-SAMs, but this effect was suppressed upon 
BMP receptor inhibition. The expression of OPN mRNA was higher in heparin-binding RGD-
SAMs than in polystyrene surfaces, but it was not significantly different from control RGD-SAMs, 
and was not affected by BMP signaling, probably being up-regulated on SAMs as a 
consequence of hMSCs–RGD interactions. In summary, this strategy demonstrated that 
biomaterials can be designed to indirectly modulate cell behavior by: (i) non-covalently 
sequestering specific biomolecules from the medium, in this case heparin and heparin-binding 
GFs such as BMPs; (ii) presenting those GFs at the cell-material interface at a high local 
concentration; and (iii) amplifying key signaling pathways involved in proliferation and 
differentiation.  
 
 
3.6.2. Bulk immobilization of heparin-binding peptides 
 
No studies using bulk-immobilized HBP for promoting osteogenesis were found, even if 
heparin-functionalized PEG hydrogels have been shown to induce the osteogenic differentiation 
of 3-D-cultured hMSCs [162]. Alginate scaffolds have been functionalized with HBP and RGD, 
but have only been tested for cardiac applications, showing good potential to improve cardiac 
muscle tissue formation in vitro [163]. In another, very recent, example, HBP have been used to 
modify a hydrogel obtained by the copolymerization of N-vinyl pyrolidone, diethylene glycol bis 
allyl carbonate and acrylic acid. In this case, the HBP consisted on positively charged trilysine 
(KKK) or triarginine (RRR) sequences, but the objective was the development of a pro-
angiogenic biomaterial [164].  
 
 
3.7. Calcium-binding peptides  
 
Phosphorylated amino acid (serine) residues have a high capacity for binding calcium 
ions. For this reason, they play a key role in the regulation of the early stages of mineralization 
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in vivo, being involved in the process of crystal formation. For this reason, these amino acids 
have been exploited as functionalization molecules to improve the osseointegration of implant 
materials [165,166].  
Recently, peptide amphiphile (PA) materials capable of self-assembling into well-defined 
nanofibrous hydrogels were designed using peptide sequences that contained phosphoserine 
residues (S- PA) and RGDS motifs (RGD-PA). The combination of these two modifications, 
when implanted in a critical-size rat femoral defect, showed greater bone formation compared 
with serine and RGD alone [57]. The authors hypothesized that the observed effect was related 
to the capacity of these nanofibers to stimulate hydroxyapatite (HA) nucleation and enhance 
mineral deposition.  
Later, an in vitro study, in which calcium-supplemented medium was used, demonstrated 
that these PA nanofibers containing serine and phosphoserine were effectively able to nucleate 
spheroidal aggregates of carbonated hydroxyapatite [167].  
A number of strategies have been proposed to localize GF activity to mineralized ECMs 
and mineral-based biomaterials [54].  
With this aim, a class of modular peptides conjugating BMP-2-derived peptides with a 
natural HA binding unit present in OCN (γEPRRγEVCγEL, γ-carboxylated glutamic acid) has 
been proposed by Lee et al. [168–170]. The Gla residues coordinate with calcium ions in the HA 
crystal lattice to promote high levels of binding. The modular peptide 
KIPKASSVPTELSAISTLYL-AAAA-γEPRRγEVAγEL, where the (Ala)4 sequence acts as a 
spacer, has been prepared by solid-phase peptide synthesis. In a first set of studies, the 
sequence that more effectively binds to a HA-coated poly (lactide-co-glycolide) surface was 
identified, and then its biological activity on hMSCs osteogenic differentiation was evaluated. 
ALP activity, BMP-2 secretion and OCN, OPN and Cbfa1 production were enhanced when cells 
were cultured in HA surfaces modified with the modular peptide under induction standard 
medium, as compared with cells treated with the soluble modular peptide.  
Recently, another interesting type of material with HA-binding ability has been proposed, 
consisting on recombinamers (recombinant protein materials obtained from a synthetic gene) 
containing peptide motifs derived from elastin, a structural protein, and statherin, a salivary 
protein that has a high affinity for calcium phosphate [171]. Multifunctional elastin-like 
recombinamers containing the SNA15 domain of statherin (an analogue of the amino-terminal 
15-residue fragment) were prepared, and their potential as mineralization templates were tested 
by incubation in simulated body fluid at 37 ºC. In materials with a triblock structure, it was 
possible to observe calcium phosphate deposition after 1 week. However, there have been no 
studies exploiting the effect of such materials on MSCs differentiation in vitro nor on bone 
formation in vivo. 
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Parental 
molecule 
Peptide sequence Material Cells Principal effects Ref. 
BMP-2 
KIPKASSVPTELSAISTLY
L 
SAMs hBMSCs 
↑ of osteogenic markers in OM improved 
by the synergistic effect of coupled RGD 
and BMP-2 peptide 
[51] 
pACAA hBMSCs 
↑ of osteogenic markers in BM, in stiffer 
matrices and in the presence of BMP-2 
peptide 
[64] 
PET MC3T3-E1 
↑ of osteogenic markers in OM (> BMP-7 
and BMP-9) 
[63] 
PLEOF Rat BMSCs 
Mineralization extent and ALP expression 
improved by the synergistic effect of 
coupled RGD and BMP-2 peptide in OM 
[21] 
PLEOF 
Rat BMSCs 
 
↑ of osteogenic and vasculogenic markers 
in OM improved by the synergistic effect of 
coupled RGD, BMP-2 and OPD peptides 
[65] 
PLGA 
Rat BMSCs 
 
↑ of ALP expression in OM and promotion 
of ectopic bone formation in vivo 
[66] 
DWIVA SAPs hMSCs 
↑ of osteogenic markers in OM through the 
activation of Smad signal transduction. 
[58] 
BMP-7 
RTVPKPSSAPTOLNAIST
LYF 
PET MC3T3-E1 
↑ of osteogenic markers in OM (< BMP-2 
and > BMP-9) 
[63] 
BMP-9 
 
RKVGKASSVPTKLSPISIL
YK 
↑ of osteogenic markers in OM (< BMP-2 
and < BMP-7) 
COL-I 
NGLPGPIGP Skelite
TM
 
Rat calvaria 
cells 
↑ of ALP expression in BM [61] 
GFOGER 
Titanium Rat BMSCs 
↑ of osteogenic markers via α2β1 integrin–
ligand interaction in OM, and enhanced 
osseointegration in vivo 
[28] 
Agarose Calf BMSCs 
↑ of osteogenic markers and  of 
chondrogenic markers in CM (similar to 
RGD) 
[71] 
BSP CGGNGEPRGDTYRAY 
Quartz 
Rat calvaria 
cells 
↑ of mineralization  in OM for peptide 
densities >0.6 pmol/cm
2
 
[29, 
134] 
PCL MC3T3-E1 
Spread on pRGD-PCL and responded to 
rhBMP-2 by activating their canonical 
Smad pathway in BM 
[135] 
OPN 
DVDVPDGRGDSLAYG OPF Rat MSCs 
↑ of osteogenic markers, cell attachment 
and proliferation in OM in a concentration-
dependent manner (similar to RGD) 
[20, 
144] 
GLRSKSRRFRRFDIQYF
DATDEDITSHM 
Alginate hMSCs 
↑ of osteogenic markers in OM and new 
bone formation in vitro 
[69] 
OCN γEPRRγEVCγEL HA-PLG hMSCs ↑ of osteogenic markers in OM [169] 
PTH 
SVSEIQLMHNLGKHLNS
MERVEWLRKKLQDVHNF 
Silk Saos-2 
↑ of osteogenic markers in BM (< than 
RGD) 
[30] 
HBPs MC3T3-E1 
↑ HBPs affinity to bone and improved 
HBPs interaction with osteoblastic cells in 
BM 
[60] 
OGP 
YGFGG 
SAMs MC3T3-E1 
Higher osteoblastic cells proliferation in 
BM 
[158] 
PEU MC3T3-E1 
↑ cell proliferation in BM and ↑ levels of 
degradation accompanied by higher 
number of blood vessels but no 
mineralization was observed in vivo 
[68] 
ALKRQGRTLYGF SAPs MC3T3-E1 
↑ of osteogenic markers in OM (< than 
PRG) 
[22] 
Heparin 
binding 
peptide 
FHRRIKA Quartz 
Rat calvaria 
cells 
↑ of mineralization in OM (< than RGD) [133] 
GGGKRTGQYKL SAMs hMSCs 
↑ of osteogenic markers in OM enhanced 
by the sequester of heparin and improved 
by the synergistic effect with coupled RGD 
[56] 
 
 
 
 
 
 
Table 3. Examples of covalently immobilized peptide sequences tested as osteoinductors. 
ALP – alkaline phosphatase; BM – Basal medium; BMP-2 – bone morphogenetic protein-2; BMP-7 – bone morphogenetic protein-7; 
BMP-9 – bone morphogenetic protein-9; BSP – bone sialoprotein; calf BMSCs – calf bone marrow stem cells; CM – chondroinductive 
medium; Col-I – collagen type I; HA-PLG – hydroxyapatite-poly(lactide-coglycolide); HBPs – hydrazine-bisphosphonates; hBMSCs – 
human mesenchymal stem cells; OCN – osteocalcin; OGP – osteogenic growth peptide; OM – osteoinductive medium; OPF – 
oligo[poly(ethylene glycol) fumarate; OPN – osteopontin; pACAA – poly(acrylic acid-co-acrylamide); PCL – polycaprolactone; PET – 
polyethylene terephthalate; PLEOF – poly(lactide-co-ethylene oxide fumarate); PEU – polyether urethane; PLGA – poly(lactic-co-
glycolic acid); PTH – parathyroid hormone; rat BMSCs – rat bone marrow stem cells; rat MSCs – rat mesenchymal stem cells; SAMs 
– self-assembly monolayers; SAPs – self-assembling peptides;  – decreased; ↑ – increased. 
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4. OTHER OSTEOINDUCTIVE SMALL MOLECULES  
 
There are several other classes of small compounds, with different mechanisms of action 
that have also been covalently coupled to biomaterials and used as osteoinductors. In many 
cases, the beneficial effect of those compounds in a soluble form had been previously 
demonstrated, providing the rationale for investigating their use as bioactive molecules in drug-
releasing scaffolds, to be released in situ upon material and/or linker degradation. For example, 
Nuttelman et al. [101] covalently grafted dexamethasone, typically used as supplement in 
osteoinductive medium, to PEG through a degradable lactide acid link using diisopropyl 
carbodiimide chemistry. Dexamethasone was released from this system upon degradation of 
the lactic acid bonds, and proved to be biologically active as it enhanced the osteogenic 
differentiation of encapsulated hMSCs in vitro, as suggested by a significant increase in Cbfa1 
gene expression. A similar strategy has been followed using statins as bioactive molecules 
[172]. These small naturally occurring compounds are composed of a dihydroxyheptanoic acid 
unit and a ring system with different substituents. Structural/compositional variations give rise to 
different types of statins with distinct pharmacological properties [173]. Statins are widely 
recognized for their effect in lowering blood cholesterol levels, as inhibitors of the 3-hydroxy-3-
methylglutaryl coenzyme A (HMG CoA) reductase. However, back in 1999 [174,175], statins 
were included in a study in which more than 30,000 compounds were screened for their ability 
to stimulate the BMP-2 promoter, and hence bone formation. Surprisingly, lovastatin and 
simvastatin were the only two compounds that showed a positive result [175]. Later, this effect 
was corroborated in an in vivo study, where statins were shown to stimulate bone formation 
when administered to rats, either systemically or locally in bone. In more recent studies, these 
compounds were combined with biomaterials for bone regeneration therapies. Benoit et al. 
[172] synthesized a fluvastatin-releasing monomer that was covalently incorporated into PEG 
through a lactide acid link. In the absence of other osteoinductive factor, the released fluvastatin 
not only promoted hMSCs osteogenic differentiation, as suggested by the increase in Cbfa1, 
ALP and COL-I gene expression, but also stimulated BMP-2 production. Whang et al. [176] 
grafted simvastatin to hydrolytically degradable poly (lactide-co-glycolide) before scaffold 
formation, and tested its effect on rat BMCs in vitro. The immobilized simvastatin was able to 
significantly enhance ALP activity and mineralization. Some of these novel molecules have 
been shown to act cooperatively with BMPs [177], but in many cases the molecular basis for 
their activity has not yet been identified. Most of these compounds were not included in this 
review because no studies were found describing their use in an immobilized form. 
Nevertheless, by way of example, some recently described compounds are listed in Table 4.  
With the advent of high-throughput screening (HTS), many other small molecules with 
osteogenesis-inducing activity have been identified recently [177–180]. In fact, HTS not only 
allows for the rapid checking of thousands of molecules involved in a specific biological process, 
but may also lead to the discovery of unpredicted signaling pathways and molecular 
mechanisms. For example, Alves and co-workers [179] recently identified some promising 
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compounds from a library of 1280 pharmacologically active small molecules using an in-house 
developed HTS assay, even without the need of expensive robotic techniques. From a tissue 
engineering perspective, these small molecule discoveries could be valuable for the design of 
novel biofunctional materials.  
 
 
 
Molecule Cell type Machanism/target(s) Ref. 
cAMP hMSCs Activation of PKA pathway [181] 
Forskolin hMSCs Activation of PKA pathway [182] 
Flavonoids hMSCs 
BMP and Wnt/beta-catenin signaling 
pathways 
[183] 
Purmorphamine 
Mouse embryonic mesoderm 
fibroblasts C3H10T1/2 
Unknown [178] 
Phenamil 
M2-10B4 (M2) mouse marrow 
stromal cells, 
Mouse ES cells, C3H10T1/2 
MSCs line, Mouse calvarial 
organ culture 
Trb3-dependent promotion of BMP 
action 
[177] 
Resveratrol 
Human ES-derived MSCs, 
canine AD-MSCs, mouse 
MSCs, mouse MC3T3-E1 
Upregulation of RUNX2 gene 
expression via the SIRT1/FOXO3A 
axis 
[184, 
185] 
 
 
a
 Examples depicted in this table are illustrative rather than inclusive. BMP – bone morphogenetic proteins; cAMP – 
cyclic adenosine monophosphate; canine AD-MSCs –canine adipose mesenchymal stem cells; C3H10T1/2 MSCs – 
C3H10T1/2 mesenchymal stem cells; ES cells – mouse embryonic stem; hMSCs – human mesenchymal stromal cells; 
Human ES-derived MSCs – human embryonic stem cell-derived mesenchymal progenitors; mouse MSCs – mouse 
mesenchymal stem cells; PKA – protein kinase A; Trb3 – tribbles homolog 3. 
 
 
Finally, there are additional types of small molecules that target other regulatory 
processes, namely by modulating the expression of specific genes, which also hold great 
potential in directing stem cell fate. This is the case, for example, of small interfering RNA [186], 
and other forms of gene delivery [187–191], which are not covered in the present review. 
 
 
5. CONCLUSIONS AND FUTURE PERSPECTIVES  
 
It has become clear that biomimetic approaches to modulate cell-material interactions are 
vital not only to implement advanced TE strategies involving stem cells transplantation, but also 
to improve osseointegration of current orthopedic biomaterials. In fact, by inducing peri-implant 
bone formation, these modifications might contribute to decreasing the failure rate of implant 
devices, which still represents a large socioeconomic burden [192]. As reviewed herein, several 
small compounds with different mechanisms of action have been described to enhance 
osteogenesis and bone formation. On the one hand, small molecules are advantageous 
comparing to more complex ones. On the other hand, immobilized molecules can be more 
effective than their soluble counterparts. In some cases, as with peptides, the combined use of 
different bioactive motifs also seems to be an attractive strategy, as they can act synergistically 
Table 4. Examples of small molecules recently shown to have osteogenic-inducing activity.
a
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and potentiate each other’s effects. However, while many of these compounds have shown 
promise as osteoinductors in vitro, more studies need to be done to demonstrate their 
bioactivity in vivo as well. Moreover, the beneficial effects of many of them are still limited or 
controversial, making the search for novel molecules and immobilization strategies essential.  
As pointed out, this challenging task is being facilitated by the emergence of new 
technologies and methodologies for HTS. Yet, while HTS methods will indeed deliver many new 
molecules, these can only make an impact when they can be applied to a large range of 3-D 
materials for bone regeneration. HTS approaches have already been applied to the study of 
cell-material interactions by using miniaturized material-based array platforms obtained by 
various microfabrication technologies, such as micropatterning, bioprinting and microfluidics 
[193]. Anderson et al. [194] performed one of the first studies demonstrating the usefulness of 
material-based HTS systems. This work examined the effects of different biomaterial 
compositions in human embryonic stem cell attachment, growth and differentiation using an 
array of synthetic polymers, where 1700 different conditions were screened to evaluate cell-
material interactions. Since then, many different other cell-material HTS platforms have been 
developed, both in two dimensions, e.g., microarrays of SAMs [195], ECM proteins [196] and 
biomaterials [197], and in three, such as spots of cell-laden hydrogels [198].  
Although young, this field has been progressing rapidly and more complex HTS platforms 
are being produced. Greater investment in existing and new HTS techniques will certainly 
contribute to our understanding of the role of several cues in MSCs osteogenic differentiation, 
and help to more rapidly identify novel and unique biomaterial–molecule combinations with a 
view to optimizing therapeutic approaches. In a certain way, materials become ‘‘cell-instructive’’, 
a property that was previously reserved for GFs and other signaling molecules [199]. This paves 
the way to the improvement of the biomaterials’ biological performance for clinical applications, 
in a more cost-effective way. 
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ABSTRACT 
 
Cell behaviour within 3D matrices is regulated by a number of matrix-intrinsic and extrinsic 
factors that must be carefully controlled, as they differentially affect distinct cellular activities. In 
this study, we have examined the influence of the initial cell entrapping density on the behaviour 
of human mesenchymal stem cells (hMSCs) cultured within RGD-alginate hydrogels. Initial cell 
densities in the range of 2×10
6
 to 15×10
6
 cells/mL were tested. Independently of the cell 
density, hMSCs in 3D presented steady-state levels of metabolic activity and remained in a 
nearly non-proliferating state, yet they recovered “normal” activity levels after being retrieved 
from 3D matrices and re-cultured as monolayers under standard 2D conditions. A high cell 
density showed to be crucial for promoting the establishment of cell-cell contacts and the 
formation of multicellular clusters within these matrices, which in turn promoted the deposition of 
endogenous ECM components, particularly collagen and fibronectin, and stimulated hMSCs 
differentiation along the osteoblastic lineage. The formation of such ECM-rich multicellular 
clusters present an interesting potential for tissue engineering applications. Importantly, this 
study highlights the importance of optimizing the initial cell entrapping density when establishing 
3D cultures for specific applications.  
 
 
 
 
 
 
 
 
Keywords: Cell density; 3D culture; alginate hydrogels; mesenchymal stem cells (MSCs); cell 
aggregation.  
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1. INTRODUCTION 
 
Three-dimensional (3D) matrices can be used to create cellular microenvironments that 
recapitulate many important features of native extracellular matrices (ECM). Therefore, these 
types of substrates have been widely investigated not only as advanced 3D models for in vitro 
cell culturing, but also as scaffolds for cell transplantation. Hydrogels have emerged as one of 
the most widespread types of 3D matrices, as they intrinsically exhibit several ECM-like 
properties, providing cells with highly-hydrated, permeable and mechanically compliant 
microenvironments [1, 2]. Due to a number of appealing properties, which include their ability to 
reversibly form hydrogels under mild conditions, alginates are one of the most common 
materials used for cell entrapment [3].   
More recently, alginates have also become one of the most popular cell vehicles, the so-
called bio-inks, to produce artificial tissues or organs of complex 3D structure using bioprinting 
technologies [4, 5]. Alginate hydrogels are highly versatile, and different strategies can be used 
to fine-tune their biochemical and viscoelastic properties. Although cells are apparently not able 
to directly interact with naturally occurring alginate isoforms, “bioactive” alginate derivatives can 
be easily obtained by chemical grafting with cell-instructive moieties, such as cell adhesive 
(RGD) or protease-sensitive peptides [6-11].Compared to traditional 2D, 3D cell culturing is 
much more challenging.  
In fact, the evaluation of cell behaviour in 3D microenvironments is a multi-factorial task 
that should take into account the influence of distinct parameters. These include not only matrix 
extrinsic factors, such as soluble and direct cell-cell contact signalling, but also several matrix-
related factors, such as matrix composition, mechanical properties, mesh size and degradation 
rate (including protease susceptibility).   
Interestingly, while the effect of matrix-related factors in 3D cell cultures has been widely 
investigated [9, 12, 13], the effect of cell density, which directly influences cell-cell signalling, is 
frequently overlooked, even if it plays a critical role for some cell types. For example, from 
standard 2D studies, it is known that high-density cell culture promotes cell-to-cell contact, 
which might stimulate cell cycle arrest causing cells to stop dividing, a phenomenon commonly 
known as contact inhibition [14, 15]. On the other hand, cell-to-cell contact can stimulate cellular 
differentiation [16]. Yet, only a few studies (some summarized in Table 1) have examined the 
effect of the initial cell seeding density in “true” 3D systems, with cells completely embedded 
within a hydrogel-like matrix, where cell-cell interactions may be easily hindered if cells are 
entrapped at too low densities [17].   
The “optimal” cell seeding density for a 3D culture is largely dependent on the type of 
cells and 3D matrix, and might also differently affect distinct cellular activities. For example, 
Huang et al. showed that high-density cultures (in the range of 30×10
6 
cells/mL) of bovine 
chondrocytes in agarose hydrogels produced higher glycosaminoglycans (GAG) and collagen 
contents when compared to lower density cultures (10×10
6 
cells/mL), which was related with the 
resultant higher tensile moduli of the constructs [18]. Mudera et al. evaluated the maturation of 
muscle-derived cells cultured in 3D collagen gels and showed that higher cell densities (30 and 
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40×10
6
 cells/construct) promoted the expression of contractile genes, but had a negative impact 
on the culture maturation [19].  
In certain cases, optimal effects have been found at intermediate levels within a cell 
density range. Babalola et al., showed that in alginate hydrogels seeded with chondrocytes, 
increasing the cell density from 10×10
6
 to 25×10
6
 cells/mL resulted in an increased GAG 
production (up to 4-fold), but no differences were found when cell density was further raised 
from 25×10
6
 to 50×10
6
 cells/mL, indicating that a plateau exists after which increasing cell 
density has no longer an effect [20].  
Many studies reported that increasing the cell density promoted different cellular activities 
such as cluster formation [21, 22], production of proteins [23, 24] and cell proliferation [25]. 
However, opposite trends have also been reported. For example, the proliferation of nucleus 
pulposos cells cultured within alginate beads decreased as the cell density increased from 
1.25×10
5
 to 1×10
6
 cells/mL [26]. Taken together, these examples illustrate well the great 
differences that can be observed among different matrices and cell types, underscoring the 
importance of optimizing the cell density in a “true” 3D culture for a specific application.  
Here, we have examined the influence of the cell seeding density on the behaviour of 
bone marrow-derived human mesenchymal stem cells (hMSCs), which are currently recognized 
as one promising tool for cell-based therapies, upon culture within RGD-alginate 3D matrices. 
 
 
Table 1. Effect of initial cell density in 3D cell cultures (matrix-entrapped). 
 
Matrices Cells 
Cell densities 
(10
6
 cells/mL) 
Observation 
Trend with  
cell density 
Ref 
Agarose 
Bovine chondrocytes 
and MSCs 
10; 30 
GAG and collagen 
content 
 [18] 
Alginate 
Bovine NP cells 0.125; 0.25; 0.5; 1 
Cluster formation and 
cell proliferation 
 [26] 
Bovine and equine 
AC, equine MSCs 
1; 10; 25; 50 
GAGs content (equine 
ACs and MSCs, 
intermediate/high 
concentration) 
 [20] 
Hepatocytes 1; 2; 5; 10 
Aggregate size and 
albumin production 
 [21] 
Collagen 
Human muscle 
derived cells 
4.4; 6.7; 8.9 
Myosin gene expression 
and peak force 
(intermediate cell 
density) 
 [19] 
Human MSCs 0.1; 0.5; 1; 5 GAGs deposition  [27] 
Silk- fibroin Human chondrocytes 20; 50; 100 
DNA, GAG and collagen 
content 
 [23] 
PEG 
Pancreatic β-cells 2; 5; 10 Insulin production  [24] 
Embryonic carcinoma 
cells 
0.1; 0.5 Cell proliferation  [25] 
Bovine chondrocytes 5; 20 Cluster formation  [22] 
 
AC – articular chondrocytes; DNA – deoxyribonucleic acid; GAG – glycosaminoglycan; MSCs – mesenchymal stem 
cells; NP – nucleus pulposus; PEG – poly (ethylene glycol);  –  increase;  – decrease. 
 
 
 
 
 
74 
 
2. MATERIALS AND METHODS 
 
 
2.1. Synthesis of RGD-grafted alginate 
 
Ultra-pure sodium alginate with high content of guluronic vs. mannuronic acid units 
(>60%, NovaMatrix, FMC Biopolymers) with Mw=2×10
5
 Da and Mw=3×10
4
 Da were used, 
respectively, as the high (HMW) and low molecular weight (LMW) components of the hydrogel. 
The HMW alginate was partially oxidized to a theoretical extent of 1% of sugar residues with 
sodium periodate [6], and grafted with the cell-adhesion peptide (glycine)4 - arginine - glycine - 
aspartic acid - serine - proline (hereafter abbreviated as RGD), using carbodiimide chemistry, as 
described in detail in previous studies [10]. Briefly, a 1wt.% alginate solution in 0.1M MES buffer 
(Sigma) was prepared and stirred overnight (ON). Thereafter, sulfo-NHS (Thermo Scientific) 
and EDC (Sigma) at a molar ratio of 1:2, and RGD peptides (GenScript, 17 mg/g alginate) were 
sequentially added. After stirring for 24 h, the reaction was quenched with NH2OH (Sigma). 
Non-reacted species were separated by dialysis (MWCO 3500 membrane, Spectrum Lab) 
against solutions of decreasing concentration of NaCl (Merck) and finally deionized water. The 
recovered solution was lyophilized and the RGD-alginate was stored at -20ºC until further use. 
The reaction yield was calculated using the BCA Protein Assay (Pierce), as previously 
described [9]. 
 
 
2.2. Human mesenchymal stem cells (hMSCs) culture 
 
hMSCs were purchased from Lonza (PT-2501, Lot No. 6F4392). Cells were routinely 
cultured in a basal medium (hereafter designated as BM) composed of low-glucose Dulbecco's 
Modified Eagle Medium with glutamax (DMEM, Gibco) supplemented with 10% v/v Fetal Bovine 
Serum (FBS, MSCs-qualified, Gibco) and 1% v/v Penicillin/Streptomycin (Pen/Strep, Gibco). 
Cultures were maintained at 37ºC under a humidified atmosphere of 5% v/v CO2 in air, with 
culture medium being changed twice a week, and were trypsinized when reaching 70% 
confluence. In the different studies hMSCs in passage 6 were used.  
 
 
2.3. 3D culture of hMSCs within RGD-alginate matrices  
 
hMSCs at different densities (D1=2×10
6
, D2=5×10
6
, D3=7.5×10
6
 and D4=15×10
6
 
cells/mL), were carefully mixed with sterile-filtered (0.22 µm) alginate gel-precursor solution and 
crosslinking agents, and 3D matrices were prepared by internal gelation as previously described 
[7, 9, 28]. Briefly, the gel precursor solution was a 50:50 v/v binary mixture of RGD-grafted 
HMW alginate and unmodified LMW alginate, at a total alginate concentration of 2wt.% in 
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0.9wt.% NaCl. To trigger hydrogel formation, this solution was mixed with an aqueous 
suspension of CaCO3 (Fluka), at a CaCO3/COOH molar ratio of 1.6, and a fresh solution of 
glucone delta-lactone (GDL, Sigma) at a CaCO3/GDL molar ratio of 0.125. The mixture was 
poured (20 µL per well) into a 24-well suspension culture plate (Greiner) coated with pHEMA 
[29]. After in situ crosslinking (30 min, at 37°C), fresh culture medium was added. hMSCs-laden 
matrices were cultured in BM or in an osteoinductive medium (OM) composed by low-glucose 
DMEM with 10%v/v FBS (pre-selected batch from PAA), 1% v/v Pen/Strep, 100 nM 
dexamethasone (Sigma), 10mM β -glycerophosphate (Sigma) and 0.05 mM 2-phospho-L-
ascorbic acid (Fluka). In some studies, hMSCs cultured under standard 2D conditions in tissue 
culture plates were used as a control. During culture, cell-laden matrices were maintained at 
37ºC under a humidified atmosphere of 5% v/v CO2 in air. For analyses, cells were directly 
assayed within hydrogels (whole mounts) or were recovered as a suspension after dissolving 
the hydrogels with 0.25wt.% Trypsin/ 50mM EDTA. 
 
 
2.4. Cell viability, metabolic activity and proliferation 
 
Cell viability was assessed using the Trypan Blue dye exclusion assay in recovered cells 
or the Live/Dead Assay (Invitrogen) in whole-mounts. After hydrogel dissolution, the cell 
suspension was stained with 0.4wt.% Trypan Blue (Sigma) and dead/total cells were counted 
under the microscope with a Neubauer chamber. Three replicates per condition were analysed. 
The Live/Dead assay was performed according to the manufacturer’s instructions. Briefly, 
cell-loaded matrices were washed 3 times with DMEM without phenol red (Gibco), and then 
incubated with 1 µM calcein AM (live cells) and 2.5 µM ethidium homodimer-1 (EthD-1, dead 
cells) for 45 min at 37ºC in the dark. Afterwards, the supernatant was replaced by fresh DMEM 
without phenol red. Samples were imaged by confocal laser scanning microscopy (CSLM, Leica 
SP2 AOBS).  
Cell metabolic activity was assessed using the resazurin assay. Cell-loaded matrices 
were incubated with 20% v/v of the stock resazurin solution (0.1 mg/mL, Sigma) in medium for 
2h at 37ºC. The supernatant was then transferred to a 96-well plate black with clear bottom 
(Greiner) and fluorescence measurements were carried out using a microplate reader (Biotek 
Synergy MX) with Ex/Em at 570/590 nm.  
For total dsDNA quantification, the 3D matrices were dissolved and hMSCs were 
recovered by centrifugation (10,000 rpm, 5 min,) washed with PBS, centrifuged again and 
stored at -20ºC until analysed. Cells were lysed in 1% v/v Triton X-100 for 1h at 250 rpm and 
4ºC. Samples were then diluted 1:10 in PBS and used for double-stranded DNA (dsDNA) 
quantification using the Quant-iT PicoGreen dsDNA kit (Molecular Probes, Invitrogen), 
according to manufacturer’s instructions. Briefly, samples were transferred to a 96-well plate 
black with clear bottom (Greiner) and diluted in TE buffer (200mM Tris-HCl, 20 mM EDTA, 
pH7.5). After adding the Quant-iT PicoGreen dsDNA reagent, samples were incubated for 5 min 
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at RT in the dark, and fluorescence was quantified using a microplate reader with Ex/Em at 
480/520 nm. RFUs were converted into ng/mL using a standard curve of DNA in the range of 1-
1000 ng/mL. For each condition n=3 replicates were analysed. 
 
 
2.5. Histological analysis: hematoxylin-eosin and Masson's trichrome stainings 
 
After 14 days of culture, hMSCs-laden alginate matrices were recovered, washed with 
TBS-Ca (tris-buffered saline, 50 mM Tris in 150 mM NaCl, pH 7.4, with 7.5 mM CaCl2), and 
fixed with 4% v/v paraformaldehyde (PFA) in TBS-Ca for 20 min. Dehydration was performed 
using a gradient series of ethanol and samples were then embedded in paraffin blocks. 
Thereafter, sections (3 μm) were recovered, diafanized in xylene and rehydrated with a series of 
ethanol solutions of decreasing concentrations and finally water. For the hematoxylin-eosin 
(H&E) staining, sections were incubated in Gill’s Hematoxylin for 5 min, washed in water, and 
counterstained with Eosyn Y for 1 min. For the Masson's trichrome (MT) staining a modified MT 
kit (Sigma) was used. Sections were incubated with Celestine Blue for 5 min, washed in water, 
stained with Gill’s Hematoxylin for 5 min and washed again in water for 2 min. Afterwards, 
sections were incubated for 1h with Bouin solution, washed in water, stained in Biebrich Scarlet-
Acid Fuchsin solution for 5 min, and washed again. Sections were then mordant in fresh 
phosphomolybdic acid/phosphotungstic acid solution for 5 min and stained with aniline blue for 
5 min. Finally sections were dehydrated, diafanized in xylene, mounted using histofluid 
mounting medium (Marienfeld) and imaged under an optical microscope.  
 
 
2.6. Ki67 immunostaining  
 
Paraffin sections of the different samples were obtained as already described in the 
previous section, diafanized and rehydrated. Sections were washed three times in TBS-Ca for 5 
min, and heat-induced epitope retrieval in 10 mM sodium citrate (Sigma) buffer at pH 6 was 
conducted for 10 min. After washing 3 times in TBS-Ca, cells were permeabilized with 0.1% v/v 
Triton X-100, and washed 3 times in TBS-Ca. To quench auto-fluorescence, sections were 
incubated for 5 min in fresh 0.1wt.% sodium borohydride (Sigma) in Tris/EDTA solution at pH 9, 
and washed once again in TBS-Ca. Blocking non-specific binding was performed by incubating 
with 4% v/v FBS and 1% v/v BSA in PBS for 1h at RT.  After another washing step, sections 
were incubated ON at 4°C with rabbit polyclonal anti-Ki67 (Abcam,1:100). Sections were then 
washed 3 times in TBS-Ca for 5 min each, and incubated for 1h with Alexa Fluor 594 F(ab’)2 
fragment of goat anti-rabbit (Molecular Probes-Invitrogen, 1:1000) and counterstained with 
DAPI (0.1 µg/mL), in blocking solution in the dark. Sections were washed 3 times in TBS-Ca, 
mounted with Vectashield (Vector) and finally imaged with an inverted fluorescence microscope 
(Axiovert 200M, Zeiss). 
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2.7. Analysis of whole-mounted samples: alkaline phosphatase, f-actin and fibronectin 
stainings 
 
After 7 days in culture, hMSCs-laden 3D matrices were recovered and whole-mounted 
samples and different compounds were stained.  
For alkaline phosphatase (ALP) staining, samples were washed 3 times with TBS-Ca and 
fixed with 4% v/v PFA in TBS-Ca for 20 min at RT. After washing, samples were incubated for 
30 min in Naphthol AS-MX phosphate/Fast Violet B salt (Sigma) at 37ºC, protected from light, 
and washed again. Images were obtained using an inverted fluorescence microscope.  
For F-actin staining, samples were washed with TBS-Ca, fixed with 4% v/v PFA for 20 
min and permeabilized for 5 min with 0.1% v/v Triton X-100. Afterwards samples were 
incubated for 30 min in 1wt.% BSA to block unspecific binding. F-actin filaments were stained 
with Alexa Fluor 488 phalloidin (Molecular Probes-Invitrogen, 1:40) and nuclei were 
counterstained with EthD-1 (2.5 μM). Samples were analyzed by CLSM.  
Fibronectin (FN) expression was assessed after 7 days of culture. Samples were washed 
3 times with TBS-Ca, fixed with 0.2% v/v PFA (20 min, RT), permeabilized with 0.2% v/v Triton 
X-100 (10 min) and blocked with 1wt.% BSA (20 min). Then they were incubated with rabbit 
anti-FN (f3648, Sigma, 1:400, ON at 4ºC) followed by secondary antibody Alexa Fluor 594 
F(ab’)2 fragment of goat anti-rabbit (Molecular Probes-Invitrogen, 1:1000, 1h at RT) and Alexa 
Fluor 488 phalloidin. Finally, matrices were counterstained with DAPI (0.1 µg/mL) for nuclei 
staining and were imaged by CLSM.  
 
 
2.8. Gene expression analysis by qRT-PCR 
 
At day 7, total RNA was extracted from hMSCs recovered from 3D matrices (n=3) using 
the RNeasy Mini Kit (Qiagen), as recommended by the manufacturer. Subsequently, 0.25 μg of 
the total RNA were used for random hexamers first strand synthesis to generate single-stranded 
cDNA using the SuperScript First-strand synthesis system for qReal-Time PCR (qRT-PCR) 
(Invitrogen). RNA quantification was performed by using a NanoDrop 1000 spectrophotometer. 
After the cDNA synthesis reaction, qRT-PCR was carried out in a total volume of 20 μL of a 
mixture containing 1 μL of cDNA (5 ng of total RNA), 0.25 μM of each forward and reverse 
primers, and 1× iQ SYBR Green Supermix (Bio-Rad). qRT-PCR experiments were run using an 
iQ5 (Bio-Rad) under the following conditions: 95 °C for 3 min, followed by 30 cycles at 94 °C for 
30 s, 60 °C for 45 s, and 72 °C for 30 s, and the last step at 55° for 10 s. All reactions were 
performed in duplicate. After completion of the PCR cycling, melting curves, obtained by 
increasing the temperature from 60 to 96 °C in increments of 0.5 °C, were examined to 
ascertain specificity of the PCR products. The housekeeping gene glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) was used as the endogenous assay control. Relative quantification of 
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gene amplification by qRT-PCR was performed using the cycle threshold (Ct) values and 
relative expression levels were calculated as follows: 2 
– (Ct gene of interest – Ct GAPDHgene)
. The 
expression value for each target gene was normalized to the GAPDH value at each time point. 
The sequence and length of the primer pairs used is indicated in Table 2. 
 
 
Table 2. Sequence of Primer Pairs Used for qRT-PCR. 
 
Gene 
name 
Ref. sequence Sequence of primers Length (bp) 
GAPDH NM_002046 
F: 5' -AGCCACATCGCTCAGACAC- 3' 
66 
R: 5' -GCCCAATACGACCAAATCC- 3' 
ALP BC021289 
F: 5’-AGAACCCCAAAGGCTTCTTC-3’ 
74 
R: 5’-CTTGGCTTTTCCTTCATGGT-3’ 
RUNX2 NM_001024630.2 
F: 5’-GTGCCTAGGCGCATTTCA-3’ 
78 
R: 5’-GCTCTTCTTACTGAGAGTGGAAGG-3’ 
OCN NM_199173.4 
F: 5’-AGAGTCCAGCAAAGGTGCAG-3’ 
171 
R: 5’-TCAGCCAACTCGTCACAGTC-3’ 
 
 
ALP – alkaline phosphatase; F – forward primer; GAPDH – glyceraldehyde 3-phosphate dehydrogenase; OCN – 
osteocalcin; RUNX2 – runt-related transcription factor 2; R – reverse primer. 
 
 
2.9. Statistical analysis 
 
Statistical analyses were performed using Graphpad program. All values were presented 
as the means ± stdev. Statistical significance was assessed by using Kruskal-Wallis, in 
conjunction with Dunn’s post-hoc multiple comparison test. Regarding total DNA and RT-PCR 
analysis, data was analysed using non-parametric Mann-Whitney test. Differences were 
considered statistically significant for p values < 0.05. 
 
 
3. RESULTS 
 
 
3.1. Effect of initial cell density on hMSCs viability, metabolic activity and proliferation in 
3D. 
 
The effect of cell density (D1=2×10
6
, D2=5×10
6
, D3=7.5×10
6
 and D4=15×10
6
 cells/mL 
gel) on hMSCs viability along one week of 3D culture was evaluated using the trypan blue 
exclusion assay. 
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Fig. 1. Effect of cell density on the viability, metabolic activity and proliferation of hMSCs in 3D 
along 1 week of culture. (A) viability (trypan blue assay), (B) metabolic activity (resazurin assay) and (C) 
total dsDNA (Picgreen assay) of hMSCs cultured for 1 week in RGD-alginate 3D matrices at different cell 
densities (D1=2×10
6
, D2=5×10
6
, D3=7.5×10
6
, D4=15×10
6
 cells/ml). Data is presented as mean±stdev 
(n=3), (*) denotes statistical differences (p<0.05).  
 
 
As depicted in Fig. 1A, high cell viabilities were obtained immediately after entrapment 
(day 0), ranging from 833 % (D4) to 915 % (D1). The slightly lower cell viability obtained for 
the highest cell density (D4) may in part be related to the hydrogel dissolution procedure, which 
required multiple pipetting to convert the hydrogel matrix into a single-cell suspension, which 
may have lead to some shear-induced damage as reported by others [30]. Along the time, a 
decrease in cell viability was observed for the entire cell densities tested, which was not 
statistically significant for the highest cell density (D4). Comparable values were found in the 
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literature for hMSCs cultured within alginate microspheres at a similar density [8]. The metabolic 
activity of hMSCs in 3D was monitored along 1 week of culture (Fig. 1B), after validation the 
resazurin assay in 3D cultures (supplementary data, Fig. S1 [31]). For all the densities tested, 
the metabolic activity gradually decreased along the period of culture, and for D4 it attained a 
nearly steady-state profile from day 4. 
Cell proliferation was estimated through quantification of the total dsDNA (Fig. 1C). At 
day 0, the dsDNA content of the different samples was proportional to their respective original 
cell density, as expected. Yet, in agreement with the previous observations in terms of 
metabolic activity, no increase on the dsDNA content was observed along the time, further 
suggesting that the entrapped hMSCs were essentially in a non-proliferating state.  
To evaluate the reversibility of the apparent metabolic inhibition, hMSCs cultured at the 
highest cell density (D4) were recovered from alginate matrices after 1 week of 3D culture, re-
plated under standard 2D conditions, and cultured for one additional week. As depicted in Fig. 
2A, the metabolic activity of recovered hMSCs gradually increased along the time, increasing up 
to 5-fold by day 15. Along this time, hMSCs proliferated, as detected by routine optical 
microscopy observations. Live/Dead assay images (Fig. 2B, C) show that hMSCs were mostly 
viable both at the beginning and at the end of the assay, exhibiting a round shape in 3D (Fig. 
2B) and a well spread shape in 2D, where they formed monolayers (Fig. 2C).   
 
 
 
Fig. 2. Alteration of hMSCs metabolic activity upon transference from 3D to 2D culture. (A) 
Metabolic activity of hMSCs along one week in 3D culture followed an additional week in 2D. Data is 
presented as mean±stdev (n=3). Live/Dead viability assay performed (B) at the beginning of the 
experiment in 3D, and (C) at end of the 2D culture. Live cells are stained in green (calcein AM) and dead 
cells are stained in red (EthD-1). 
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3.2. hMSCs morphology and endogenous ECM production at different densities 
 
RGD-alginate 3D matrices laden with hMSCs at different densities were cultured under 
basal and osteoinductive conditions and histological evaluation of H&E-stained samples was 
performed at day 14. As shown in Fig. 3, hMSCs under basal conditions remained essentially 
round and homogeneously distributed within the matrix, as single entities, independently of the 
cell density. A similar behaviour was observed for cells cultured at the lowest density under 
osteogenic conditions (D1). However, at the higher densities (D3 and D4), hMSCs cultured 
under osteogenic conditions exhibited a more spread shape. Cell morphology and 
rearrangement within the matrix were particularly distinct at the highest cell density (D4), where 
well-spread cells and multicellular aggregates were detected. Under these conditions, the 
alginate matrices were also more degraded (supplementary data, Fig. S2).  
  
 
 
 
 
Fig. 3. Effect of cell density and culture conditions on hMSCs spatial distribution within 3D 
matrices. H&E-stained paraffin sections of hMSCs-laden 3D matrices with different cell densities 
(D1=2×10
6
, D3=7.5×10
6
 and D4=15×10
6
 cells/ml) cultured under basal (BM) or osteoinductive (OM) 
conditions for 14 days. H&E stains cells in dark pink/purple. Alginate appears in light pink. 
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The deposition of ECM (collagen) by entrapped hMSCs was analysed on the same 
samples in MT-stained sections Fig. 4. The presence of collagen (dark blue staining) was only 
detected in high-density cultures (D4), mainly within multicellular aggregates. 
.  
 
 
 
Fig. 4. Effect of cell density on collagen deposition by hMSCs in 3D under basal and osteoinductive 
conditions. Masson's trichrome (MT)-stained paraffin sections of hMSCs-laden 3D matrices with different 
cell densities (D1=2×10
6
, D3=7.5×10
6
 and D4=15×10
6
 cells/ml) cultured under basal (BM) or 
osteoinductive (OM) conditions for 14 days. MT stains collagen in dark blue, nuclei in dark red/purple and 
cytoplasm in red/pink. Alginate appears in light blue. 
 
 
3.3. Effect of cell density on hMSCs osteogenic differentiation in 3D 
 
The differentiation of hMSCs when cultured at different densities in basal and 
osteoinductive media was firstly investigated by analysing the expression of alkaline 
phosphatase (ALP) activity, an early osteogenic marker, after 1 week of 3D culture. As depicted 
in Fig. 5A, cultures with higher cell density stained more intensely for ALP activity (in pink), 
which was particularly evident in regions where cells aggregated. Interestingly, at the highest 
density, ALP activity was detected even under basal conditions. Therefore, gene expression of 
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bone phenotypic markers by qRT-PCR was then investigated in these cultures (Fig. 5B), under 
high-density conditions (D4), RUNX2 and osteocalcin (OCN) slightly increased, as compared 
with the lower cell density (D1). Yet, ALP gene expression of D4 condition was lower than D1, 
which might be related with the pattern of ALP activity along osteogenic differentiation, which 
exhibits an early peak decreasing afterwards. Under osteogenic conditions, no differences were 
observed between D1 and D4 regarding the gene expression of the same markers (data not 
shown), probably because of the dominant effect of the exogenously added osteoinductive 
supplements. 
 
 
 
Fig. 5. Effect of cell density on hMSCs osteogenic differentiation in 3D. (A) Alkaline phosphatase 
(ALP)-stained whole mounts of hMSCs-laden 3D matrices with different cell densities (D1=2×10
6
, 
D3=7.5×10
6
 and D4=15×10
6
 cells/ml) cultured under basal (BM) or osteoinductive (OM) conditions for 7 
days. (B) qRT-PCR analysis of gene expression of ALP, RUNX2 and OCN for hMSCs-laden 3D matrices 
cultured under basal conditions for 7 days at D1=2×10
6 
cells/ml and D4=15×10
6
 cells/ml. Data is presented 
as mean±stdev (n=3), (*) denotes statistical differences (p<0.05).  
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3.4. hMSCs aggregation in high-density osteoinductive 3D cultures 
 
In view of the prior results, the process of hMSCs aggregation in high-density 
osteoinductive 3D cultures was further analysed in more detail. F-actin staining of whole-
mounted samples (Fig. 6) showed that hMSCs progressively spread and aggregated along two 
weeks of culture under osteoinductive conditions, while they remained essentially dispersed 
throughout the matrix under basal conditions.  
 
 
 
Fig. 6. Formation of hMSCs aggregates in high-density osteoinductive cultures along the time. 
Morphology and spatial reorganization of hMSCs cultured along 2 weeks in 3D, under basal (BM) or 
osteoinductive conditions (OM), at a density of D4=15×10
6
 cells/mL. Filamentous actin was stained with 
Alexa Fluor 488 phallodin (green) and images were obtained by CSLM of whole-mounted samples. 
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Several of these hMSCs clusters were found within each matrix (Fig. 7A), and were 
stabilized by an extracellular fibronectin mesh (Fig. 7B).  Fibronectin expression was also 
detected in individual cells, but only intracellularly (Fig. 7B, inset). To better investigate the 
origin of these aggregates, an immunostaining for the cell cycle-related proliferation marker 
Ki67 was performed. As depicted in Fig. 7C and Fig. 7D only a few Ki67 positive cells were 
detected, and those were only occasionally present within the hMSCs clusters. Therefore, the 
hypothesis of cell migration followed by cell–cell adhesion of neighbouring cells with subsequent 
aggregate formation, as opposed to mitosis, seems more convincing. 
 
 
 
Fig. 7. Formation of hMSCs aggregates in high-density osteoinductive cultures. (A) Several hMSCs 
clusters (black arrows) were detected within RGD-alginate 3D matrices under osteoinductive conditions 
(OM), after 2 weeks of culture. (B) These aggregates were stabilized by a fibronectin mesh (red, inset: FN 
expression in isolated cells). (C) and (D) Only a few proliferating hMSCs (Ki67 positive cells, arrows) were 
detected within the 3D matrices, and only occasionally within clusters (dashed circles). (E) qRT-PCR 
analysis showed that hMSCs retrieved from high-density osteoinductive cultures expressed several 
osteogenic genes (ALP, RUNX2 and OCN). Data is presented as mean±stdev (n=3), (*) denotes statistical 
differences (p<0.05).  
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Finally, the expression of osteogenic markers in high-density hMSCs 3D cultures was 
analysed at the gene level (Fig. 7E). After 7 days in osteoinductive medium, hMSCs expressed 
higher levels of RUNX2, ALP and OCN, confirming that upon high-density 3D entrapment within 
alginate hydrogels, hMSCs remained responsive to osteoinductive stimuli and able to 
differentiate along the osteoblastic lineage 
 
 
4. DISCUSSION 
 
The effect of cell seeding density on the behaviour of hMSCs cultured under 3D 
conditions within RGD-alginate hydrogels was evaluated. Densities in the range of 2 to 15 
million cells per mL of hydrogel were tested, and cells were cultured in basal and osteoinductive 
media. Independently of the cell density, low levels of (mitochondrial) metabolic activity were 
observed when cells were cultured in 3D, which attained a nearly steady state after 
approximately 3 days of culture. This was consistent with the total dsDNA quantifications that 
showed that hMSCs in 3D were essentially in a non-proliferative state. Similar results have 
been previously observed by us [8] and confirmed by other authors, namely with 3D cultures 
within alginate hydrogels. For example, Markusen and co-workers did not observe MSCs 
proliferation after cell entrapment at a density of 10×10
6
 cell/mL within 1wt% RGD-alginate 
beads after 2 weeks of culture [30], neither did Duggal et al. in similar matrices of 1.8wt% RGD-
alginate but at lower cell density (2×10
6
 cell/mL) [32]. Studies from Lan and co-workers, using a 
hepatocytic cell line (HepG2) grown on 2D (collagen-coated plates) and in 3D (1wt% unmodified 
alginate matrices) at a final density of 2×10
6
 cell/mL, have shown that the number of cells 
cultured on 2D culture increased dramatically after 2 weeks of culture (4.5-fold), while in 3D no 
significant differences were seen [33]. In addition, Ma and colleagues entrapped MSCs within 
1.2wt% alginate beads and observed no proliferation since cells entered the G0/G1 phase but 
did not progress along the cell cycle to the S phase, remaining in a nearly steady-state [34]. 
Those studies suggest that cell proliferation in 3D requires strategies to overcome the physical 
impediment posed by the matrix, which is dependent on the matrix stiffness [35]. Those 
restrictions may induce growth-arrest, stimulating cell senescence or favouring a quiescent-like 
steady state. Although future studies need to be carried out to draw a valid conclusion, the 
results presented here seem to support the last hypothesis. In fact, the cardinal feature of 
quiescence, which distinguishes it from other non-dividing cell states, such as senescence, 
apoptosis, and terminal differentiation, is that quiescence is reversible [36].  
As shown here, hMSCs not only maintained high viability throughout the 3D culture 
period, but also seemed to have re-entered the cell cycle when transferred from 3D to 2D, with 
a concomitant increase in metabolic activity. This is in accordance with the results from Hunt et 
al., who reported that fibroblasts significantly decrease their metabolic activity upon entrapment 
within alginate hydrogels, but subsequently recovered a normal mitotic activity upon retrieval 
from 3D [37].  
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At the highest cell density tested here (D4=1510
6
 cells/mL), and especially under 
osteoinductive conditions, 3D-cultured hMSCs were shown to spread along the time, 
establishing contacts with neighbouring cells and forming multicellular aggregates. These 
clusters apparently resulted from the self-assembling and intercellular adhesion of previously 
isolated cells, and not from clonal expansion. This hypothesis is supported by the changes in 
cell morphology along the time, characteristic of migrating cells, and by the low number of Ki67 
positive cells within aggregates.  
The fact that cell aggregation is favoured in osteoinductive medium, compared with the 
basic medium, is probably related to the highest rate of degradation of the hydrogels observed 
under these conditions. This might be due to the presence of different hydrogel-destabilizing 
agents in OM, including non gelling-sodium ions and calcium-sequestering agents such as 
phosphates, which reverse the gelation mechanism [38], and of reducing agents such as 
ascorbic acid that might contribute to alginate hydrolysis [39]. The alginate hydrogel degradation 
might in turn be accelerated by the presence of cells, as suggested by others [40]. Clearly, 
hydrogel swelling and degradation facilitates cell mobility, spreading and aggregation inside the 
matrix [41]. Other authors have reported a correlation between cell density and the formation of 
cell aggregates within 3D matrices. For example, Maguire et al. [21] described the aggregation 
of hepatocytes within alginate beads, a process that played a central role in controlling cell 
differentiation. The aggregation process was dependent on the initial cell seeding density, with 
larger aggregates being obtained at the highest density tested (5×10
6
 cells/ml). Zhang C et al. 
described the spontaneous aggregation of chondrocytes within PEG-based hydrogels [22]. 
Again, higher cell densities (20×10
6
 cells/ml) resulted in an earlier onset of cluster formation and 
in larger clusters. Notably, cell aggregation resulted in enhanced endogenous ECM production, 
which is in accordance with our results, as we also demonstrated that the formation of hMSCs 
aggregates was related with the local deposition of ECM components, namely fibronectin and 
collagen. Actually, fibronectin polymerization is known to play an important role in the self-
assembly of multicellular structures, acting as a “glue” by promoting α5β1-integrin mediated 
intercellular cohesion [42].  
In our study, high-density cultures were also shown to efficiently differentiate along the 
osteoblastic lineage, as demonstrated by the expression of osteogenic markers at both gene 
and protein levels. In particular, hMSCs clusters stained intensively for ALP activity after 1 week 
of culture, even under basal conditions. A correlation between MSCs aggregation and 
osteogenic differentiation has also been described in some studies, but it has not been fully 
clarified. In classical 2D studies, for example, the formation of bone nodules has been 
associated with the expression of a mineralized ECM in MSCs cultures [43], suggesting the 
importance of cell-cell interactions in osteogenesis. In 3D, a positive effect of cell aggregation in 
osteogenesis has been mainly reported in studies using MSCs spheroids [44, 45]. As proposed 
in some of those studies, self-organized cellular structures might be interesting for use in tissue 
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engineering strategies, since they may function as building blocks for tissue reconstruction [46, 
47], and might also enhance the therapeutic efficacy of hMSCs. In fact, the use of hMSCs 
aggregates in cell-based therapies has been recently proposed as a means to overcome the 
limitations related with dissociated-cell delivery [48].   
The culture of hMSCs as 3D aggregates can self-activate important cellular functions, 
promoting cell survival and migration, improving resistance to oxidative stress, and enhancing 
secretion of pro-regeneration mediators [49-51]. Moreover, the presence of an endogenous 
ECM environment in MSCs aggregates can be regarded as an added benefit, as it might have 
additional cytoprotective effects promoting cell survival under ischemic and oxidative stress, and 
even extending hMSCs retention at the injury site [48]. This feature is also important in tissue 
engineering strategies, as the deposition of new ECM is essential to provide structural support 
to cells and replace the artificial matrix as it degrades.  
 
 
5. CONCLUSIONS 
 
The initial cell seeding density at which hMSCs are entrapped within RGD-alginate 
hydrogels regulates cellular activities within this type of 3D matrices. On high-density cultures, 
cell viability is better maintained, and cell-cell signalling is promoted as hMSCs are induced to 
connect to each other and aggregate into multicellular structures, particularly under 
osteoinductive conditions. Clustered hMSCs produced their own ECM, rich in fibronectin and 
collagen, and successfully differentiated along the osteoblastic lineage. These hMSCs-ECM 
microtissues may function as building blocks for tissue reconstruction, and find interesting 
applications in tissue engineering strategies, especially when combined with advanced 
bioprinting technologies. Taken together, the results present herein also confirm and highlight 
the importance of selecting the most appropriate cell entrapping density when establishing 3D 
cultures for a specific application.  
 
 
Acknowledgements  
This work was financed by FEDER funds through the Programa Operacional Factores de 
Competitividade (COMPETE) and by Portuguese funds through Fundação para a Ciência e a 
Tecnologia (FCT): Pest-C/SAU/LA0002/2011, PTDC/SAU-BEB/101235 /2008 and FCOMP-01-
0124-FEDER-010915. FRM acknowledges INL-International Iberian Nanotechnology 
Laboratory for her PhD scholarship. CB has a research position (Ciência 2008) funded by FCT-
POPH-FSE, and GMG has an FCT post-doctoral scholarship (SFRH/BPD/85651/2012).  
 
 
 
 
89 
 
6. REFERENCES 
 
[1] Tibbitt MW, Anseth KS. Hydrogels as extracellular matrix mimics for 3D cell culture. 
Biotechnol. Bioeng. 2009;103:655-63. 
[2] Huang G, Wang L, Wang S, Han Y, Wu J, Zhang Q, et al. Engineering three-dimensional cell 
mechanical microenvironment with hydrogels. Biofabrication 2012;4:1758-5082. 
[3] Vacharathit V, Silva EA, Mooney DJ. Viability and functionality of cells delivered from peptide 
conjugated scaffolds. Biomaterials 2011;32:3721-8. 
[4] Zhang Y, Yu Y, Chen H, Ozbolat IT. Characterization of printable cellular micro-fluidic 
channels for tissue engineering. Biofabrication 2013;5:025004. 
[5] Buyukhatipoglu K, Jo W, Sun W, Clyne AM. The role of printing parameters and scaffold 
biopolymer properties in the efficacy of a new hybrid nano-bioprinting system. Biofabrication 
2009;1:035003. 
[6] Evangelista MB, Hsiong SX, Fernandes R, Sampaio P, Kong H-J, Barrias CC, et al. 
Upregulation of bone cell differentiation through immobilization within a synthetic extracellular 
matrix. Biomaterials 2007;28:3644-55. 
[7] Bidarra SJ, Barrias CC, Fonseca KB, Barbosa MA, Soares RA, Granja PL. Injectable in situ 
crosslinkable RGD-modified alginate matrix for endothelial cells delivery. Biomaterials 
2011;32:7897-904. 
[8] Bidarra SlJ, Barrias CC, Barbosa MrA, Soares R, Granja PL. Immobilization of Human 
Mesenchymal Stem Cells within RGD-Grafted Alginate Microspheres and Assessment of Their 
Angiogenic Potential. Biomacromolecules 2010;11:1956-64. 
[9] Fonseca KB, Bidarra SJ, Oliveira MJ, Granja PL, Barrias CC. Molecularly designed alginate 
hydrogels susceptible to local proteolysis as three-dimensional cellular microenvironments. Acta 
Biomater. 2011;7:1674-82. 
[10] Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular 
matrix materials. Biomaterials 1999;20:45-53. 
[11] Fonseca KB, Maia FR, Cruz FA, Andrade D, Juliano MA, Granja PL, et al. Enzymatic, 
physicochemical and biological properties of MMP-sensitive alginate hydrogels. Soft Matter 
2013;9:3283-92. 
[12] Lutolf MP, Gilbert PM, Blau HM. Designing materials to direct stem-cell fate. Nature 
2009;462:433-41. 
[13] Huebsch N, Arany PR, Mao AS, Shvartsman D, Ali OA, Bencherif SA, et al. Harnessing 
traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat. Mater. 
2010;9:518-26. 
[14] Puliafito A, Hufnagel L, Neveu P, Streichan S, Sigal A, Fygenson DK, et al. Collective and 
single cell behavior in epithelial contact inhibition. Proc. Natl. Acad. Sci. 2012;109:739-44. 
[15] Heckman CA. Contact inhibition revisited. J. Cell. Physiol. 2009;220:574-5. 
[16] Hohn HP, Grümmer R, Boßerhoff S, Graf-Lingnau S, Reuss B, Bäcker C, et al. The role of 
matrix contact and of cell-cell interactions in choriocarcinoma cell differentiation. Eur. J. Cell 
Biol. 1996;69:76-85. 
 
 
90 
 
[17] Cukierman E, Pankov R, Stevens DR, Yamada KM. Taking cell-matrix adhesions to the 
third dimension. Science 2001;294:1708-12. 
[18] Huang AH, Yeger-McKeever M, Stein A, Mauck RL. Tensile properties of engineered 
cartilage formed from chondrocyte- and MSC-laden hydrogels. Osteoarthr. Cartil. 
2008;16:1074-82. 
[19] Mudera V, Smith AST, Brady MA, Lewis MP. The effect of cell density on the maturation 
and contractile ability of muscle derived cells in a 3D tissue-engineered skeletal muscle model 
and determination of the cellular and mechanical stimuli required for the synthesis of a postural 
phenotype. J. Cell. Physiol. 2010;225:646-53. 
[20] Babalola OM, Bonassar LJ. Effects of seeding density on proteoglycan assembly of 
passaged mesenchymal stem cells. Cell. Mol. Bioeng. 2010;3:197-206. 
[21] Maguire T, Davidovich AE, Wallenstein EJ, Novik E, Sharma N, Pedersen H, et al. Control 
of hepatic differentiation via cellular aggregation in an alginate microenvironment. Biotechnol. 
Bioeng. 2007;98:631-44. 
[22] Zhang C, Sangaj N, Hwang Y, Phadke A, Chang C-W, Varghese S. Oligo(trimethylene 
carbonate)–poly(ethylene glycol)–oligo(trimethylene carbonate) triblock-based hydrogels for 
cartilage tissue engineering. Acta Biomater. 2011;7:3362-9. 
[23] Talukdar S, Nguyen QT, Chen AC, Sah RL, Kundu SC. Effect of initial cell seeding density 
on 3D-engineered silk fibroin scaffolds for articular cartilage tissue engineering. Biomaterials 
2011;32:8927-37. 
[24] Lin C-C, Raza A, Shih H. PEG hydrogels formed by thiol-ene photo-click chemistry and 
their effect on the formation and recovery of insulin-secreting cell spheroids. Biomaterials 
2011;32:9685-95. 
[25] Kraehenbuehl TP, Zammaretti P, Van der Vlies AJ, Schoenmakers RG, Lutolf MP, Jaconi 
ME, et al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: 
Systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials 
2008;29:2757-66. 
[26] Stephan S, Eustace Johnson W, Roberts S. The influence of nutrient supply and cell 
density on the growth and survival of intervertebral disc cells in 3D culture. Eur. Cells Mater. 
2011;22:97-108. 
[27] Hui TY, Cheung KMC, Cheung WL, Chan D, Chan BP. In vitro chondrogenic differentiation 
of human mesenchymal stem cells in collagen microspheres: Influence of cell seeding density 
and collagen concentration. Biomaterials 2008;29:3201-12. 
[28] Oliveira SM, Barrias CC, Almeida IF, Costa PC, Ferreira MRP, Bahia MF, et al. Injectability 
of a bone filler system based on hydroxyapatite microspheres and a vehicle with in situ gel-
forming ability. J. Biomed. Mater. Res., Part B 2008;87B:49-58. 
[29] Folkman J, Moscona A. Role of cell shape in growth control. Nature 1978;273:345-9. 
[30] Markusen JF, Mason C, Hull DA, Town MA, Tabor AB, Clements M, et al. Behavior of adult 
human mesenchymal stem cells entrapped in alginate-GRGDY beads. Tissue Eng. 
2006;12:821-30. 
 
 
91 
 
[31] Ng KW, Leong DT, Hutmacher DW. The challenge to measure cell proliferation in two and 
three dimensions. Tissue Eng. 2005;11:182-91. 
[32] Duggal S, Frønsdal KB, Szöke K, Shahdadfar A, Melvik JE, Brinchmann JE. Phenotype 
and gene expression of human mesenchymal stem cells in alginate scaffolds. Tissue Eng., Part 
A 2008;15:1763-73. 
[33] Lan S-F, Safiejko-Mroczka B, Starly B. Long-term cultivation of HepG2 liver cells 
encapsulated in alginate hydrogels: A study of cell viability, morphology and drug metabolism. 
Toxicol. In Vitro 2010;24:1314-23. 
[34] Ma H-L, Hung S-C, Lin S-Y, Chen Y-L, Lo W-H. Chondrogenesis of human mesenchymal 
stem cells encapsulated in alginate beads. J. Biomed. Mater. Res., Part A 2003;64A:273-81. 
[35] Bott K, Upton Z, Schrobback K, Ehrbar M, Hubbell JA, Lutolf MP, et al. The effect of matrix 
characteristics on fibroblast proliferation in 3D gels. Biomaterials 2010;31:8454-64. 
[36] Coller HA, Sang L, Roberts JM. A new description of cellular quiescence. PLoS Biol. 
2006;4. 
[37] Hunt NC, Shelton RM, Grover LM. Reversible mitotic and metabolic inhibition following the 
encapsulation of fibroblasts in alginate hydrogels. Biomaterials 2009;30:6435-43. 
[38] Nicodemus GD, Bryant SJ. Cell encapsulation in biodegradable hydrogels for tissue 
engineering applications. Tissue Eng. Part B Rev. 2008;14:149-65. 
[39] Smidsrod O, Haug A, Larsen B. Degradation of alginate in the presence of reducing 
compounds. Acta Chem. Scand. 1963;17:2628-37. 
[40] Hunt NC, Smith AM, Gbureck U, Shelton RM, Grover LM. Encapsulation of fibroblasts 
causes accelerated alginate hydrogel degradation. Acta Biomater. 2010;6:3649-56. 
[41] Khetan S, Guvendiren M, Legant WR, Cohen DM, Chen CS, Burdick JA. Degradation-
mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional 
hydrogels. Nat. Mater. 2013;12:458-65. 
[42] Robinson EE, Foty RA, Corbett SA. Fibronectin matrix assembly regulates α5β1-mediated 
cell cohesion. Mol. Biol. Cell 2004;15:973-81. 
[43] Maniatopoulos C, Sodek J, Melcher AH. Bone formation in vitro by stromal cells obtained 
from bone marrow of young adult rats. Cell Tissue Res. 1988;254:317-30. 
[44] Wang W, Itaka K, Ohba S, Nishiyama N, Chung U-i, Yamasaki Y, et al. 3D spheroid culture 
system on micropatterned substrates for improved differentiation efficiency of multipotent 
mesenchymal stem cells. Biomaterials 2009;30:2705-15. 
[45] Hildebrandt C, Büth H, Thielecke H. A scaffold-free in vitro model for osteogenesis of 
human mesenchymal stem cells. Tissue and Cell 2011;43:91-100. 
[46] Lin R-Z, Chang H-Y. Recent advances in three-dimensional multicellular spheroid culture 
for biomedical research. Biotechnol. J. 2008;3:1172-84. 
[47] Guo C-L. Mechanical models for the self-organization of tubular patterns. Biomatter 
2013;3:e24926. 
[48] Kim J, Ma T. Endogenous extracellular matrices enhance human mesenchymal stem cell 
aggregate formation and survival. Biotechnol. Prog. 2013;29:441-51. 
 
 
92 
 
[49] Bartosh TJ, Ylöstalo JH, Mohammadipoor A, Bazhanov N, Coble K, Claypool K, et al. 
Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their 
antiinflammatory properties. Proc. Natl. Acad. Sci. 2010;107:13724-9. 
[50] YlÖstalo JH, Bartosh TJ, Coble K, Prockop DJ. Human mesenchymal stem/stromal cells 
cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated 
macrophages into an anti-inflammatory phenotype. Stem Cells 2012;30:2283-96. 
[51] Bhang SH, Lee S, Shin JY, Lee TJ, Kim BS. Transplantation of cord blood mesenchymal 
stem cells as spheroids enhances vascularization. Tissue Eng., Part A 2012;18:2138-47. 
[52] Friedl P, Bröcker EB. The biology of cell locomotion within three-dimensional extracellular 
matrix. Cell. Mol. Life Sci. 2000;57:41-64. 
 
 
 
93 
 
SUPPLEMENTARY DATA  
 
 
 
Fig. S1. Resazurin assay performed in 2D and 3D cultured hMSCs for all densities tested. The metabolic 
activity of hMSCs immediately after entrapment within 3D alginate matrices at low-to-high cell densities 
was analyzed and compared to that of cells cultured under standard 2D conditions (same total cell number 
per sample). This test was important to evaluate the effectiveness of using this type of colorimetric 
metabolic assay, which do not necessarily correlate linearly with increasing cell densities, and might be 
inadequate to monitor 3D-cultures, as already suggested in the literature [52]. In 2D-cultured hMSCs, a 
clear rise in metabolic activity was recorded as cell density increased, with a linear response (R
2
=0.998) 
from D1 (40 000 cells per sample) to D3 (150 000 cells per sample), but a loss of linearity at D4. 
Compared with the 2D-culture, 3D-cultured cells produced a significantly lower fluorescent signal but a 
linear relationship between fluorescence and cell numbers was still maintained for the entire range of 
densities (R
2
=0.974). 
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Fig. S2.  Dynamic mechanical analysis (DMA) of acellular RGD-alginate matrices after two weeks of 
culture in BM and OM.  The mechanical properties of the hydrogels are more rapidly lost in OM than in 
BM. Samples (hydrogel cylinders, 5.5 mm diameter and 1.5 mm height) were retrieved from culture and 
immediately loaded onto the Compression Mode clamp assembly of a TRITEC2000B DMA (Triton 
Technology). Measurements were performed under RT conditions (humidity ~44%, 20ºC). A user-defined 
small compression load was applied to guarantee an adequate contact between the swollen samples and 
the device. A time-scan at a frequency of 1Hz and a strain of 1% (within the linear viscoelastic regimen) 
was performed during 5 min, and the compressive storage modulus (E’, elastic component), loss modulus 
(E’’, viscous component) and damping (E’’/E’, tan δ) were calculated. At least 6 replicas were tested for 
each condition. Results are presented as mean±SD. (*) denotes statistical differences (p<0.05). 
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ABSTRACT 
 
Mesenchymal stem cells (MSCs) can be driven to self-assemble into microtissues in response 
to specific matrix cues, a process that depends on a balance between cell-matrix and cell-cell 
interactions. The effect of such cues, and especially their interplay, is still not fully clarified, 
particularly in 3D-systems. Here, the behaviour of human MSCs (hMSCs) cultured within 
hydrogel matrices with tailored stiffness and composition was evaluated. hMSCs aggregation 
only occurred in more compliant matrices (G’ ≤ 120 Pa), when compared to stiffer ones, both in 
the presence and absence of matrix-bound arginine-glycine-aspartic cell-adhesion ligands 
(RGD; 0, 100 and 200 µM). Fibronectin assembly stabilized cell-cell contacts within aggregates, 
even in non-adhesive matrices. However, hMSCs were only able to substantially contract the 
artificial matrix when RGD was present. Moreover, compliant matrices facilitated cell 
proliferation and provided a permissive environment for hMSCs osteogenic differentiation, even 
without RGD. Cell interactions with the original matrix became less important as time 
progressed, while the de novo produced extracellular matrix (ECM) turned into a more critical 
determinant of cell fate. These data provide further insights into the mechanisms by which 
hMSCs sense their microenvironment to organize into tissues, and provide new clues to the 
design of cell-instructive 3D matrices. 
 
 
 
 
 
 
 
 
Keywords: hydrogels, viscoelastic properties, cell traction, cell-matrix interactions, cell 
aggregation 
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1. INTRODUCTION 
 
The important role of the microenvironment in cell behaviour is currently recognized, 
being well established that cells respond to the intrinsic properties of their matrix, namely to 
mechanical cues [1]. The work of Engler et al. has largely contributed to shed light on the 
processes of mechanosensing, notably by demonstrating that matrix elasticity directs stem cell 
lineage specification [2]. It has also long been known that the matrix dimensionality plays a key 
role in cell signalling events [3, 4] affecting, in particular, the way cells experience mechanical 
stresses and strains [5]. However, there are still many open questions on the intersection 
between mechanobiology and 3D, as most studies have been carried out using 2D or “on top” 
3D assays that do not recapitulate the normal environment of most cell types.  
The effect of matrix cues in “true” 3D systems, where cells are embedded within a 
hydrogel-like matrix, has been traditionally addressed using ECM-derived hydrogels, such as 
collagen and fibrin, which do not allow a great level of control over signal presentation. More 
recently, engineered artificial matrices, with tuneable biochemical and mechanical properties, 
have also been explored [6, 7]. These 3D models have been vital for systematically 
deconstructing the role of different signals and their interplay [8, 9]. Surprisingly, only a few 
studies have focused on the use of very soft hydrogels (storage modulus, G’ < 1000 Pa), 
although the reported results are quite stimulating. In fact, compliant matrices have been shown 
to facilitate different cellular activities, including spreading [10, 11], proliferation [10, 12], and 
migration [13], among others, in different cell types.  
Apart from the matrix stiffness, the molecular characteristics of the hydrogels, and their 
resulting viscoelastic behaviour, also have a direct impact on these processes. Cells in 3D must 
overcome the physical barrier imposed by the polymeric network, and will clearly encounter less 
resistance in softer and more deformable matrices (G’ < 1760 Pa) [14]. For example, Bott et 
al.[10] have shown that the spreading and proliferation of fibroblasts within PEG matrices are 
increased in softer (G’ < 250 Pa) vs. stiffer (G’ > 1200 Pa) hydrogels, irrespectively of their 
degradation profile. Interestingly, the authors also show that fibroblasts are able to contract 
viscous-like collagen gels [15], but not elastic-like PEG hydrogels with a similar G’ (G’ ≈ 200 Pa) 
[10]. Ehrbar et al. have shown that preosteoblastic cells entrapped within soft matrices (G’ < 94 
Pa) can engage in a degradation-independent 3D migration mode, and overcome the matrix 
resistance by deforming the network and/or using hydrogel defects [13]. Different studies 
demonstrated that endothelial cells network assembly and tubulogenesis are favoured in low 
stiffness matrices [16, 17]. Recently, Matyash et al. have shown that soft alginate hydrogels (G’ 
< 64 Pa), prepared with sub-stoichiometric concentrations of crosslinking ions, promote 
extensive neurite growth, even in the absence of cell-adhesion ligands, while protecting neurons 
against oxidative stress [11]. The communication between cells also seems to be facilitated in 
compliant matrices. In particular, Reinhart-King et al. have shown that pairs of endothelial cells 
in compliant substrates (G’ = 500 Pa) communicate through mechanical signals in a stiffness-
dependent manner: when the matrix stiffness is low enough, cells can perceive and react to 
substrate strains created by the traction stresses of neighbouring cells [18, 19]. Altogether, 
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these examples emphasize the interest of further exploring cell behaviour in compliant 3D 
matrices. They also suggest that the molecular characteristics and viscoelastic profile of 
hydrogels, which are generally poorly discussed, are relevant features with a clear impact on 
the process of mechanosensing. 
Here, the polymer dry-mass content of alginate hydrogels with a bimodal molecular 
weight distribution was modulated to prepare 3D matrices with very different viscoelastic 
profiles. While 2 wt.% alginate hydrogels are stiffer and behave predominantly as elastic-like 
materials, similar to synthetic hydrogels [10], 1 wt.% hydrogels are softer and display a more 
viscous-like behaviour, typically observed in ECM-derived hydrogels [10]. The hydrogels were 
also modified with controlled densities of RGD peptides to promote integrin-mediated cell-matrix 
adhesion. Integrin receptors act as major sensors and integrators of microenvironmental 
signals, being particularly relevant as mechanotransducers [20]. This versatile system was used 
to investigate the effect of matrix cues on human mesenchymal stem cells behaviour (hMSCs) 
in 3D, at different levels, and the interplay between viscoelastic properties and ligand 
presentation was addressed. A new approach was established to foster the formation of hMSCs 
aggregates stabilized by endogenous ECM, which better mimic complex tissue structures and 
provide interesting 3D in vitro model systems or building blocks for regenerative therapies [21, 
22]. 
 
 
 
2. MATERIALS AND METHODS  
 
 
2.1. Synthesis and characterization of RGD-alginate 
 
Sodium alginate (Protanal LF 20/40, a gift from FMC Biopolymers) with a high ratio of 
guluronate to mannuronate content (>60%) with Mw=1.510
5
 Da and Mw=2.510
4
 Da were 
used, respectively, as the high (HMW) and low molecular weight (LMW) components of the 
hydrogel matrices [23]. Both were purified through dialysis against deionized water for 3 days 
(MWCO 3500 membrane, Spectrum Labs), and with activated charcoal (Sigma, 0.5 g per g 
alginate). The HMW alginate was partially oxidized to a theoretical extent of 1% of sugar 
residues with sodium periodate [24]. Both components were grafted with the cell-adhesion 
peptide (glycine)4-arginine-glycine-aspartic acid-serine-proline (hereafter abbreviated as RGD), 
using aqueous carbodiimide chemistry as previously described [25]. Briefly, alginate solutions (1 
wt.%) in MES buffer (0.1M MES, 0.3M NaCl, pH 6.5) were prepared and stirred overnight (ON) 
at room temperature (RT). N-hydroxy-sulfosuccinimide (Sulfo-NHS, Pierce) and 1-ethyl-
(dimethylaminopropyl)-carbodiimide (EDC, Sigma, 27.4 mg/g alginate) were sequentially added 
at a molar ratio of 1:2, followed by 17 mg of RGD peptide (Genscript) per g of alginate. Control 
samples were prepared without addition of peptide (hereafter designated as HMW0 or LMW0). 
After stirring for 20h at RT, the reaction was quenched with hydroxylamine and the solution was 
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dialysed against deionized water for 3 days (MWCO 3500). After purification with charcoal, 
RGD-alginate was lyophilized and stored at -20ºC until further use.  
The amount of grafted RGD was quantified using the BCA Protein Assay (Pierce). Briefly, 
samples (1 wt.% RGD-alginate) were incubated in BCA reagent for 60 min at 37ºC in the dark 
and the absorbance was read at Ex/Em of 540/620 nm in a microplate reader (Power Wave Xs, 
Biotek). A set of RGD solutions (0 to 1 mg/mL in 1 wt.% HMW0 or LMW0) were used as 
standards to produce a calibration curve. Typically, the reaction yield was of ca. 90%, 
determined by the BCA Total Protein assay as described in [6]. 
 
 
2.2. RGD-alginate 3D matrices: compositions and in situ hydrogel formation  
 
In-situ forming alginate hydrogel matrices were prepared by internal gelation as described 
previously [16, 25, 26]. Hydrogel precursor solutions were composed by binary mixtures (50:50 
v/v) of HMW and LMW sodium alginate, at different polymer concentrations (1 and 2 wt.%) and 
RGD densities (0, 100 or 200 µM: along the manuscript these formulations are often referred as 
1-0, 1-100, 1-200; and 2-0, 2-100, 2-200; where the first number represents the concentration of 
alginate and the second number denotes the concentration of RGD). The range of RGD density 
selected herein is comparable to that of commonly used ECM-derived biological matrices [7]. 
Sodium alginate solutions were sterile-filtered (0.22 µm) and mixed with an aqueous suspension 
of CaCO3 (Fluka) at a CaCO3/COOH molar ratio of 1.6 [26]. Then, a fresh sterile solution of 
glucone delta-lactone (GDL, Sigma) was added to trigger gelation. The CaCO3/GDL molar ratio 
was set at 0.125, and the gelation time was 1h. For the 3D-culture studies, hydrogel precursor 
solutions were combined with human mesenchymal stem cells (hMSCs) prior to hydrogel 
formation, as described in section 2.5. 
 
 
2.3. Dynamic mechanical analysis of RGD-alginate hydrogels 
 
Samples were assayed in a TRITEC2000B DMA (Triton Technology). Hydrogel cylinders 
(=5.5 mm; h=1.5 mm) were prepared in a QGel
TM 
3D disc caster. After crosslinking, the discs 
were pre-equilibrated ON at 37ºC in DMEM with HEPES (Sigma, 25 mM) and 0.01% NaN3 
(Sigma), and then loaded onto the Compression Mode clamp assembly. Measurements were 
performed under RT conditions (humidity ~44%, 20ºC). A user-defined small compression load 
was applied to guarantee an adequate contact between the swollen samples and the device. A 
time-scan (1Hz and 1% strain, within the LVR – linear viscoelastic region) was performed during 
5 min, and the compressive storage modulus (E’, elastic component), loss modulus (E’’, viscous 
component) and damping (E’’/E’, tan δ) were calculated. The influence of polymer concentration 
(1 and 2 wt.%) and RGD density (0, 100 and 200 μM) on the hydrogel mechanical properties 
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was analysed. At least 5 replicas were tested for each condition, and the experiment was 
repeated twice. Averages and standard deviations were reported. 
 
 
2.4. Oscillatory shear rheometry of RGD-alginate hydrogels 
 
Rheological measurements were carried out using a Kinexus Pro rheometer (Malvern). 
Swollen hydrogel discs were analysed at day 0 (after swelling to equilibrium in culture media for 
2h) and after incubation (24h) under standard culture conditions. To guarantee the dimensional 
homogeneity of the samples, cylindrical discs were casted with 8 mm, and then 4 mm cylinders 
were punched from the original ones immediately before analysis. All samples were assayed 
using a plate-and-plate geometry (=4 mm, sandblasted surfaces) and were compressed to 
20% of their original thickness to avoid slippage. A solvent trap was used to minimize sample 
drying. All measurements were performed at 37ºC (Peltier system). Stress sweeps (0.1 Hz) 
were first performed to determine the LVR for all the tested conditions. Frequency sweeps 
(0.01-2Hz) were then performed within the LVR.  
The values of the shear storage modulus (G’) presented in Table 1 were obtained at a 
frequency of 0.1Hz. Samples were analysed in triplicate and the experiment was repeated 
twice. The initial mesh size (ξ) of alginate hydrogels was calculated as described in [12] using 
the measured value of the shear modulus to calculate the molecular weight between crosslinks 
(further details are provided as supplementary information).  
 
 
2.5. 3D-cultures of hMSCs within RGD-alginate hydrogel matrices 
 
hMSCs were purchased from Lonza (PT-2501, Lot No. 6F4392) and routinely cultured in 
low-glucose DMEM with glutamax (Gibco), supplemented with Fetal Bovine Serum (FBS, 
MSCs-qualified, 10% v/v Gibco) and penicillin/streptomycin (1% v/v Pen/Strep, Gibco). RGD-
alginate solutions in NaCl (0.9 wt.%) were combined with crosslinking agents and hMSCs 
(810
6
cell/mL). The mixture was pipetted (20 µL) onto the wells of a pHEMA-treated [27] 24-well 
suspension culture plate for crosslinking (1h). Thereafter, fresh medium was added and 
renewed after 1h. hMSCs-laden hydrogels were finally incubated under standard conditions 
(37ºC, 5% v/v CO2). As a control, hMSCs-laden hydrogels inactivated with methanol (20 min) at 
the onset of culture were used. Samples were imaged at different time points using a 
stereoscope (SZX10, Olympus) equipped with a digital camera (DP21, Olympus) and an 
inverted fluorescence microscope (Axiovert 200M, Zeiss). Cell viability was assessed using the 
Live/Dead assay. Cell-laden matrices were washed 3 times with DMEM without phenol red 
(Gibco), then incubated (45 min, 37ºC in the dark) with Calcein AM (1 µM, live cells) and 
Ethidium homodimer-1 (EthD-1, 2.5 µM, dead cells), and finally washed again. Samples were 
imaged by confocal laser scanning microscopy (CLSM, Leica SP2 AOBS SE).  
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2.6. Cell morphology and spatial-distribution (f-actin staining and histology) 
 
After 1 and 7 days of culture, cell-laden hydrogels were washed with Tris-buffered saline 
(TBS, 50 mM Tris in 150 mM NaCl, pH 7.4, Sigma), and fixed with 4 wt.% paraformaldehyde 
(PFA, Sigma) in TBS-Ca (TBS with 7.5 mM CaCl2) for 20 min.  
For cytoskeleton analysis, samples were permeabilized for 5 min with 0.1% v/v Triton X-
100/ TBS-Ca and incubated for 30 min in 1 wt.% BSA/TBS-Ca to block unspecific binding. F-
actin filaments were stained with Alexa Fluor 488 phalloidin (Invitrogen, 1:40 in 1 wt.% 
BSA/TBS-Ca, 1h at RT) and nuclei were counterstained with Ethidium homodimer-1 (EthD-1, 
Invitrogen, 2.5 μM). Samples were analyzed by CLSM.  
For histology, samples were dehydrated with a series of ethanol solutions of increasing 
concentrations and included in paraffin blocks. Thereafter, sections (3 μm) were recovered, 
diafanized in xylene and rehydrated with a series of ethanol solutions of decreasing 
concentrations and finally water.  
For Hematoxilin and Eosin (H&E) staining, sections were incubated in Gill’s Hematoxylin 
for 5 min and counterstained with Eosyn Y for 1 min. Finally sections were dehydrated, 
diafanized in xylene and mounted in glass slides using histofluid (Marienfeld) mounting medium. 
Samples were imaged by optical microscopy. 
 
 
2.7. Outward cell migration (modified Boyden chamber assay) 
 
Cell migration was analysed using FluoroBlok™ inserts with an 8 μm pore size (Becton 
Dickenson) placed in a 24-well tissue culture insert carrier plate (Becton Dickenson). hMSCs 
were pre-labelled with CellTracker Green CMFDA (Molecular Probes) at 15 μM for 30 min, and 
then entrapped within alginate matrices as previously described. Cell-laden hydrogel matrices 
were transferred to the FluoroBlok inserts and serum-free medium (upper chamber) or medium 
with 30% v/v FBS (lower chamber) were added. Every 24h, the serum-free medium in the upper 
chamber was renewed and fresh FBS was added to the lower chamber to maintain a gradient 
and promote chemo-attraction. At different time points (0, 24, 48 and 72h), fluorescence 
intensity from the basal side was measured using a microplate spectrofluorometer (BioTek) in 
area-scan bottom-reading mode, at wavelengths of 492/517 nm (Ex/Em).  
Results are presented as the increase of fluorescence in relation to time 0. Fluorescence 
images of migrating cells were collected using an inverted fluorescent microscope. 
Fluorescence-labelled cells within the alginate matrices were imaged by CLSM. 
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2.8. Assessment of FN fibril formation and α5-integrin subunit expression by 
immunostaining 
 
Expression of fibronectin (FN) and α5 integrin was assessed by whole-mount 
immunostaining to better preserve ECM structure and allow for 3D visualization. After 4h and 
24h of culture, samples were washed 3 times with TBS-Ca and fixed with 0.2 wt.% PFA in TBS-
Ca (20 min at RT). Samples were then permeabilized with 0.2% v/v Triton X-100 during 10 min 
and blocked with 1 wt.% BSA for 20 min. Matrices were incubated ON at 4ºC with rabbit anti-
fibronectin (f3648, Sigma, 1:400) or rabbit anti-integrin α5 antibody (AB1928, Millipore, 1:300), 
and then with goat anti-rabbit secondary antibody Alexa Fluor 594 F(ab’)2 fragment (Molecular 
Probes-Invitrogen, 1:1000, 1h at RT). Samples were finally incubated with Alexa Fluor 488 
phalloidin (Invitrogen, 1:40) for actin staining, and with 4’,6-diamidino-2-phenylindole (DAPI, 0.1 
µg/mL) for nuclei staining, and were imaged by CLSM. 
 
 
2.9. DNA synthesis (
3
H-TdR and BrdU incorporation assays)  
 
For the Tritiated thymidine (
3
H-TdR) assay, 
3
H-TdR was added to the 3D culture medium 
at a final concentration of 110 
-3
 Ci/mmol at different time points, and samples were analysed 
24h later. As a positive control, hMSCs cultured under 2D-conditions in T25 culture flasks were 
used, and the initial density (6400 cells/cm
2
) was adjusted to yield a number of cells per flask 
equivalent to that in each 3D matrix. At days 1, 3, 5 and 7, hMSCs were recovered from the 3D 
matrices after treatment with 0.25 wt.% Trypsin/ 50mM EDTA, and incubated for 10 min with 5% 
v/v trichloroacetic acid to precipitate nucleic acids. The precipitates were then dissolved with 1M 
NaOH, and the scintillation liquid (LSC cocktail, ULTIMA GOLD, PerkinElmer) added. After 1h in 
the dark, samples were analysed in a scintillation counter (MicroBeta Trilux, PerkinElmer).  
For the Bromodeosyuridine (BrdU) assay, 0.01 mM BrdU (Sigma-Aldrich) was added to 
the 3D culture medium. After 1 week, cells were recovered from the hydrogels and transferred 
to glass slides by cytospinning (Shandon Cytospin 4, Thermo). Cells were fixed with 4 wt.% 
PFA in PBS for 20 min, treated with 2M HCl for 20 min, and incubated for 5 min in PBS 
containing 0.5% v/v Tween 20 and 0.05 wt.% BSA to block unspecific binding. Samples were 
then incubated in monoclonal mouse anti-BrdU (DakoCytomation, 1:10, 1h at RT), followed by 
secondary antibody Alexa Fluor 568 goat anti-mouse IgG (H+L) (Molecular Probes-Invitrogen, 
1:1000, 30 min at RT).  Nuclei were counterstained with 1 μg/mL DAPI, and slides were 
observed and imaged using an inverted fluorescence microscope. Total and BrdU+ nucleus 
were counted using Image J software and the percentage of proliferating cells was calculated.  
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2.10. Osteogenic differentiation (ALP and OCN expression) 
 
hMSCs-laden alginate matrices were cultured  for up to 3 weeks in osteogenic medium 
consisting of low-glucose DMEM with 10% v/v FBS (pre-selected batch from PAA), 1% v/v 
Pen/Strep, 100 nM dexamethasone (Sigma), 10mM β-glycerophosphate (Sigma) and 0.05 mM 
2-phospho-L-ascorbic acid (Fluka).  
For alkaline phosphatase (ALP) staining, samples were washed 3 times with TBS-Ca and 
fixed with 4% v/v PFA in TBS-Ca (20 min at RT). After washing, samples were incubated for 30 
min in Naphthol AS-MX phosphate/Fast Violet B salt (Sigma, 30 min at 37ºC, protected from 
light) and then washed again. Samples were imaged using a stereoscope.  
Expression of osteocalcin (OCN) was probed in paraffin sections obtained as described 
in section 2.6. Samples were first treated with 10 mM Tris / 1 mM EDTA (pH 9) for 35 min at 95-
98°C for antigen recovery. Sections were then incubated with rabbit anti-osteocalcin (ab13420, 
abcam, 1:400, ON at 4ºC), and then with Alexa Fluor 594 goat anti-rabbit IgG (1:1000, 
Molecular Probes-Invitrogen, 1h at RT) secondary antibody. Finally, sections were mounted in 
Fluoroshield™ with DAPI (Sigma) and imaged by CSLM. 
 
 
 
2.11. Statistical analyses 
 
Statistical analyses were performed using GraphPad Prism 5.0 software version 5.0a. 
The non-parametric Mann–Whitney test was used to compare two groups, whereas comparison 
between more than two groups was performed using the Kruskal–Wallis test followed by Dunn’s 
comparison test. A value of p < 0.05 was considered statistically significant. 
 
 
3. RESULTS 
 
 
3.1. Physicochemical properties of RGD-alginate hydrogels 
 
Alginate hydrogels with a bimodal molecular weight (MW) distribution (50% LMW and 
50% HMW) were prepared with different polymer concentrations (1 and 2wt.%) and densities of 
tethered RGD peptides (0, 100 and 200 µM). This previously optimized bimodal MW formulation 
[28] enables the preparation of low stiffness hydrogels (LMW contribution) without impairing the 
gelling capacity of the precursor solution (HMW contribution).  
The hydrogels’ microstructures are depicted on Fig. 1A, to illustrate that the network gets 
less dense as the polymer concentration is decreased from 2wt.% to 1wt.% but, in both cases, it 
spatially confines the entrapped cells forcing them to adopt a round shape at the onset of the 
culture (Fig. 1A, insets). Yet, CryoSEM images do not reflect the actual hydrogels mesh sizes, 
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which were determined using an alternative technique as described below. The influence of 
polymer concentration and RGD density on the initial mechanical properties of alginate 
hydrogels was analysed by DMA.  
As shown in Fig. 1B, the compressive storage modulus (E’, elastic component) was 
highly dependent of the polymer content. In fact 2wt.% hydrogels presented a storage modulus 
that was ca. 10-fold higher than that of 1wt.% hydrogels. Additionally, tan ∂ measurements (Fig. 
1B) revealed that the 2wt.% hydrogels were predominantly elastic (tan ∂ ≈ 0.2; E’>>E’’), while in 
the 1wt.% hydrogels the viscous component was more prevalent (tan ∂ ≈ 0.4-0.6). The presence 
of tethered RGD tended to decrease E’ while increasing tan ∂, but statistically significantly 
differences were only observed in terms of E’ for the formulation 2-200 as compared to other 
hydrogels at 2wt.%. 
 
 
Fig. 1. Microstructure and mechanical properties of alginate hydrogels. (A) Microstructural CryoSEM 
analysis of acellular and hMSCs-laden (inset) alginate hydrogels at 1wt.% and 2wt.%. (B) DMA analysis 
showing average values for the compressive storage modulus (E’, elastic component) and tan ∂ (loss-to-
storage modulus ratio) of swollen hydrogel discs under unconfined compression. Error bars represent 
standard deviations for the mean (n=4 or 5).  
 
 
Table 1 presents additional characterization of acellular and cellularized alginate matrices 
in terms of their original mesh size and rheological properties along the first 24h of culture. Only 
matrices with 0 and 200 μM of RGD were analysed, as no great differences were expected 
when varying the RGD content from 100 to 200 μM.  
The mesh size increased as the polymer content decreased, as expected, and was 
slightly higher in the presence of RGD. Overall the obtained values were within the same range 
of those reported for alginate hydrogels of similar composition [12], being ca. 2-3 orders of 
magnitude below the mean cell body size (~10 μm).  
In terms of rheological properties, the elastic component of the storage moduli G’ was in 
general lower in RGD-grafted hydrogels compared to unmodified ones. Cellularized hydrogels 
A                                    B                                                              C 
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tended to be less stiff than acellular gels at similar polymer concentrations, and exhibited 
weaker concentration-dependence in the absence of RGD. Most importantly, the bulk shear G’ 
decreased along the first 24h of culture in all the formulations, with the exception of the RGD-
containing hMSCs-laden 1wt.% matrices, where it effectively increased. 
 
 
Table 1. Composition, rheological properties and original mesh size of alginate hydrogels. 
Name 
Polymer dry 
mass (wt.%) 
RGD 
(μM) 
Cells 
Incubation 
time (h) 
Storage 
modulus 
(G’, Pa) 
G’ after 
24h (
a
) 
Mesh size 
(ξ, nm) 
1-0 1 0 no 0 121 ± 0.1 –
 
 10.9 ± 0.1 
   no 24 82 ± 12  – 
   yes 0 71 ± 14 – – 
   yes 24 51 ± 12  – 
1-200 1 200 no 0 99 ± 3 – 12.1 ± 0.1 
   no 24 65 ± 7  – 
   yes 0 39 ± 3 – – 
   yes 24 61 ± 21  – 
2-0 2 0 no 0 888 ± 38 – 3.8 ± 0.0 
   no 24 518 ± 34  – 
   yes 0 234 ± 105 – – 
   yes 24 235 ± 21 = – 
2-200 2 200 no 0 461 ± 43 – 5.3 ± 0.1 
   no 24 358 ± 17  – 
   yes 0 244  ± 42 – – 
   yes 24 165 ± 31  – 
  
 
(
a
)
 
 increase;  decrease; =   no alteration; – not assayed. 
 
 
3.2. Matrix contractility and cell spreading  
 
Upon entrapment, hMSCs remained viable (>80% after 1 week), independently of the 
hydrogels composition (Fig. 2A). At the onset of the culture, hMSCs exhibited a round shape 
and were homogeneously distributed through the matrix (Fig. 2B).  
As time progressed, hMSCs began to remodel the more pliable 1wt.% matrices. After 24h 
in 1wt.% RGD-alginate matrices, and independently of the amount of RGD, hMSCs had already 
contracted the polymeric network, with an average decrease of 47.9±3.5% in diameter, and 
concomitantly formed a dense multicellular aggregate at the core. In contrast, the 2 wt.% 
matrices were macroscopically unchanged and cells remained essentially round and dispersed, 
independently of the density of RGD ligands.  
Morphological alterations were not detected in control samples: 1wt.% matrices loaded 
with inactivated (methanol-treated) cells. In the absence of RGD (Fig. 2C), the contraction of 
1wt.% matrices was much less pronounced (12.0±0.8%). 
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Fig. 2. Cell viability and hMSCs-driven contraction of soft 3D hydrogel matrices. (A) hMSCs 
entrapped within 1 and 2wt.% alginate remained viable after 1 week of culture. (B) At the onset of the 
culture hMSCs were round and dispersed (hMSCs in 1wt.% matrices are depicted as an example, the 
inset shows entrapped cells at higher magnification), but rapidly (24h) contracted the 1wt.% matrices 
(independently of the RGD content, 1-100=1-200) forming a multicellular aggregate at the core, which was 
not observed in non-viable hMSCs (control), nor in hMSCs cultured in stiffer 2wt.% matrices 
(independently of the RGD content, 2-100=2-200). (C) In the absence of RGD, the contraction of 1wt.% 
matrices after 24h was much less pronounced (original magnification = 10). 
 
 
To investigate in more detail the morphology of hMSCs and their spatial re-arrangement 
within the 3D matrices, F-actin (Fig. 3A) and H&E (Fig. 3B) stainings were performed.  
In 1wt.% RGD-alginate matrices (1-100 or 1-200), hMSCs were able to spread and 
establish cell-cell contacts forming multicellular networks. The H&E staining (Fig. 3B) clearly 
show that in 1wt.% matrices hMSCs were directed axially towards the core, where they formed 
a large and dense cell aggregate.  
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Inside the 2wt.% RGD-alginate matrices, hMSCs remained dispersed throughout the 
matrix and did not spread significantly. Yet, the presence of short cytoplasmic extensions 
around the cell (inset in Fig. 3A) suggests that hMSCs were able to interact with matrix-bound 
RGD motifs. 
 
 
 
Fig. 3. Morphology and spatial distribution of hMSCs within soft 3D hydrogel matrices. (A) F-actin 
and (B) H&E staining of hMSCs-laden matrices, showing that hMSCs entrapped within softer 1wt.% RGD-
alginate hydrogels were able to migrate into the core, adopt a more spread shape and establish contacts 
with neighbouring cells (1-100=1-200). In contrast, hMSCs within stiffer 2wt.% RGD-alginate matrices 
remained individually dispersed within the matrix and essentially round, albeit showing some cytoplasmic 
protrusions into the matrix (A, inset). 
 
 
3.3. Influence of external biochemical stimulation on cell-cell aggregation 
 
It was then investigated if this tendency of hMSCs to migrate into the matrix-core and 
coalesce in a large cellular aggregate could be inhibited by an applied biochemical stimulus. 
Outward cell migration was induced by creating an external chemotactic gradient of FBS and 
was quantified using a modified Boyden chamber assay.  
Inserts with fluorescence-blocking membranes were used to monitor the kinetics of 
outward cell migration. 3D matrices loaded with labelled hMSCs were placed in the upper 
compartment of the insert (Fig. 4B), and cells leaving the matrix were allowed to migrate 
through the pores of the membrane into the lower compartment, where the total fluorescence 
was measured (Fig. 4C). As shown in Fig. 4A, during the first 24h, more hMSCs were able to 
migrate from the 1wt.% matrices than from the 2wt.% matrices, as anticipated. 
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After that, hMSCs migration from 1wt.% matrices (where cell aggregates formed, Fig. 4D) 
stopped or proceeded at very low rates and differences between the various conditions became 
less significant. hMSCs within 2wt% matrices remained dispersed (Fig. 4E). 
 
 
  
Fig. 4. Outward migration of hMSCs from RGD-alginate 3D matrices in response to an external 
chemotactic gradient of FBS. (A) Entrapped hMSCs (labelled with CellTracker Green) more easily 
evaded the softer 1wt.% matrices than the stiffer ones. After the first 24h, cell migration decreased and 
differences became attenuated. () Denotes statistically significant differences (p<0.05) in comparison with 
2wt.% matrices. (B) Representative picture of a hMSCs-laden disc at the onset of the assay (1=2wt.%). 
(C) Migrating hMSCs attached to the lower side of the insert membrane. (D) Aggregated hMSCs within 
1wt.% matrices at 24h. (E) Dispersed hMSCs within 2wt.% matrices at 24h. 
 
 
3.4. Expression of fibronectin and its role in the stabilization of cell-cell contacts 
 
Clearly, in the case of the more pliable matrices, and in a time frame of hours, the 
interactions of entrapped hMSCs with their surrounding matrix, as well as with other cells, 
globally changed with time. To better characterize this new microenvironment, we determined if 
matrix properties could affect the ability of the entrapped hMSCs to produce their own ECM. 
Particular attention was given to the expression of fibronectin (FN), as FN polymerization is 
known to play an important role in the self-assembly of multicellular structures [29]. After 4h 
(Fig. 5A-C), intracellular FN expression was detected by immunostaining in all hydrogel 
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formulations. After 24h (Fig. 5D-F), hMSCs assembled a pericellular FN network only within the 
1wt.% matrices (Fig. 5D, E).  
In soft RGD-modified matrices, both with 100 μM and 200 μM RGD, this de novo formed 
FN-rich matrix enmeshed the cells, forming an extensive network of elongated, branching fibrils 
(Fig. 5E). FN fibrils were also generated between aggregated cells even in the non-adhesive 
1wt.% matrices (Fig. 5D). In 2wt.% matrices, after 24h (Fig. 5F), FN expression remained 
mainly restricted to the intracellular space, independently of the presence and density of RGD 
(0, 100 and 200 μM).  
 
 
  
Fig. 5. Fibronectin (FN) matrix assembly assessed by immunofluorescence. hMSCs were cultured 
within alginate matrices for 4h and 24h, and whole-mounts were fixed for immunostaining with a polyclonal 
antibody against FN. FN was visualized with Alexa Fluor 594 (red), F-actin was visualized with Alexa Fluor 
488 (green) and nuclei were visualized with DAPI (blue) by CLSM. FN expression after 4h in: (A) 1-0, (B) 
1-100 (= 1-200) and (C) 2-100 (=2-0 and 2-200). FN expression after 24h in: (D) 1-0, (E) 1-100 (=1-200) 
and (F) 2-100 (=2-0 and 2-200). Insets: higher magnification images. 
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Since the α5β1 integrin is the primary receptor for FN, and is known to mediate 
intercellular cohesion of 3D cellular aggregates [29, 30], the expression of α5 was also analyzed 
at the same time points. Consistently with the assembly of a FN network, the expression of α5 
integrin sub-unit after 24h of culture was also enhanced in the more pliable 1wt.% matrices, 
particularly at sites of cell aggregation (Figs. 6A and B), independently of the presence and 
density of RGD.  
Interestingly, some α5 integrin expression was also detected in RGD-alginate matrices in 
cases where FN was mainly detected intracellularly, namely in 2wt.% matrices after 24h (Fig. 
6C) and in 1wt.% matrices after 4h (Fig. 6D). 
 
 
 
Fig. 6. Expression of 5 integrin sub-unit assessed by immunofluorescence. hMSCs were cultured 
within alginate hydrogels for 4h and 24h, and whole-mounts were fixed for immunostaining with a 
polyclonal antibody against α5 integrin. Expression of α5 integrin was visualized with Alexa Fluor 594 
(red), F-actin was visualized with Alexa Fluor 488 (green) and nuclei were visualized with DAPI (blue) 
under CLSM. Black and white images are presented, and the bright white dots (some are indicated with 
arrows) represent a positive staining. Expression of 5 integrins after 24h in: (A) 1-0; (B) 1-200 (=1-100), 
(C) 2-100; and after 4h in (D) 1-200. 
 
 
3.5. Effect of matrix stiffness and ligand presentation on hMSCs proliferation 
 
As matrix properties are also likely to affect other cellular activities, namely proliferation, 
DNA synthesis was followed using the 
3
H-TdR assay. The proliferative activity of hMSCs within 
hydrogels was compared between formulations and also with cells cultured under standard 2D 
conditions.  
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Cell proliferation in 3D (Fig. 7A) occurred at lower rates than in 2D (Fig. 7B), but 
considerably varied among matrices of different compositions. Higher proliferation was 
observed in 1wt.% vs. 2wt.% matrices, and proliferation increased with the amount of RGD.  
The BrdU staining showed the presence of a few mitotically-active cells on the 
populations of hMSCs recovered from the 3D cultures (Fig. 7c, the formulation 1-100 is depicted 
as an example). Using this assay, a higher number of proliferating cells were detected in the 
softer matrices (ca. 3% in 1-100 and 9% in 1-200, as compared to ca. 2% both in 2-100 and 2-
200 hydrogels), confirming the results obtained with the 
3
H-TdR assay. 
 
 
 
Fig. 7. Effect of hydrogel matrix physico-chemical properties on hMSCs proliferation. The 
3
H-TdR 
assay showed that (A) hMSCs in 3D proliferated at a much lower rate than (B) in 2D. However, in 3D, 
hMSCs proliferated more in 1wt.% than in 2wt.% matrices. Proliferation also increased in a RGD-
dependent manner. Symbols denote statistically significant differences (p<0.05) in comparison to: () day 
1, (†) 2wt.% matrices, and (§) 100 μM RGD. (C) BrdU immunostaining showing proliferating (red) vs. non-
proliferating (blue, DAPI) hMSCs recovered from 1-200 RGD-alginate matrices. 
 
 
3.6. Effect of matrix stiffness and ligand presentation on hMSCs differentiation 
 
Finally, as the biochemical/mechanical interactions between MSCs and their matrix are 
known to be key mediators of cell fate, it was further investigated how matrix properties 
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regulated hMSCs differentiation in 3D. In particular, the expression of the osteogenic markers 
alkaline phosphatase (ALP) and osteocalcin (OCN) was evaluated, as cell aggregation has 
been shown to induce osteogenic differentiation [31, 32].  
In 1 wt.% matrices, hMSCs expressed high levels of ALP activity (Fig. 8A), even in the 
absence of RGD and under basal conditions, suggesting a clear relationship between hMSCs 
aggregation and osteogenic differentiation. In contrasts, in 2wt.% matrices ALP activity was only 
detected in the presence of RGD. In both cases, the effect of using an osteoinductive medium 
(OM) added to the effect of the matrix, suggesting that the matrix intrinsic properties and the 
soluble induction factors acted synergistically in driving hMSCs osteogenic differentiation. In 
accordance with the ALP results, OCN expression (Fig. 8B) was detected in all the 1wt.% 
matrices and also in RGD-modified 2wt.% matrices, both under basal and osteoinductive 
conditions. 
 
 
 
Fig. 8. Effect of hydrogel matrix properties on hMSCs osteogenic differentiation. Expression of (A) 
ALP activity and (B) OCN by hMSCs cultured in 3D alginate matrices for 21 days, under basal (BM) and 
osteoinductive (OM) conditions. 
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4. DISCUSSION  
 
The present results confirmed that hMSCs are extremely responsive to the viscoelastic 
properties of their matrix [33], and that these can be modulated to promote specific cell 
behaviours. Differences on hydrogel rheological and mechanical properties had a clear effect on 
the tension that hMSCs could exert upon the polymeric network. The entrapped hMSCs were 
able to significantly contract the softer and more deformable 1wt.% hydrogels, as typically 
observed with other contractile cell types, such as fibroblasts, when cultured in floating collagen 
matrices [10, 15]. This suggests that hMSCs were able to pull over the soft gels and connect to 
each other, driven by a mechanosensing mechanism [18, 19]. As proposed by others, dispersed 
cells are able to sense their physical microenvironment and balance the mechanical signals 
conveyed by cell-matrix and cell-cell adhesions [18, 19]. When the matrix stiffness is low 
enough, cells can perceive and react to substrate strains created by the traction stresses of 
neighbouring cells. If matrix signals provide a weaker mechanical input than cell-cell 
interactions, than cells migrate towards one another and coalesce to form multicellular tissue-
like structures [19]. Even if it remains to be elucidated whether a similar mechanism of cell 
communication applies to this particular system, the present results show that matrix 
mechanical properties can be harnessed to foster tissue formation by promoting cell-cell 
connection.  
By locally remodelling the original alginate matrix, and increasing local matrix density via 
network contraction and FN assembly, hMSCs dynamically altered their original mechanical 
environment, and actually reinforced their mechanical shelter [19], which is consistent with 
previous findings from studies of hMSCs embedded in fibrin gels [33]. Although this is difficult to 
predict from rheometry data, which describe bulk phase material characteristics but provide 
limited information on local mechanical features, hMSCs in the softer RGD-alginate matrices 
effectively stiffened the shear modulus of the hydrogel after 24h of culture.  
Here, we additionally show that cell-driven matrix traction was dependent on integrin-
mediated cell-matrix adhesion. In fact, while hMSCs also formed FN-stabilized cell-cell 
aggregates within non-adhesive 1wt.% matrices, they were unable to substantially contract the 
matrix. On one hand, hMSCs were capable of sensing and responding to matrix stiffness, even 
in the absence of RGD-activated integrin mechanotransduction. On the other hand, without 
RGD ligands, even if hMSCs were driven to interact, they were unable to exert significant 
traction to pull over the matrix, probably due to the lack of matrix-anchor points. The capacity of 
fibroblasts to organize and contract collagen lattices has also been shown to depend on integrin 
ligation [34], which further highlights that mechanical regulation is tightly coupled to matrix 
ligand presentation [5, 35]. Even if a detailed analysis of 3D cell migration was out of the scope 
of the present study, the results presented here also support the idea that hMSCs entrapped 
within the softer matrices did not behave as typical path-creating mesenchymal migrating cells, 
but rather adopted an ameboid-like motility mechanism, behaving more as path-finding cells 
[36]. In fact, in order to connect to each other, hMSCs had to move within alginate hydrogel 
matrices without proteolytically degrading them, since alginate is not cleavable by mammalian 
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enzymes, and even in the absence of RGD ligands. Apart from requiring little or no receptor-
facilitated adhesion to the ECM for moving, cells with amoeboid-like motility are able to exert 
sufficient “pushing” forces to deform the surrounding matrix and deal with the imposed steric 
hindrance [36]. The viscoelastic properties of the matrix have clearly a direct impact on this 
process, since a moving cell will encounter less resistance to travel in softer and more 
deformable matrices [14]. In accordance, Ehrbar et al. recently showed that spreading and 
migration of osteoblasts in PEG hydrogels were impaired in stiffer matrices, even when those 
were protease-sensitive, but facilitated in hydrogels with lower stiffness, even if cell’s proteolytic 
activity was inhibited. Apparently, cells could transit from a mesenchymal to an amoeboid mode 
of migration that was independent of matrix proteolysis but related with matrix deformation, cell 
shape changes and local matrix defects [13].  
In what concerns the microstructure of hydrogels used herein, it is important to 
emphasize that, while the calculated mesh size was several orders of magnitude below the 
mean cell body size, this measure only provides a rough estimate of the global microstructure of 
an “ideal” hydrogel network. As such, it does not give any insight about the existence of network 
imperfections, which can be caused by different factors such as closed loops of polymer chains, 
hanging chain ends, slipping chain entanglements, among others [37]. The presence of grafted 
RGD peptides at crosslinking sites (COOH groups) and, more importantly, the presence of cells 
during the formation of the hydrogel network, is also anticipated to locally disturb its assembly 
and result in nano- or micro-sized defects near cells [12]. All these types of network 
inhomogeneities and defects, which can be a significant source of non-affine deformation [37], 
have certainly facilitated hMSCs motility by ameboid-like mechanisms in soft alginate hydrogels. 
In our system, hMSCs aggregation in softer matrices also correlated with FN fibril 
assembly and actin stress fiber formation. This is consistent with several reports that highlighted 
the contribution of FN in promoting intercellular cohesion in 3D microenvironments. In particular, 
FN fibrillogenesis has been shown to stimulate the self-assembly of fibroblast tissue bodies on 
collagen gels [38]. In a broader sense, tissue compaction and cohesivity, which are essential 
both during embryogenesis and wound healing, have also been spatiotemporally correlated with 
increased FN expression and deposition[29]. In this process, FN acts as “glue” that links 
adjacent cells by promoting α5β1-integrin mediated strong intercellular cohesion [39]. In the 
present study, a high expression of α5-integrin subunit was effectively observed, particularly at 
sites of cell aggregation and FN deposition, as expected. The increased FN deposition might 
also promote tension generation, accelerating compaction and altering the behaviour of cells 
responding to mechanical cues [29]. Notably, here it was shown that hMSCs assembled FN 
patches, even in the absence of matrix-bound RGD, which co-localized with cell aggregates. 
Some expression of α5 integrin was also detected in cases where FN expression was only 
intracellular, such as in all RGD-modified matrices after 4h, and also in 2wt% RGD-matrices 
after 24h. In those cases, α5 integrins were probably activated by engagement with tethered 
RGD ligands. Although ligation to α5 integrin is conventionally known to additionally require the 
PHSRN synergy sequence of FN, a recent study by Huebsch et al. suggested that this might 
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not totally apply to “true” 3D set-ups. In fact, the authors demonstrated that in MSCs cultures in 
RGD-alginate matrices in 3D, α5 integrin expression localized to the cell-matrix interface in a 
RGD-dependent manner, suggesting the involvement of RGD moieties [7]. 
While cell proliferation in 3D progressed at much lower rates than in 2D, as also 
demonstrated by others [40], it was also favoured in softer vs. stiffer matrices. This was 
anticipated, as several studies have shown that cell proliferation in 3D is facilitated in more 
pliable substrates, probably because cells can more easily overcome the physical impediment 
posed by the matrix and create additional space to grow [10, 12]. FN polymerization, which only 
occurred in the more compliant matrices, is also known to stimulate cell growth by RGD-
dependent and independent mechanisms [41].  
Perhaps more surprisingly, it was also shown here that low-stiffness matrices provided a 
permissive environment for hMSCs osteogenic differentiation, even in the absence of RGD 
ligands. These results show an opposite trend to most studies found in the literature, which 
demonstrated not only that osteogenesis is favoured in stiffer matrices [7], but also in the 
presence of RGD [24]. Here, however, concurrent processes of local matrix stiffening, cell 
shape, cell-cell aggregation and α5β1 integrin-mediated FN binding certainly played a role, as 
all these factors have been, in and on themselves, correlated with osteogenesis induction. For 
example, several studies have shown a correlation between cell aggregation and osteoblastic 
differentiation [31, 32, 42], and activation of the α5β1 integrin is known to have an important role 
in MSCs osteogenic differentiation [43, 44]. Consequently, upon cellular self-assembly, a new 
biochemical/mechanical microenvironment is created by cell–cell and cell–ECM interaction that 
in turn controls MSCs behaviour. 
 
 
5. CONCLUSIONS 
 
 The present results show that when hMSCs were entrapped within very soft alginate 
hydrogels they rapidly modified their local mechanical and biochemical environment, became 
embedded and ultimately resided within a self-synthesised ECM. In such a system, cell 
interactions with the original matrix become less important as time progresses and the de novo 
produced cell-derived matrix turns into a more critical determinant of cell fate. Even so, the 
intrinsic properties of the original artificial matrix were clearly central guidance variables, 
showing not only that hMSCs are particularly responsive to microenvironmental cues, but also 
that the first hours of interaction with the matrix are decisive. Moreover, this work provided new 
clues to the design of cell-instructive 3D microenvironments, and better elucidated the interplay 
between substrate compliance and ligand presentation in cell-in-gel responses. In particular, it 
established a biomaterial-driven strategy to induce the self-aggregation of MSCs and the 
formation of MSCs-ECM micro-tissues, with higher proliferation and osteogenic differentiation 
ability, which might be potentially interesting for therapeutic applications.  
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SUPPLEMENTARY DATA  
 
The initial mesh size (ξ) of alginate hydrogels, after being pre-swollen in culture medium, 
was calculated as described in
 
[12], using rheometry data (the measured value of the shear 
modulus) to calculate the molecular weight between crosslinks (Mc). Immediately after 
crosslinking, matrices were incubated in medium for 2h, freeze-dried and weighed. The swelling 
ratio (qF) and polymer volume fraction (2) were calculated from the following equations: 
 
1) qF = (mass of gel after 2h incubation) / ( mass of gel after freeze-drying) 
 
2) 2 =1+ (qF - 1) ρP/ρM 
 
Where: ρP is the density of the alginate (1.601 g.cm
-3
) and ρm is the density of the culture 
medium (0.99 g.cm
-3
). 
 
The crosslink density η was calculated using the Flory–Rehner equation: 
 
3) η = - [ln(1-2) + 2 + χ12
2
] / [V1(2
1/3  
– 0.5 2) 
 
Where: χ1 is the Flory–Huggins interaction parameter (≈ 0.5), V1 is the molar volume of the 
solvent (NaCl, 0.5 cm
3
), and η is the number of active network chain segments per unit volume 
(mol.cm
-3
).  
 
The molecular weight between crosslinks was calculated from the measured value of the G’ 
using the following equation: 
 
4) Mc = CpRT / G’ 
 
Where: CP is the concentration of alginate in solution (1 or 2wt.%), R is the gas constant (8.314 
m
3
.Pa mol
-1
.K
-1
) and T is the temperature. 
 
Finally, the mesh size, ξ, was calculated using the following equation: 
 
5) ξ = 2
-1/3
 l * (2Mc/Mr)
1/2
 Cn
1/2 
 
Mr is the molecular weight (390.1 g.mol
-1
) of the repeat unit, l is the carbon–carbon bond length 
of monomer unit (assumed to be 5.15 Å), and Cn is the ratio for alginate calculated as Cn = 
0.021Mn + 17.95 = 21.1.  
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ABSTRACT 
 
The outcome of cell-based therapies can benefit from carefully designed cell carriers. Injectable 
vehicles able to direct human mesenchymal stem cells (hMSCs) differentiation down the 
osteoblastic lineage are particularly relevant for minimally-invasive bone healing strategies. 
Here we report on the use of alginate (Alg) hydrogels as depots for the co-delivery of 
osteoinductive signals and hMSCs. Two osteogenic growth peptide (OGP) analogues were 
synthesized and conjugated to Alg via distinct linkers with high and low sensitivity to proteolytic 
degradation (OGP2 and OGP3, respectively). Both analogues released bioactive OGP-like 
fragments in vitro, with different kinetics, which stimulated hMSCs proliferation and 
osteogenesis. hMSCs-laden OGP-Alg hydrogels were tested at an ectopic site in a xenograft 
mouse model. After 4-weeks, OGP-hydrogels were more degraded and colonized by new 
vascularized tissue than the control (without OGP). hMSCs produced extracellular matrix, 
migrated outward the hydrogels and proliferated to some extent. OGP groups stimulated 
hMSCs osteogenic differentiation, as compared with the control, and none of the groups 
expressed adipogenic genes. Interestingly, OGP3 also stimulated hMSCs chondrogenic 
differentiation. Overall, the ability of the proposed platform to direct the fate of transplanted 
hMSCs in loco was demonstrated, and OGP-releasing hydrogels emerged as potentially useful 
system to promote bone regeneration. 
 
 
 
 
 
 
 
 
Keywords: Injectable alginate hydrogels, osteoinductive peptides, co-delivery systems, 
mesenchymal stem cells, guided differentiation, bone regeneration. 
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1. INTRODUCTION 
 
Hydrogels show great potential as cell vehicles for minimally invasive bone regeneration 
therapies [1]. These materials form hydrophilic 3D microenvironments that recreate some 
features of native extracellular matrices (ECM), and can be decorated with cell-instructive cues 
to facilitate adhesion and direct the phenotype of entrapped cells. Therapeutic approaches 
aiming at driving mesenchymal stem cells (MSCs) fate in a controlled manner, namely by 
promoting their differentiation into bone-forming cells through the co-delivery of osteoinductive 
compounds, are promising for bone healing applications [2, 3]. 
Strategies involving the use of small and simple compounds, such as peptides, can be 
advantageous as compared to more complex biomolecules, by leading to less expensive, more 
stable and easily tunable biomaterial formulations [4]. Up to now, different kinds of 
osteoinductive peptides have been proposed [5, 6]. In this study, we evaluated the potential of 
OGP, a naturally occurring tetradeca-peptide identical to the C-terminus of histone H4 (residues 
89-102, ALKRQGRTLYGFGG), which is present in plasma at micromolar concentrations [7-9].  
The physiologically active form of OGP, which corresponds to its C-terminal pentapeptide 
sequence YGFGG (OGP10–14), is generated from full-length OGP by proteolytic cleavage [10]. 
This fragment directly interacts with the cell surface [11-13], activating the OGP signaling 
pathways MAP kinase, Src and RhoA [14]. Upon intravenous administration, synthetic OGP and 
OGP10-14 were shown to promote increased bone mass and fracture healing in vivo [6, 8, 14]. 
In vitro, OGP peptides were shown to increase the proliferation of osteoblastic-like cells and 
MSCs and accelerate osteogenesis [15]. In pursuit for superior osteoinductive compounds for 
bone regeneration therapies, OGP has provided a useful basis for engineering additional OGP 
analogues with enhanced bioactivity, stability and bioavailability. This includes the design of 
different peptide sequences to be used on soluble form [10], as well as more complex systems 
with physically or chemically immobilized OGP for local administration [15-18]. In this context, 
the aim of this study was to develop protease-responsive delivery systems for OGP analogues, 
which could simultaneously act as injectable hMSCs vehicles, for minimally invasive healing of 
small bone defects.  
Among the numerous proteases that can be selected to trigger enzyme-activated drug 
release, those belonging to the metalloproteinases (MMPs) family are particularly attractive. 
MMPs actively participate in ECM remodeling and degradation, having a key role in wound 
healing and tissue regeneration, and some are constitutively expressed by both naïve and 
differentiated hMSCs [19, 20]. Here, different OGP analogues were designed, by flanking the 
YGFGG N-terminus with the MMP-substrate PVGLIG or its scrambled sequence GIVGPL [21]. 
Both were chemically grafted to alginate, a polymer with the ability to form hydrogels in situ, and 
one of the materials most widely used for cell entrapment [16, 22]. We hypothesized that in 
presence of specific MMPs, in particular MMP-2 [19, 21], the bioactive YGFGG fragment would 
be released from the hydrogel upon enzymatic cleavage of the PVGLIG sequence, while it 
would remain mostly immobilized when using the scrambled linker. Such OGP-delivery systems 
may thus be used to provide a local OGP depot that remains in close proximity of target cells at 
130 
 
the injury site, for prolonged time periods. Moreover, these hydrogels can simultaneously be 
used as hMSCs carriers and delivery vehicles, and specifically act on the transplanted cells, by 
regulating their proliferation and/or guide their differentiation along the osteoblastic lineage. In 
this study, the designed OGP analogues and OGP-alginate conjugates were firstly 
characterized at different levels, and then used for the preparation of OGP-alginate hydrogels. 
The in vivo performance of hMSCs-laden hydrogels was evaluated after 4-weeks of 
implantation at an ectopic site in a xenograft mouse model. 
 
 
2. MATERIALS AND METHODS  
 
 
2.1. Peptides 
 
 
2.1.1.    Synthesis and characterization of OGP analogues 
 
Different OGP-based oligopeptide sequences, hereafter designated by OGP1, OGP2 and 
OGP3 (full sequences and additional information are depicted in Table 1) were synthesized by 
solid-phase peptide synthesis (SPPS) using the Fmoc/tBu protection scheme [23]. The 
polymeric support selected, Fmoc-Gly-Wang resin (1 mmol/g, Iris Biotech), was an 
hydroxymethylated resin pre-loaded with the Fmoc-protected C-terminal amino acid; it was first 
deprotected by a 20% solution of piperidine (Sigma-Aldrich) N,N-dimethylformamide (DMF, 
Sigma-Aldrich). After washing with DMF and dichloromethane (DCM, Sigma-Aldrich), the next 
Fmoc-protected amino acid (Fmoc-AA-OH, Novabiochem or Bachem) was coupled to the Gly-
Wang resin by means of DIPCDI (Fluka) coupling reagent. Then, the Fmoc protecting group 
was removed again with 20% piperidine in DMF and, after resin washing with DMF and DCM, 
the following Fmoc-AA-OH was coupled to the peptidyl-resin as before. This process was 
repeated in the C→N direction until the full amino acid sequence was assembles. Peptide 
cleavage from the resin occurred in acidic conditions using triﬂuoroacetic acid (TFA, Sigma-
Aldrich), triisopropylsilane (TIS, Sigma-Aldrich) and H2O (95:2.5:2.5) cocktail [23, 24]. 
Liquid chromatography-mass spectroscopy (LC-MS) was used to check the molecular 
weight of the synthesized peptides. Samples were prepared in methanol and all data were 
collected in positive ion mode, in a LCQ-Deca XP LC-MS system from ThermoFinnigan, 
equipped with both a diode-array detector (DAD) detector and an electrospray ionization-ion 
trap mass spectrometer (ESI/IT MS). A high pressure LC (HPLC) method was established for 
the quantification of the peptides purity on a LaChrom Elite system (Hitachi-Merck) equipped 
with a quaternary pump a thermostatted (Peltier) automated sampler and a DAD. A Purospher 
Star RP-C18 column (particle size 5 μm, 4.6 mm i.d. × 150 mm length) was used for the 
separations. The solvents used for the analysis were: solvent A (0.05% TFA in water) and 
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solvent B (HPLC-grade acetonitrile). The mobile phase consisted of a linear gradient of 0 to 
100% of B in A in 30 min. The flow rate was set at 1 mL/min and the analytes were detected at 
220 nm. When necessary (if purity < 90%), peptides were purified by preparative reverse phase 
LC at medium pressure (RP-MPLC). The elution conditions consisted of a linear gradient from 
20% to 30% of acetonitrile in water. The effluent was monitored at an absorbance of 220 nm, 
absorbing peaks were collected, peptides were lyophilized and analyzed by HPLC and LC-MS. 
Assessment of the peptides’ purity by HPLC was based on the calculation of the relative % of 
the peptide’s peak area as compared to the sum of the areas of all detected peaks. 
FRET peptides, kindly provided by Drª Maria Aparecido (UNIFESP, Brazil), were used for 
some assays. These incorporated an ortho-aminobenzoyl (Abz) fluorescent group and an N-
(2,4-dinitrophenyl)-ethylenediamine (EDDnp) quenching group at each side, as donor/acceptor 
pair, and also a Q residue as a requirement for SPPS (Table 1). FRET-peptides were 
synthesized using the Fmoc-procedure in an automated solid-phase peptide synthesizer (PSSM 
8 system from Shimadzu-Tokyo, Japan), as described elsewhere [25]. Peptides were purified by 
semi-preparative HPLC, and their molecular weight and purity were checked by amino acid 
analysis and matrix-assisted laser desorption/ionisation-time of flight (MALDI-TOF) MS, using a 
Microflex−LT mass spectrometer (Bruker−Daltonics, Billerica, MA, USA). The concentration of 
the FRET substrates was obtained by colorimetric determination of the EDDnp group (ε=17300 
M-1cm-1 at 365 nm), using peptide solutions at 1mg/mL in DMF:Water (1:1). 
 
 
2.1.2. Enzymatic cleavage of free OGP analogues 
 
Peptide solutions were prepared at 828 μM in Dulbecco’s phosphate-buffered saline 
(DPBS) containing calcium and magnesium (Invitrogen, Carlsbad, CA). Recombinant active 
human MMP-2 (Calbiochem, 25 nM) was added to each peptide solution. In control samples, 
the same volume of DPBS was added instead of the enzyme. After 24h of incubation at 37ºC, 
MMP-2 was removed by ultrafiltration (Amicon Centrifugal Filter, MWCO 10 kDa, Millipore) for 
2-5 min at 14,000xg, and the filtrates were recovered for analyses. The extent of peptide 
cleavage was estimated using the fluorescamine assay [26]. Briefly, each solution was placed 
(50 μL) into the wells of a 96 black-well plate and reacted with 7 μL of 21.6 mM fluorescamine 
(Sigma). Fluorescence was measured with an excitation wavelength of 400 nm and an emission 
wavelength of 460 nm in a microplate reader (SynergyTM Mx, Biotek). All measurements were 
made using at least n = 3 replicates, and are reported in relative fluorescence units (RFU). The 
molar masses of intact and digested peptides (t = 24h) were determined by LC-MS analysis. 
The kinetics of peptide cleavage by MMP-2 was analyzed using FRET peptides. These 
were incubated in DPBS and fetal bovine serum (FBS; Gibco; 10% v/v in DPBS), with or without 
MMP-2 (10 nM). Each solution was placed in triplicate (50 μL) into the wells of a 96 black-well 
plate maintained on ice, and the peptides were added to a final concentration of 5 μM. The plate 
was then placed in a thermostatized (37ºC) microplate reader and fluorescence was 
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continuously measured (Ex= 320 nm, Em= 420 nm) along the first hour of incubation, and then 
again after 48h at 37ºC. All measurements were made using at least n = 3 replicates. 
 
 
2.1.3. Effect of peptides on hMSCs proliferation and osteogenic differentiation  
 
Human mesenchymal stem cells (hMSCs) were purchased from Lonza (PT-2501, Lot No. 
6F4392) and routinely cultured in basal medium (BM) consisting on low-glucose Dulbecco's 
Modified Eagle Medium (DMEM) with glutamax (Gibco), supplemented with 1% v/v 
Penicillin/Streptomycin (Gibco) and 10% v/v FBS (MSCs-qualified, Gibco). Cultures were 
maintained at 37ºC under a humidified atmosphere of 5% v/v CO2 in air, with the culture 
medium changed twice a week, and were trypsinized at 70% confluency. For these studies, 
hMSCs were seeded at 3000 cells/cm
2
 in 24-well tissue culture plates. 
Cell proliferation was analyzed using the tritiated thymidine (
3
H-TdR) incorporation assay. 
Free peptides were added at a final concentration of 10
-5
 M or 10
-12
 M to culture medium without 
FBS. The control consisted on culture media with 0.5% v/v FBS. 
3
H-TdR was added to the 
different media at a final concentration of 1×10
-3
 Ci/mmol, and cells were incubated for 24h prior 
to analysis. Cells were detached and treated with trichloroacetic acid (5% v/v, 10 min) to 
precipitate nucleic acids. The precipitates were then dissolved with NaOH (1M) and scintillation 
liquid (PerkinElmer) was added. After 1h of incubation in the dark, samples were analyzed in a 
scintillation counter (MicroBeta Trilux, PerkinElmer). 
For analysis of osteogenic differentiation, hMSCs were cultured for 7 days under basal 
and osteoinductive conditions. The osteogenic medium (OM) consisted of low glucose DMEM 
supplemented FBS (10% v/v, pre-selected batch, PAA), dexamethasone (Sigma, 100 nM), β-
glycerophosphate (Sigma, 10mM) and 2-phospho-L-ascorbic acid (Sigma, 0.05 mM). Free 
peptides were added at a final concentration of 10
-5
 M or 10
-12
 M to both media. Medium was 
renewed every 4 days and fresh peptides were added each time. At day 7, cell monolayers 
were stained for alkaline phosphatase (ALP) activity. After fixation with 4% v/v 
paraformaldehyde (PFA) in PBS for 20 min, cells were incubated for 30 min in Naphthol AS-MX 
phosphate/Fast Violet B salt at 37ºC in the dark. After washing, stained monolayers were air-
dried and observed under an inverted microscope (Axiovert 200 M, Zeiss). In order to quantify 
ALP activity, cells were lysed and incubated with the chromogenic substrate p-nitrophenol 
phosphate (2 mM in 0.2 M bicarbonate buffer, pH 10; 0.05% v/v Triton X-100 and 4 mM MgCl2; 
1h at 37 °C). Absorbance was read at 405 nm in a microplate reader (Biotek Synergy MX), and 
converted into product concentrations using a calibration curve built with serially diluted p-
nitrophenol standards. 
 ALP activity was normalized to total protein content, calculated using the bicinchoninic 
acid assay (BCA Total Protein assay, Pierce), and expressed as nmol/min/mg protein.  
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2.2. Peptide-alginate hydrogels 
 
 
2.2.1. Synthesis of peptide-alginate conjugates 
 
PRONOVA ultrapure sodium alginates LVG and VLFG (hereafter designated as high 
molecular weight, HMW and low molecular weight, LMW; respectively) with a high guluronic 
acid content (68% and 67%, respectively) were purchased from FMC Biopolymers. The HMW 
alginate was partially oxidized with sodium periodate [27, 28]. Aqueous carbodiimide chemistry 
was used to connect peptide N-terminal amino groups to alginate carboxyl groups via a peptide 
bond [29]. Briefly, LMW and HMW alginate solutions at 1wt.% in MES buffer (0.1 M, 0.3 M NaCl, 
pH 6.5, Sigma) were prepared and stirred ON at RT. N-hydroxy-sulfosuccinimide (sulfo-NHS, 
Pierce) and 1-ethyl-(dimethylaminopropyl)-carbodiimide (EDC, Sigma, 27.4 mg/g alginate) at a 
molar ratio of 1:2 were sequentially added to the solution, followed by peptides. OGP analogues 
were conjugated to LMW alginate, and cell-adhesion RGD peptides (GenScript, USA) were 
conjugated to HMW alginate. Alginate samples that were subjected to the same procedure but 
without the addition of peptides were used as controls (hereafter designated H0 and L0). The 
modified alginates were purified by dialysis (MWCO 3500 membrane, Spectrumlabs) against 
distilled water and saline, filtered (0.2 µm), freeze-dried and stored at -20ºC until used. The 
grafting efficiency was obtained using the BCA assay [21]. Absorbance readings were 
converted into peptide concentrations using a calibration curve built with serially diluted peptide 
solutions in 1wt.% of L0 or H0 alginate. Grafted amounts (mg peptide per gram of alginate) for 
the different peptides are depicted in Table 1. The OGP-Alg conjugates were reconstituted at 
the same peptide concentration in DPPB or MMP-2 (25 nM) and incubated for up to 48h at 
37ºC. The extent of peptide cleavage by MMP-2 was estimated at 0, 24 and 48h using the 
fluorescamine assay, as described for the free peptide. At least three replicates per condition 
were analyzed. 
 
 
Table 1. Different peptide sequences used and their characteristics. 
Name Amino acid sequence 
Mw 
g/mol 
Purity 
% 
Grafted amount 
mg/g Alg 
OGP1 GGGYGFGG 671 90 11.4 
OGP2 GGPVGLIGGYGFGG 1207 92 20.5 
FRET-OGP2 (Abz)-GGPVGLIGGYGFGG-Q-(EDDnp) 1662 ≥ 95 n.a. 
OGP3 GGGIVGPLGYGFGG 1207 99 31.0 
FRET-OGP3 (Abz)-GGGIVGPLGYGFGG-Q-(EDDnp) 1662 ≥ 95 n.a. 
RGD GGGGRGDSP 759 96 15.9 
 
Note: Alg – alginate; Abz – ortho-aminobenzoyl; EDDnp – N-(2,4-dinitrophenyl)-ethylenediamine;  F-phenylalanine; 
FRET – fluorescence resonance energy transfer; G-glycine; I-isoleucine; L-leucine; n.a. – not applicable; P-proline; V-
valine; Y-tyrosine. In MMP-sensitive sequences the cleavage site is indicated by an arrow (GL). In all OGP analogues 
the bioactive YGFGG fragment is underlined. 
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2.2.2. Preparation of peptide-alginate hydrogels: films and cell-laden 3D matrices  
 
Hydrogel-precursor solutions with a previously optimized bimodal molecular weight 
composition [21, 30] were prepared by combining HMW alginate (modified with RGD) and LMW 
alginate (modified with OGP analogues) at a 1:1 volume ratio and a final polymer concentration 
of 2wt.%. For adjusting the final amount of each peptide (150 μM RGD, 190 μM OGP 
analogues) unmodified and peptide-modified alginates were combined at different ratios and 
dissolved ON in NaCl (Sigma, 0.9wt.%). Alginate hydrogel films (OGP/RGD-Alg and RGD-Alg) 
were prepared by spincoating, as described in the next section. To obtain cell-laden hydrogels 
for in vivo studies, hMSCs were added to an alginate solution (15×10
6
 cells/mL) with CaCO3 
(Fluka, Ca
2+/
COO
-
= 0.288) and δ-gluconolactone (GDL, Sigma, Ca
2+/
GDL= 0.125), and the 
mixture was loaded (85 µL) into a QGel
TM
 3D disc caster and allowed to crosslink (20 min, RT) 
as previously described [31]. 
 
 
2.2.3. hMSCs proliferation on peptide-alginate hydrogels 
 
To prepare alginate films, 100 μL of peptide-alginate solutions (1.5wt%) was deposited 
onto round plastic coverslips (13 mm), which had been previously treated with positively-
charged poly-D-lysine (30 min in 0.1 mg/mL solution, followed washing and drying) to improve 
surface-adhesion and retention of negatively-charged alginate films. Samples were spinned for 
1 min at 9000 rpm (SCS Cookson Electronics Spincoater model G3P-8) to ensure a 
homogeneous distribution of the polymer. Films were then crosslinked with calcium (0.1 M 
CaCl2, 0.01wt% NaN3, 10 min). Coverslips were transferred to pHEMA-treated 24-well cell 
culture plates, washed twice with sterile distilled water and culture medium, and seeded with 
hMSCs at 20000 cells/cm
2
. At each time point, 
3
H-TdR was added to the medium (1×10
-3 
Ci/mmol) and cells were incubated for 24h prior to analysis. At 24h, 48h and 72h, cells were 
recovered and analyzed as described above.  
 
 
2.3. In vivo studies with hMSCs-laden peptide-alginate hydrogels 
 
 
2.3.1. Subcutaneous implantation in immunodeficient mice 
 
All animal experiments were conducted following protocols approved by the Ethics 
Committee of the Portuguese Official Authority on Animal Welfare and Experimentation (DGV). 
Severe combined immunodeficient (SCID) male mice (CB17/Icr-Prkdc scid/Crl, C17SSMA04S, 
Charles River, Spain) with 6-week of age were used as recipients. Animals were housed at 
22°C with a 12h light/dark cycle and had ad libitum access to water and food. Analgesics 
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(Butorfanol) were administrated 30 min prior to surgery. The animals were anesthetized by 
inhalation of isoflurane, which was continuously delivered over the course of surgery. The 
dorsal surgical sites were shaved and sterilized. Single incisions were made and subcutaneous 
pockets were created for the insertion of hMSCs-laden hydrogel discs (8.5 mm diameter, 1.5 
mm height). Three groups were tested: OGP2/RGD-Alg, OGP3/RGD-Alg and RGD-Alg 
(control), and one of each were placed in each mouse (n= 8 mice, 3 discs per mouse). After 
implantation, incisions were closed with sutures and analgesics were administrated (0.05 mg 
Buprenorphine HCl per kg). Animals were routinely monitored for general appearance, activity, 
and healing of the implant sites, and were euthanized after 4 weeks for implants retrieval. No 
mice were lost during the study. 
 
 
2.3.2. Histology 
 
After explantation, collected samples that included the entire hydrogel discs and some 
adjacent tissue were fixed in PFA (4wt.%,ON at 4ºC) and paraffin embedded. Three-micrometer 
cross-sections were obtained from 2-3 standardized transversal planes using a Thermo 
Scientific HM550 microtome. 
Histochemical staining: For analysis of alginate degradation/host tissue invasion, sections 
were stained with Safranin-O/Light-Green (Sigma, hematoxylin was used as counterstain), and 
glass slides (n=4 mice, 2 slides per mouse) were digitalized using a scanner (NanoZoomer 2.0, 
Hamamatsu). In each, the total area of the implanted disc was first delineated and then images 
were analyzed and processed using MeVisLab software (Fraunhofer MEVIS, Bremen, 
Germany, in order to quantify the partial areas of residual alginate (% orange area) vs. invasion 
tissue (% blue/green area). Results are presented as average % of host tissue area. 
Immunolabelling: Expression of collagen type I (COL1) was probed after antigen recovery 
with 10mM Tris/1mM EDTA (pH 9) for 35 min at 95-98°C. Sections were incubated with rabbit 
anti-collagen I primary antibody (ab21285 Abcam, 1:200, ON at 4ºC), and then with Alexa Fluor 
594-labelled goat anti-rabbit IgG (Invitrogen-Molecular Probes, 1:1000, 1h at RT) secondary 
antibody. For proliferating human/mice cells detection, masked epitopes were exposed by 
treatment with sodium citrate (10mM, pH 6, 35 min at 95-98°C). Sections were incubated with 
mouse anti-human nuclei (MAB4383-3E1.3 Millipore, 1:400, ON at 4ºC) and rabbit anti-Ki67 
(ab15580 Abcam, 1:50) primary antibodies. This was followed by incubation with mouse-on-
mouse biotinylated anti-mouse IgG (MOM Kit Vector, 1:1000, 10 min at RT), and finally with 
Alexa Fluor 555-streptavidin (Invitrogen-Molecular Probes, 1:500, 30 min at RT) and Alexa 
Fluor 488-labelled goat anti-rabbit IgG (Invitrogen-Molecular Probes, 1:1000, 30 min at RT), 
respectively. All sections were mounted in Fluoroshield™ with DAPI (Sigma). Control sections 
for each immunolabeling excluded primary antibody staining. From each disc, 4 whole-section 
images were obtained using Mosaix-reconstruction (inverted microscope, Axiovert 200 M, 
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Zeiss). In each image, the total amounts of HuNu+ (human) and HuNu- (mouse) and Ki67+ 
(proliferating) cells per unit area were counted. Results are presented as average percentages 
of HuNu+ Ki67+ (proliferative, human) and HuNu- Ki67+ (proliferative, mouse) cells. 
 
 
2.3.3. qRT-PCR analysis of hMSCs gene expression 
 
Total RNA was extracted from hMSCs recovered from 3D matrices (n=3) using the 
RNeasy Mini Kit (Qiagen), as recommended by the manufacturer. Subsequently, 0.25 μg of the 
total RNA were used for random hexamers first strand synthesis to generate single-stranded 
cDNA using the SuperScript First-strand synthesis system for qReal-Time PCR (qRT-PCR) 
(Invitrogen). RNA quantification was performed by using a NanoDrop 1000 spectrophotometer. 
After the cDNA synthesis reaction, qRT-PCR was carried out in a total volume of 20 μL of a 
mixture containing 1 μL of cDNA (5 ng of total RNA), 0.25 μM of each forward and reverse 
primers, and 1× iQ SYBR Green Supermix (Bio-Rad). qRT-PCR experiments were run using an 
iQ5 (Bio-Rad) under the following conditions: 95 °C for 3 min, followed by 30 cycles at 94 °C for 
30 s, 60 °C for 45 s, and 72 °C for 30 s, and the last step at 55° for 10 s. All reactions were 
performed in duplicate. After completion of the PCR cycling, melting curves, obtained by 
increasing the temperature from 60 to 96 °C in increments of 0.5 °C, were examined to 
ascertain specificity of the PCR products. The housekeeping gene glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) was used as the endogenous assay control. Relative quantification of 
gene amplification by qRT-PCR was performed using the cycle threshold (Ct) values and 
relative expression levels were calculated as follows: 2 
– (Ct gene of interest – Ct GAPDHgene)
. The 
expression value for each target gene was normalized to the GAPDH value at each time point. 
The sequence and length of the primer pairs used is indicated in Table 2. For all primers used, 
the tool NCBI/Primer Blast was used to confirm specificity for human genes only and later 
corroborated by the absence of bands when tested in mouse cells.  
 
 
2.4. Statistics 
 
Statistical analyses were performed using GraphPad Prism 5.0 software version 5.0a. 
The non-parametric Mann–Whitney test was used to compare two groups, whereas comparison 
between more than two groups was performed using the Kruskal–Wallis test followed by Dunn’s 
comparison test. The critical level of statistical significance chosen was p < 0.05. 
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Table 2. Overview of primer pairs used for qRT-PCR. 
Gene name Ref. sequence Sequence of primers 
Length 
(bp) 
GAPDH NM_002046 
F: 5' -AGCCACATCGCTCAGACAC- 3' 
66 
R: 5' -GCCCAATACGACCAAATCC- 3' 
ALP BC021289 
F: 5’-AGAACCCCAAAGGCTTCTTC-3’ 
74 
R: 5’-CTTGGCTTTTCCTTCATGGT-3’ 
Runx2 NM_001024630.2 
F: 5’-GTGCCTAGGCGCATTTCA-3’ 
78 
R: 5’-GCTCTTCTTACTGAGAGTGGAAGG-3’ 
OCN NM_199173.4 
F: 5’-AGAGTCCAGCAAAGGTGCAG-3’ 
171 
R: 5’-TCAGCCAACTCGTCACAGTC-3’ 
APM1 NM_004797.3 
F: 5′-TGTTGCTGGGAGCTGTTCTACTG-3′ 
235 
R: 5′-ATGTCTCCCTTAGGACCAATAAG-3′ 
COMP NM_000095.2  
F: 5’-GCACCGACGTCAACGAGT-3’ 
63 
R: 5’-TGGTGTTGATACAGCGGACT-3’ 
Sox9 NM_000346 
F: 5’-TTCCTCCTGCCTTTGCTTGT-3’ 
93 
R: 5’-GCTGCTGAAACATTCCCAGAAC-3’ 
VEGF165 AB021221.1 
F: 5’-GCTGCACCCATGGCAGAA -3’ 
204 
R: 5’-CTCCAGGCCCTCGTCATTG-3’ 
 
 
Note: ALP – alkaline phosphatase; APM1 – adiponectin; COMP – cartilage oligomeric matrix protein; F – forward 
primer; GAPDH – glyceraldehyde 3-phosphate dehydrogenase; OCN – osteocalcin; Runx2 – runt-related transcription 
factor 2; Sox9 – transcription factor SRY (sex determining region Y)-box 9; VEGF165 – vascular endothelial growth factor 
165; R – reverse primer. 
 
 
3. RESULTS AND DISCUSSION 
 
 
 3.1. Enzymatic cleavage of free and alginate-conjugated OGP analogues 
 
Different OGP analogues were designed and synthesized by Fmoc/tBu SPPS, where the 
target bioactive fragment YGFGG was either flanked by a poly-G sequence (in OGP1), the 
MMP-cleavable substrate PVGLIG (in OGP2) [21], or the PVGLIG-scrambled sequence 
GIVGPL (in OGP3). Their molecular weight and purity were assessed by LC-MS and HPLC, 
respectively (Table 1). Mass spectra were acquired in the positive mode, and in all cases the 
base peaks at m/z 1207.67 and 1207.60, respectively, were consistent with the peptide’s 
molecular ion M+. Base peaks were always significantly more intense than remaining peaks, 
revealing that the target peptides were obtained as the major synthesis product (purity ≥ 90%, 
Table 1). 
OGP2 and OGP3 were incubated with MMP-2, and enzymatic cleavage was analyzed by 
reacting fluorescamine with the peptide’s primary amines to form fluorescent moieties [32]. The 
emitted fluorescence was measured at the moment of incubation and after 24h, to estimate the 
accumulation of N-amino termini in excess over that of the intact substrate, which in turn 
represents the extent of enzymatic cleavage. As predicted, no significant hydrolysis was 
detected in DPBS, and the OGP2 peptide was more efficiently cleaved by MMP-2 than OGP3, 
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with a statistically significant 4-fold increase in RFU in relation to time 0 (p=0.0286), and a 2 
fold-increase in relation to OGP3 in MMP-2 (p=0.0286). 
 
 
  
Fig. 1. LC-MS analysis of OGP-based peptides after 24h of incubation with MMP-2. (A) OGP2: the 
base peak at m/z 840.27 is consistent with the molecular ion, M
+
, of peptide LIGGYGFGG, an expected 
fragment of MMP-2-mediated cleavage of the substrate peptide. The peak presents a retention time of 
14.02 min (inset). (B) OGP3: the base peak corresponds to the peptide’s molecular ion M
+
 (m/z 1207.40), 
whereas the peak detected at m/z 604.20 corresponds to the diprotonated peptide [M+2H]
+
. The peaks 
detected at m/z 726.33 and at m/z 500.13 correspond to unspecific cleavage. The base peak has a 
retention time of 15.02 minutes; the fragments detected at m/z 726.33 and at m/z 500.13 have a retention 
time of 13.44 and 12.38 min, respectively (inset). 
 
 
Both the intact peptides and their fragments, obtained after enzymatic digestion, were 
analyzed by LC−MS (Fig. 1). In both cases, only one major peak, corresponding to the original 
peptides (MW=1207.34), was present at the moment of incubation. Also, when peptides were 
incubated in DPBS without enzyme, their integrity was fully maintained, suggesting their 
hydrolytic stability (data not shown). After 24h of incubation with MMP-2, and in the case of 
OGP2, the original sequence was present in only minute amounts in the recovered sample, 
whereas the rather intense base peak emerged at m/z 840.27 a.m.u. presenting a retention time 
of 14.02 min, which is consistent with the molecular ion of the sequence LIGGYGFGG, one of 
the fragments expected to be released upon MMP-2 cleavage at the predicted scissile bond 
(GL, see Table 1). In what concerns OGP3, the presence of the original peptide sequence in 
considerable amounts could be confirmed by the fact that the base-peak matched its molecular  
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Fig. 2. FRET analysis of OGP analogues cleavage. Kinetics of (A) FRET-OGP2 and (B) FRET-OGP3 
cleavage along 1h of incubation in DPBS or FBS, with or without MMP-2 (10 nM). Samples were 
maintained in the microplate reader at 37ºC and the emitted fluorescence was monitored in real time. 
Results are presented as fold change in relation to time 0, as mean ± SD (n=3). The extent of enzymatic 
cleavage after 48h of incubation (37ºC) in DPBS with and without MMP-2 is depicted for (C) FRET-OGP2 
and FRET-OGP3. Results are presented as fold change in relation to the control (without MMP-2) as mean 
± SD (n=3). Symbols denote statistically significant differences in relation to () DPBS (p=0.05) and (δ) 
FRET-OGP3 48h (p=0.05).  
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ion at m/z 1207.40; still, other peaks emerged at m/z 840.27, m/z 726.33 and m/z 500.13 a.m.u, 
though at lower intensities. The new fragments at m/z 726.33 and m/z 500.13 a.m.u are 
consistent with unspecific cleavage of OGP3 at between G and Y (see Table 1), yielding 
GGGIVGPLG (MW=725.8) and YGFGG (MW=499.5). According to Turk et al. [33], the scissile 
bond at GY might in fact exhibit some susceptibility to MMP-2 digestion, although much lower 
than that of GL in PVGLIG. Interestingly, cleavage of OGP3 at the proposed site will also result 
in the release of YGFGG. 
Peptide cleavage kinetics was further analyzed using FRET-peptides. These exhibit 
internal fluorescence quenching when intact, but emit fluorescence once cleaved [34], providing 
a useful tool to monitor peptide digestion in real-time. The increase in emitted fluorescence 
(RFUs) along the first hour of incubation is presented in Fig. 2A and 2B. In both cases, no 
hydrolysis occurred in DPBS without MMP-2, and both peptides were cleaved in FBS, even in 
the absence of added MMP-2. However, while cleavage of OGP2 increased in the presence of 
MMP-2, this was not observed with OGP3. The fluorescence emitted by the two FRET-OGP 
analogues when incubated in DPBS with or without MMP-2 was measured again after 48h of 
incubation (Fig. 2C). In accordance with the previous results obtained using the fluorescamine 
assay, some cleavage of OGP3 occurred in the presence of MMP-2, but OGP2 was cleaved to 
a much higher extent.  
The two OGP analogues were cleaved in presence of FBS, suggesting that both may be 
hydrolyzed to some extent by indeterminate serum proteases. Under in vitro (cell cultures) and 
in vivo conditions, this feature may account for unspecific OGP release from both peptides. 
Similar observations have been previously reported by Chau et al. [35-37], who designed two 
dextran–peptide–methotrexate (MTX) conjugates for tumor targeting, where the peptide linkers 
corresponded to the same sequences used in this study (PVGLIG and GIVGPL) [35-37]. In 
vitro, GIVGPL-dextran conjugates were only minimally hydrolyzed by MMP-2, and PVGLIG-
dextran conjugates released the drug in the presence of MMP-2, but remained intact in all the 
serum-containing conditions [35]. However, in vivo, in a more complex proteolytic scenario [36], 
drug release also took place via cleavage by lysosomal enzymes, which were able to degrade 
both peptide linkers, leading to nonspecific drug (MTX) release. This probably accounted for the 
tumor-inhibiting ability of MTX-GIVGPL-dextran conjugate, despite its lack of sensitivity towards 
MMPs [36].  
As shown in Fig. 3, OGP2 retained the susceptibility to MMP-2-cleavage in alginate-
conjugated form (OGP2-Alg). Similarly to that observed with the free peptides, OGP3-Alg was 
also cleaved to some extent, but at a slower rate.  
Overall, this part of the study provided proof-of-concept on the correct design of protease 
sensitive OGP2-Alg conjugates, in the sense that, as expected, these were sensitive to MMP-2 
mediated cleavage. Yet, both OGP-Alg may be useful platforms for the delivery of OGP10-14-
like fragments. 
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Fig. 3. Enzymatic cleavage Alg-conjugated OGP analogues in the presence of MMP-2. The 
fluorescamine assay was used to determine the amount of free amine groups present in each sample, 
which increase as the peptides are cleaved. Results are presented as fold change in relation to t=0 as 
mean values ± SD (n=3). Symbols denote statistically significant differences in relation to () w/o MMP2 
(p=0.05) and (δ) OGP3 (p=0.0383). 
 
 
3.2. Effect of free and alginate-conjugated OGP analogues in hMSCs: in vitro screening 
studies 
 
To assess the bioactivity of OGP analogues, hMSCs were cultured in the presence of 
free peptides (added to serum-free culture medium) or OGP-Alg conjugates (used as culture 
substrates in the form of hydrogel films), and cell proliferation was analyzed by the 
3
H-TdR 
assay. Cells were cultured in serum-free conditions to measure the direct action of OGP 
analogues on hMSCs proliferation without masking effects from serum-OGP. As soluble 
peptides, the classical forms of OGP and OGP10-14 have been shown to regulate the 
proliferation of osteoblastic and stromal cells in a biphasic-dependent manner, indicative of an 
autocrine/paracrine mode of action [38, 39]. As depicted in Fig. 4, we were also able to 
demonstrate that all the OGP analogues tested in this study enhanced hMSCs proliferation after 
24h in relation to the control (culture medium with 0.5% v/v FBS). 
The effect of OGP-Alg conjugates was analyzed using OGP2 and OGP1 to evaluate, 
respectively, the effect of OGP-releasing vs. non-releasing formulations. The tested hydrogels 
also contained RGD to promote cell adhesion to the films, and RGD-Alg was used as a control. 
As depicted in Fig. 4, no significant differences were observed between the different groups 
after 24h. However, after 48h, both OGP analogues enhanced hMSCs proliferation in relation to 
the control. This effect was even more pronounced after 72h for OGP2-Alg, but it was no longer 
observed with OGP1-Alg, suggesting that the bioavailability of the active fragment may be 
important for its bioactivity. This is consistent with previous studies demonstrating the low 
impact of surface-immobilized OGP10-14 on pre-osteoblastic MC3T3-E1 cells proliferation [11].  
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To evaluate the effect of OGP analogues on hMSCs differentiation only free peptides 
were used, as the stability of alginate hydrogels films was lost after 7 days in culture, 
compromising the ALP assay. After 1 week of culture in BM, ALP activity was increased in the 
presence of OGP, except when OGP2 was used at 10
-5 
M. In OM, ALP activity increased 
dramatically in the presence of OGP2, especially when present at 10
-12 
M, which has been 
defined as being within the optimal effective range in previous studies [40, 41]. 
 
 
 
Fig. 4.  Effect of free and Alg-conjugated OGP analogues on hMSCs behaviour. (A, B) Cell 
proliferation upon exposure for 24h to (A) free or (B) Alg-conjugated OGP analogues, assessed by the 
3
H-
TdR assay. (C) Expression of ALP activity by hMSCs after 7 days of culture in the presence of free OGP 
analogues (10
-5 
M
 
or 10
-12
 M) added to BM or OM.  Cells cultured in the absence of peptides where used 
as controls. Symbols denote statistically significant differences in relation to: (*) no peptide within BM or 
OM groups (** p< 0.02; *** p< 0.005); and (δ) OGP2 (10
-5
 M). (D) ALP staining of control and OGP2 (10
-12
 
M)-treated cultures in OM (scale bar =100μm). 
 
 
3.3. In vivo studies with hMSCs-laden OGP-alginate hydrogels 
 
After confirming that both OGP2 and OGP3 release bioactive YGFGG-like fragments, the 
in vivo performance of alginate hydrogels as depots for local co-delivery of OGP analogues and 
hMSCs was evaluated. For this first set of studies, implants were performed at an ectopic site 
instead of a bone defect, to mitigate the effect of osteoinductive signals intrinsically present at 
the bone compartment, and to more specifically evaluate the direct impact of OGP analogues 
on hMSCs. Both OGP-releasing analogues were tested (OGP2/RGD-Alg and OGP3/RGD-Alg 
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hydrogels) and RGD-Alg hydrogels were used as a control. Given the previous in vitro results, 
both OGP-hydrogels were expected to locally release a bioactive portion of OGP, via proteolytic 
cleavage of the peptide linkers, albeit at different rate: a faster release from OGP2-Alg, which 
incorporates the MMP-sensitive PVGLIG linker, was anticipated.  
 
 
3.3.1. Degradation and host tissue invasion of peptide-alginate hydrogels 
 
The degradation pattern of implanted cell-laden hydrogels was first characterized, as it is 
a relevant determinant of their in vivo performance. Ideally, it should take place within a 
balanced time frame. It should not prevent cell release, or impede the invasion of host tissue, 
but should allow the deposition of new ECM before the complete disintegration/dissolution of 
the hydrogels. As depicted in Fig. 5, alginate fragmentation and host tissue invasion were 
detected in all samples, but were more significant in OGP groups, although the reasons for this 
are still unclear. Increased implant degradation in the presence of immobilized OGP peptides 
has been reported in previous studies, where these were used as covalent crosslinkers for 
amino acid-based poly(ester urea)s materials [42]. In that case, the higher degradation was 
explained by the additional free volume in the polymer plugs imparted by the OGP crosslinker 
and increased swelling due to the presence of peptides [42]. 
 
 
 
 
 
Fig. 5. In vivo degradation and host tissue invasion of peptide-Alg hydrogels. (A) Images of 
Safranin-O/Fast green-stained paraffin-sections of hMSCs-laden Alg hydrogels (Alg in orange-red, 
cells/ECM in blue-green) at day 0 (scale bar: 100 μm), or after 28 days of implantation within the different 
hydrogels (scale bar: 1mm). (B) Quantitative analysis of host tissue invasion (% of blue area per disc) at 
day 28. Alginate fragmentation/host tissue invasion was more significant in OGP groups. Data is presented 
as mean ± SD (n=4 mice, 2 sections per mice), * denotes statistical significant differences in relation to 
control (p=0.0104). 
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Perfused blood vessels were detected at the implant site in all groups, located mainly 
within the newly formed tissue but also within the hydrogels (Fig. 6A, where the OGP3 group is 
depicted as an example). Neo-vascularization was enhanced in OGP3/RGD-Alg, compared to 
the other groups tested (Fig. 6). It is well accepted that proper vascularization is a prerequisite 
for the survival of transplanted cells and new tissue formation. Also, it is well established that 
there is a key interplay between angiogenesis and osteogenesis [43]. So, an osteoinductive 
compound capable of also stimulating neo-vessels formation would certainly represent a 
promising therapeutic agent for bone regeneration. Interestingly, an effect of OGP on implant 
vascularization has been recently reported [42], but the underlying mechanisms remained 
unclear and, to our knowledge, the authors have not further investigated this phenomenon. In 
another study, Bocci et al. demonstrated the lack of mitogenic and pro-adhesive activity of OGP 
on microvascular endothelial cell cultures [44]. Here, we investigated whether the level of neo-
vascularization correlated with the secretion of proangiogenic factors by transplanted hMSCs 
[45], and examined the expression of vascular endothelial growth factor 165 (VEGF165), which 
represents one of the most potent endothelial cells mitogens. Unexpectedly, our results 
revealed higher VEGF165 mRNA expression in the OGP2/RGD-Alg, as compared to the other 
groups. So, it remains to be elucidated whether the higher vascularization observed in the 
OGP3/RGD-Alg group was promoted by other cell-secreted angiogenic factors, or simply 
resulted from the higher degradation/invasion of these matrices that, in turn, probably facilitated 
neo-vascularization. 
 
 
 
 
 
 
Fig. 6. Implant vascularization and VEGF165 expression by transplanted hMSCs. (A) Perfused blood 
vessels (black arrows) at the implant site were identified by MT-staining (erythrocytes in red;  Alg in pale 
blue; host tissue in green/blue; the dashed line represents host tissue/Alg interface, the OGP3 group is 
presented as an example; scale bar: 10 μm). (B) Quantitative analysis of the average number of vessels at 
the implant site. Data is presented as mean ± SD (n=4 mice, 6 sections per mice). (C) Expression of 
VEGF165 mRNA by transplanted hMSCs analyzed by qRT-PCR (n=3 mice). Results were normalized 
internally with GAPDH. Symbols denote statistically significant differences in relation to () RGD-Alg 
(p=0.004) and (δ) OGP2/RGD-Alg (p=0.0359). 
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ECM deposition (COL1) at the implant site was detected in all the formulations (Fig. 7). 
OGP groups, especially OGP3/RGD-Alg, stained more intensely for COL1 than the control, and 
the new collagenous matrix appeared more uniformly distributed throughout the implant area. 
Within the hydrogels, COL1 was detected intracellularly and in the pericellular space, indicating 
that transplanted hMSCs were able to produce and secrete their own ECM.  
 
 
 
Fig. 7. Expression of collagen type 1 at the implant site. (A) Representative images of COL1 (in red) 
expression on tissue sections from the different groups at day 28 (scale bar: 10 μm). (B) Quantification of 
% of COL1+ cells relative to the total number of cells. Data is presented as mean ± SD (n=4 mice, 4 
sections per mice), * denotes statistical differences in relation to the control (p=0.0019).  
 
 
To evaluate the effect of OGP on cell proliferation, transplanted hMSCs were 
distinguished from mouse cells by immunolabeling using a human nuclei-specific antibody 
(HuNu). Although the in vitro studies with hMSCs cultures demonstrated a mitogenic effect for 
all the tested OGP analogues, we have not been able to demonstrate any significant outcome of 
OGP2 or OGP3 on cell proliferation in vivo, at least after 4 weeks of implantation (Fig. 8). A few 
proliferating cells (Ki67+), both from human (HuNu+ hMSCs) and mouse (HuNu- cells) origin, 
have been detected within the hydrogel and adjacent host tissue, but there was no statistically 
significant difference between groups in terms of % of proliferating cells, even if mean values 
were slightly higher in OGP3 group. This may be in part related with the follow-up time frame. 
Possibly, OGP analogues may increase cell proliferation in an early stage in the regenerative 
process but, after 4 weeks of implantation, hMSCs were probably already transiting from a 
proliferative to a maturation phase, which seems to correlate with our data on hMSCs 
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expression of lineage-specific genes (see below). A transitory effect of surface-immobilized 
OGP and OGP10-14 on cell proliferation has been previously shown in osteoblastic MC3T3-E1 
cultures, where a positive outcome was observed at day 3, but was no longer seen at day 7 
when cells were presumably in a more mature state [11]. 
 
 
 
Fig. 8. Proliferative vs. non-proliferative human and mouse cells at the implant site. (A) Double 
immunolabeling with anti-HuNu (red) and Ki67 antibodies (green). Nuclei were counter-stained with DAPI 
(blue), scale bar represents 5 m: (left) HuNu+ Ki67- non-proliferative hMSCs; (center) HuNu+ Ki67+ 
proliferative hMSCs; and (right) HuNu- Ki67+ proliferative mice cells (B) Percentage of proliferative hMSCs 
(HuNu+ Ki67+) in relation to total hMSCs (HuNu+). (C) Percentage of proliferative mice cells (HuNu- 
Ki67+) in relation to total mice cells (HuNu-). Data is presented as mean ± SD (n=4 mice, 4 sections per 
mice). (D) HuNu+ cells (arrows) were also detected outside, integrated in the host tissue. The dashed line 
represents tissue/alginate interface. 
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Noteworthy, the human-nuclei specific labeling allowed us to confirm that transplanted 
hMSCs were located not only inside the alginate matrix, but also outside, integrated in the host 
tissue (Fig. 8D), demonstrating that the hydrogels effectively acted as cell-delivery systems. 
The phenotype of transplanted hMSCs was analyzed by quantifying mRNA expression of 
osteogenic (Runx2, ALP and OCN), chondrogenic (COMP) and adipogenic (AMP1) markers 
(Fig. 9). In what concerns the expression of Runx2 and OCN, a key osteoblast transcription 
factor and its target gene, respectively, we found higher levels of OCN expression in OGP 
groups, with a concomitant decrease in Runx2 expression, which is consistent with published 
results on the temporal mRNA expression of these two bone-specific markers during 
development of the osteoblast phenotype in MC3T3-E1 cultures [12]. The expression of ALP 
mRNA was also detected in all samples, being higher in OGP2/RGD-Alg than in the other 
groups. Taken together, these results suggest that hMSCs within OGP-releasing hydrogels 
were in a more mature stage of osteoblastic differentiation, as compared to the control. An 
effect of OGP on OCN expression has been previously demonstrated in other in vivo 
experimental settings, namely during healing of femoral fractures in rats [46]. After parental 
administration of OGP for 1 week, systemic and local mRNA expression of different growth 
factors were examined after 1, 2, 3 and 4 weeks [46]. Local expression of OCN increased 
earlier in the OGP-treated group, and its systemic expression remained increased throughout 
the 4-week period [46]. In what concerns the other investigated lineages, we did not detect 
expression of the adipogenic gene APM1 in none of the groups, which is consistent with 
previous in vitro data on the effect of OGP on hMSCs adipogenesis [8], but we detected a 
higher expression of the chondrogenic genes COMP and Sox9 in the OGP3 group, as 
compared with the control. Although we have not found any in vitro studies investigating the 
effect of OGP in chondrogenesis, previous in vivo studies suggested that OGP stimulates 
endochondral bone formation in fracture callus of rabbits and rats [46]. Moreover, parentally 
administered OGP has been shown to regulate the expression of different factors associated 
with chondrogenesis, both locally and systemically [12], which also suggests that the mode of 
action of OGP may involve or be mediated by the action of other growth factors. Although this 
will require further investigation, it seems possible that OGP overlaps the potential to enhance 
chondrogenesis and osteogenesis, similarly to other growth factors, which have been shown to 
strongly support the formation of bone as well as of cartilage [47].  
One recognized limitation of this study is that all groups have been implanted in the same 
animal. Thus, circulating peptides released from OGP-hydrogels may have had a systemic 
effect, affecting also the response observed in the control group. Even so, overall, the most 
promising results were obtained with the OGP groups, confirming our initial hypothesis on the 
significance of OGP/hMSCs co-delivery systems. Differences between the two OGP analogues 
may be related with their different release kinetics and/or the potency of the released bioactive 
fragment (LIGGYGFGG in OGP2 and YGFGG in OGP3). 
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Fig. 9. qRT-PCR analysis of lineage-specific gene expression by hMSCs. (A) Osteogenic genes: 
Runx2, ALP and OCN. (B) Chondrogenic genes: Sox9 and COMP. (C) Adipogenic gene: APM1. Data is 
presented as mean ± SD (n=3 mice), (*) denotes statistical significant differences (p=0.0383) relative to 
RGD-Alg control. Results were normalized internally with GAPDH. 
 
 
This and other open questions should be addressed in future experiments. In particular, it 
will be essential to test the proposed system using clinically relevant models, such as critical-
sized bone defects or bone fractures, where the effect of locally delivered OGP may be 
potentiated by the adjuvant action of osteoinductive stimuli, naturally present in the bone 
compartment. 
 
 
4. CONCLUSIONS 
 
This study provided proof-of-concept on the correct design of OGP-Alg conjugates with 
protease-sensitive linkers, and demonstrated their usefulness as a platform for the in situ co-
delivery of synthetic OGP analogues and hMSCs. Two different peptides were tested and both 
showed interesting effects. While in vitro OGP2 presented better results probably due to 
increased bioavailability, the more interesting in vivo outcome was obtained with OGP3, 
probably due to its increased resistance to proteolytic degradation and consequent longer 
persistence at the target site. Importantly, we demonstrated that the local co-delivery of OGP 
analogues and hMSCs from injectable hydrogels directed the osteogenic and/or chondrogenic 
differentiation of transplanted hMSCs in an ectopic setting, showing in parallel a positive effect 
on implant vascularization and ECM production. This novel strategy might provide a useful 
alternative for minimally invasive healing of small bone defects. 
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1. CONCLUDING REMARKS AND FUTURE PERSPECTIVES 
 
The development of improved cell-based therapeutics based on the use of adult 
mesenchymal stem cells (MSCs) for tissue regeneration has been attracting great deal of 
attention. Cell therapies have shown great therapeutic potential in preclinical testing and even in 
some clinical trials, but have not yet demonstrated consistent positive results, and only a few 
strategies have reached commercial success. In spite of intensive research in this area, there 
are still major concerns regarding the selection of the most appropriate MSCs source, their fate 
after transplantation, as well as the adequacy and standardization of protocols for isolating, 
expanding and characterizing these cells [1]. Moreover, there is still a limited understanding of 
their normal biological functions and their role in tissue repair [1].  
On the other hand, several technical/scientific issues have to be addressed, namely in 
what concerns their delivery routes. Compared to systemic infusion, local administration seems 
more advantageous as it inherently prolongs cell retaining at the target site. Moreover, a new 
paradigm is that repair of tissues by MSCs is far from being only dependent on the myriad of 
factors produced by, or provided to, MSCs in culture. Instead, MSCs are highly responsive to 
the microenvironment generated by injured tissues. Such cross-talk induces them to express 
factors that seem to be specifically tailored to the immediate needs of the tissue, supporting the 
suggestion that one of the most useful therapeutic strategies will consist in injecting cells locally 
for enhancing tissue repair [1, 2].  
Compared to direct local administration, advanced delivery strategies using biomaterial 
carriers, namely 3D hydrogel matrices, are expected to provide additional benefit, as previously 
discussed. In an attempt to provide an adequate microenvironment to transplanted cells, the 
tissue engineering field is moving toward the development of increasingly sophisticated 
matrices that recreate several features of the native ECM. Notably, these “artificial” yet 
biologically meaningful systems represent complex milieus where cell behaviour is regulated by 
a number of matrix-intrinsic and -extrinsic cellular and molecular factors that must be carefully 
controlled, as they differentially affect distinct cellular activities. 
In the first experimental section of this thesis (Chapters III and IV), the role of different 
factors on human MSCs (hMSCs) behaviour upon entrapment in RGD-alginate hydrogels was 
investigated, particularly in what concerns their effect on the formation of multicellular 
aggregates. The process by which cells self-assemble to form 3D structures is central to 
morphogenesis and development of living tissues, and is of growing interest to the field of 
regenerative medicine. Therefore, the success of engineered living structures will ultimately 
depend on one hand on our capacity to unraveling the mechanisms of cellular self-assembly 
and, on the other hand, on our capacity to translate that knowledge into functional therapeutic 
strategies. In Chapter III, the effect of cell density, a key and frequently overlooked parameter, 
was shown to have a profound impact on hMSCs behaviour. In high-density cultures, cell 
 
 
158 
 
viability was better maintained, and cell-cell signaling was promoted inducing hMSCs to connect 
to each other and aggregate into multicellular structures, particularly under osteoinductive 
conditions. Clustered hMSCs produced their own ECM, rich in fibronectin and collagen, and 
successfully differentiated along the osteoblastic lineage. The importance of selecting the most 
appropriate cell entrapping density when establishing 3D cultures for a specific application was 
confirmed.  
In Chapter IV, it was possible to shed some light on the mechano-chemical coupling 
mechanisms involved in the process of hMSCs aggregation within RGD-alginate matrices, and 
better elucidated the interplay between substrate compliance and ligand presentation in cell-in-
gel responses. In particular, it was clearly demonstrated that the intrinsic properties of the 
artificial matrix are clearly central guidance variables to which hMSCs are particularly 
responsive. It was demonstrated that artificial matrices can be designed in such a way to 
provide dynamic cellular microenvironments where cells can rapidly, and by their own, modify 
the local mechanical and biochemical milieu, becoming embedded and ultimately residing within 
a self-synthesized ECM. In such a system, cell interactions with the original artificial matrix 
become less important as time progresses and the de novo produced cell-derived ECM turns 
into a more critical determinant of cell fate. Importantly, this study established a biomaterial-
driven strategy to induce the self-aggregation of hMSCs and the formation of hMSCs-ECM 
micro-tissues, promoting higher hMSCs proliferation and osteogenic differentiation ability, which 
might be potentially interesting for therapeutic applications. 
Overall, these two studies represent a contribution to the growing body of literature on 
cellular microenvironments and their effect on hMSCs behaviour, and have provided new clues 
to the design of cell-instructive 3D matrices. Yet, several topics remained to be addressed and 
new ideas arose during the course of this investigation, which should be the object of future 
studies. In particular, it would be interesting to further explore the assembly and potential of 
hMSCs-ECM microtissues. At a more fundamental level, it would be fascinating to follow the 
dynamics of self-assembly using appropriate bioimaging techniques, namely to be able to 
clearly measure cell migration and its dependency on matrix viscosity and cell-adhesion anchor 
points. The present study also fell short on the quantitative measurements of traction stresses, 
cell-cell and cell-matrix contact points, which would be important to better characterize the 
interrelated cellular, molecular and mechanical events leading to cell aggregation under the 
specific conditions tested herein.  
As already stated, a vast array of soluble, cellular and matrix signals affect cells response 
in 3D. Therefore, in order to capture a more global picture of extrinsic control of cell fate to 
define optimal cellular microenvironments, it would be important to systematically deconstruct 
the role of each signal and their interplay. Still, while conceptually attractive, such combinatorial 
studies are also very demanding, requiring high-throughput screening (HTS) tools [3, 4]. To 
address this challenge, it would be interesting to perform such studies using a cell-in-gel 
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microarray format, to allow the concomitant analysis of different trial conditions, using less 
material and cells, on a single microscope slide. With this type of HTS it would be possible to 
increase even further the complexity of the system, not only in terms of hydrogel composition, 
using for example protease-sensitive alginate hydrogels [5, 6], but also exploring the co-culture 
of hMSCs with other relevant cell types [7], which are strategies already under study in our 
group. The use of high-content bioimaging tools would obviously be the key to perform those 
studies. 
Another important aspect that requires further investigation is whether the reported in 
vitro observations correlate with an in vivo response: do ECM-hMSCs aggregates actually have 
a higher therapeutic potential than individually dispersed entrapped cells? It would be clearly an 
important achievement to obtain such as proof of concept by testing these systems in a relevant 
animal model. 
 
In the bone tissue engineering field, it is also becoming clear that pro-regenerative 
strategies should recapitulate the natural bone regenerative process, involving the coordinated 
effort of cells, soluble factors and matrix signals, in a time, concentration and site specific 
fashion [2]. Therefore, the integration of bioactive factors with controlled spatio-temporal kinetics 
with the appropriate biomaterial carriers will be the key to designing innovative treatments.  
In the second experimental part of the present work (Chapter V), a sophisticated 
approach toward the development of a multifunctional injectable hMSCs carrier was explored, 
by functionalizing alginate with OGP analogues. The goal was to develop a delivery system 
incorporating osteoinductive cues, which would induce hMSCs differentiation along the 
osteoblastic lineage, and remain available at the injury site for prolonged periods of time, in 
close proximity of target cells. The study provided a proof-of-concept on the correct design of 
OGP-alginate conjugates with protease-sensitive linkers, and demonstrated their usefulness as 
a platform for the in situ co-delivery of synthetic OGP analogues and hMSCs.  
The background composition of the hydrogel matrices selected for implantation (in terms 
of hMSCs density and alginate concentration) was based on the results from previous chapters: 
matrices demonstrating absence of hMSCs aggregation and lower osteogenic differentiation 
were selected, to ensure that the observed effects would be related to the presence of OGP, 
and not to other factors. Two different peptides were tested and both showed interesting effects. 
While in vitro the OGP analogue with faster release kinetics presented better results probably 
due to increased bioavailability, the more interesting in vivo outcome was obtained with the 
analogue with lower release kinetics, probably due to its increased resistance to proteolytic 
degradation and consequent longer persistence at the target site. Importantly, we demonstrated 
that the local co-delivery of OGP analogues and hMSCs from injectable hydrogels directed the 
osteogenic and/or chondrogenic differentiation of transplanted hMSCs in an ectopic setting, 
showing in parallel a positive effect on implant vascularization and ECM production. Thus, the 
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proposed combined strategy involving the co-delivery of osteoinductive factors and hMSCs via 
biomaterial carriers appears promising, and may provide a useful alternative for minimally 
invasive healing of small bone defects.  
Nevertheless, further investigation is needed in terms of system optimization, and several 
topics remained to be addressed. In particular, it will be critical to further characterize the co-
delivery system, by moving forward in the in vivo studies. For the studies presented in this 
thesis, SCID mice recipients were chosen as the classical model for xenograft studies. Also, 
implantations were performed at an ectopic site instead of a bone defect, to mitigate the effect 
of osteoinductive signals intrinsically present at the bone compartment, and to more specifically 
evaluate the direct impact of OGP analogues on hMSCs.  
In future studies it will be essential to test the proposed system using clinically relevant 
models, such as critical-sized bone defects or bone fractures, where the effect of locally 
delivered OGP may be even potentiated by the adjuvant action of osteoinductive stimuli, 
naturally present in the bone compartment. An evaluation at later time points will also be 
important to clearly detect new bone formation. The capacity of OGP peptides to also induce 
neo-vessel formation was unexpected but particularly interesting given that bone regeneration is 
strongly dependent of adequate vascularization, and therefore should be further investigated. A 
deeper analysis of local and systemic OGP effects on the host is also important. As previously 
recognized, one limitation of the study was that all groups have been implanted in the same 
animal. Therefore, it remained unclear whether OGP released from alginate hydrogels entered 
the circulation, having a systemic effect at distal sites. Moreover, the study was mainly focused 
on the local effect of the OGP-delivery system on transplanted MSCs, and not on host cells. 
This will be particularly relevant when implanting OGP-hydrogels at the bone compartment. The 
use of labeled peptides could be useful to trace their biodistribution in relevant tissues/organs. 
Finally, although these materials are able to form hydrogels in situ, they have been 
implanted as pre-formed discs due to technical constraints, and their injectability profile upon in 
vivo administration was not adequately evaluated. However, preliminary studies, both ex vivo 
and in vivo showed that alginate hydrogels could be easily injected, using a standard syringe, 
into critical-sized femoral defects created in the rat, and then crosslink in situ after 
approximately 5 min post injection. In this context, it should be highlighted that this type of 
injectable biomaterials would only be appropriate for the clinical management of small-sized 
defects. Nevertheless, these hydrogels can be combined with other biomaterials to obtain 
mechanically compatible scaffolds for the repair of large bone defects. One possibility relies in 
preparing injectable hybrid systems, currently under investigation in our group, where hydrogels 
are reinforced with ceramic components [8-10]. 
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